A Protocol for Couples' Microbiome Analysis: Linking Microbial Transmission to Health Outcomes in Biomedical Research

Dylan Peterson Nov 27, 2025 431

This article presents a comprehensive protocol for the analysis of couples' microbiomes, detailing a reproducible framework to study the couple as the analytical unit.

A Protocol for Couples' Microbiome Analysis: Linking Microbial Transmission to Health Outcomes in Biomedical Research

Abstract

This article presents a comprehensive protocol for the analysis of couples' microbiomes, detailing a reproducible framework to study the couple as the analytical unit. It covers the foundational evidence for microbial convergence between partners, a rigorous methodological pipeline for multi-site microbiome analysis using public datasets, and strategies for troubleshooting and data validation. Aimed at researchers, scientists, and drug development professionals, the content explores how dyadic analytics and strain-resolved transmission metrics can advance hypotheses on person-to-person microbial transmission and its relevance for preconception care, fertility optimization, and chronic disease management. The protocol emphasizes the use of standardized tools like MetaPhlAn and HUMAnN for functional profiling and outlines analytical approaches, including partner-interdependence models, to uncover associations with reproductive, metabolic, and child health outcomes.

The Couple as a Microbial Unit: Exploring Transmission, Similarity, and Health Links

Evidence for Microbial Sharing in Cohabiting Partners Across Body Sites

The human microbiome, a complex ecosystem of microorganisms inhabiting various body sites, is now recognized as a key factor in health and disease. Emerging evidence indicates that this microbial community is not static but is influenced by close interpersonal contact. Cohabiting partners, through sustained physical interaction and shared environments, develop distinctly similar microbiomes across gut, oral, skin, and genital sites—a phenomenon termed the "social microbiome" [1]. This convergence has profound implications for understanding health outcomes that manifest at a dyadic level, including reproductive health, metabolic conditions, and immune-mediated diseases. This Application Note synthesizes current evidence for microbial sharing between partners and provides detailed protocols for researchers investigating couple-based microbiome dynamics within clinical and translational research settings.

Body Site-Specific Evidence and Quantitative Data

Microbial sharing between cohabiting partners follows distinct patterns across different body sites, influenced by transmission routes, contact frequency, and microbial ecology.

Gut Microbiome

The gut microbiome demonstrates significant, though moderate, convergence between partners. Spouses exhibit more similar gut microbiota compositions and share more bacterial taxa than siblings or unrelated individuals, even after accounting for shared diet [1] [2]. A landmark strain-level analysis of over 9,700 metagenomes revealed that cohabiting partners share a median of 12% of gut microbial strains [3]. This transmission occurs horizontally between partners, with strain sharing rates between cohabiting individuals significantly higher than between non-cohabiting adults in the same village [3]. Furthermore, married individuals harbor greater gut microbial diversity and richness compared to those living alone, with the highest diversity observed in couples reporting very close relationships [1] [2].

Oral Microbiome

The oral cavity represents a hotspot for microbial transmission between partners. Intimate contact, particularly kissing, facilitates rapid microbial exchange, with a single 10-second intimate kiss potentially transferring approximately 80 million bacteria [1]. This direct contact results in significantly higher strain sharing in cohabiting partners, with a median sharing rate of 32% for oral microbiomes [3]. The duration of cohabitation strongly influences oral microbiome similarity, suggesting continuous exchange and establishment of shared strains over time [3].

Skin Microbiome

Skin surfaces demonstrate the most pronounced partner effects due to direct contact and shared environmental exposures. Partners' skin microbiomes are significantly more similar to each other than to those of unrelated individuals, with algorithms capable of identifying couples with approximately 86% accuracy based solely on skin microbiome similarity [1]. The strongest convergence occurs on the feet, likely due to walking barefoot on shared surfaces, while gender-specific differences persist in areas like the inner thighs [1]. Regular physical contact within shared environments fosters consistent microbial exchange on skin surfaces [4].

Reproductive Microbiome

The genital microbiome exhibits clinically significant sharing patterns with direct health implications. Studies on bacterial vaginosis (BV) demonstrate that male partners can harbor BV-associated bacteria that contribute to recurrence in female partners [1]. A clinical trial showed that treating both partners reduced BV recurrence to 35% compared to 63% when only the woman was treated [1], underscoring the importance of couple-focused approaches for microbiome-mediated reproductive conditions.

Table 1: Quantitative Evidence for Microbial Sharing Between Cohabiting Partners Across Body Sites

Body Site Similarity Metric Key Findings Primary Transmission Route
Gut Median strain-sharing rate: 12% [3] Spouses more similar than siblings; Increased diversity in married individuals [1] [2] Horizontal, environmental
Oral Median strain-sharing rate: 32% [3] ~80 million bacteria transferred per 10-second kiss [1]; Similarity increases with cohabitation duration [3] Direct contact (kissing)
Skin Couple identification accuracy: 86% [1] Strongest convergence on feet; Gender-specific patterns in some areas [1] Direct contact & shared surfaces
Reproductive BV recurrence reduction: 44% (35% vs. 63%) with partner treatment [1] Sharing of BV-associated bacteria; Partner treatment crucial for preventing recurrence [1] Intimate contact

Methodological Framework for Couples' Microbiome Analysis

Sample Collection and Processing

Comprehensive couples' microbiome studies require standardized protocols for multi-site sampling:

  • Sample Types: Collect paired samples from partners across gut (stool), oral (saliva, mucosal swabs), skin (multiple sites), and reproductive (vaginal, penile) niches [1] [5].
  • Temporal Design: Implement longitudinal sampling to capture stability and dynamics of shared microbes, with consideration for menstrual cycle phases in female participants [5].
  • Metadata Collection: Document cohabitation duration, intimacy behaviors, shared activities, dietary patterns, health status, and medication use [1] [2].

Table 2: Essential Research Reagents and Platforms for Couples' Microbiome Studies

Category Specific Tools/Reagents Application in Couples' Microbiome Research
Sequencing Platforms Shotgun metagenomics; 16S rRNA amplicon sequencing Comprehensive strain-level profiling; Cost-effective community profiling [1] [3]
Bioinformatic Tools MetaPhlAn 4; HUMAnN 3; StrainPhlAn; inStrain; QIIME 2/DADA2 Species profiling; Pathway analysis; Strain-level tracking; Amplicon processing [1] [3]
Analytical Frameworks Actor-Partner Interdependence Models; Mixed-effects models; PERMANOVA Dyadic data analysis; Accounting for non-independence within couples; Testing group differences [1] [2]
Specialized Reagents Host depletion kits; Standardized swab kits; DNA extraction kits Enhancing microbial sequencing depth; Standardized sample collection; High-yield DNA isolation [1] [6]
Analytical Workflow

The analytical pipeline for couples' microbiome data involves both standard microbiome analyses and specialized approaches for dyadic data:

G Raw Sequencing Data Raw Sequencing Data Quality Control & Preprocessing Quality Control & Preprocessing Raw Sequencing Data->Quality Control & Preprocessing Metagenomic Assembly Metagenomic Assembly Quality Control & Preprocessing->Metagenomic Assembly Taxonomic Profiling (MetaPhlAn 4) Taxonomic Profiling (MetaPhlAn 4) Quality Control & Preprocessing->Taxonomic Profiling (MetaPhlAn 4) Strain-Level Analysis (StrainPhlAn/inStrain) Strain-Level Analysis (StrainPhlAn/inStrain) Metagenomic Assembly->Strain-Level Analysis (StrainPhlAn/inStrain) Functional Profiling (HUMAnN 3) Functional Profiling (HUMAnN 3) Taxonomic Profiling (MetaPhlAn 4)->Functional Profiling (HUMAnN 3) Similarity Metrics (Beta-diversity) Similarity Metrics (Beta-diversity) Taxonomic Profiling (MetaPhlAn 4)->Similarity Metrics (Beta-diversity) Strain Sharing Quantification Strain Sharing Quantification Strain-Level Analysis (StrainPhlAn/inStrain)->Strain Sharing Quantification Dyadic Statistical Models Dyadic Statistical Models Similarity Metrics (Beta-diversity)->Dyadic Statistical Models Strain Sharing Quantification->Dyadic Statistical Models Network Analysis & Visualization Network Analysis & Visualization Dyadic Statistical Models->Network Analysis & Visualization

Strain-Level Transmission Analysis

Definitive evidence for microbial sharing requires strain-level resolution:

  • Strain Identification: Use normalized phylogenetic distance (nGD) thresholds to distinguish shared strains from unrelated individuals, with thresholds set to minimize false positives (<5%) [3].
  • Food-Derived Strain Filtering: Exclude strains with high similarity to microorganisms from commercial fermented foods (e.g., Bifidobacterium animalis) to focus on human-to-human transmission [3].
  • Transmission Quantification: Calculate strain-sharing rates as the proportion of shared strains normalized by the number of species profiled in common between individuals [3].

Health Implications and Clinical Applications

The clinical significance of couples' microbiome sharing spans multiple health domains:

Reproductive Health and Fertility

The reproductive microbiome significantly influences fertility and pregnancy outcomes. Dysbiosis in the vaginal microbiome has been associated with increased susceptibility to sexually transmitted infections, early miscarriage, and preterm birth [5] [7]. The couple-based approach is essential, as male partners harbor BV-associated bacteria that can lead to recurrence in female partners [1]. Current research is investigating the role of gut, oral, and reproductive microbiomes in endometriosis and recurrent pregnancy loss [5].

Chronic Disease Risk

Couples often share similar risks for metabolic conditions, potentially mediated by microbiome convergence. Shared dietary patterns and microbial exchange may contribute to correlated metabolic profiles between partners [1]. The gut microbiome influences energy harvest and metabolism, suggesting that dysbiosis in one partner could potentially influence metabolic disease risk in the other [1].

Therapeutic Implications

Microbiome-based interventions require consideration of partner dynamics:

  • Partner-Inclusive Treatment: For conditions like bacterial vaginosis, treating both partners significantly reduces recurrence rates [1].
  • Live Biotherapeutic Products: Developing LBPs that consider the couple's shared microbial ecosystem may enhance efficacy [8] [6].
  • Preconception Care: Optimizing both partners' microbiomes before conception may improve reproductive outcomes and early-life microbiome seeding [1].

The evidence for extensive microbial sharing between cohabiting partners across body sites establishes the couple as a relevant biological unit for microbiome research. Quantitative data demonstrates significant strain sharing (median 12% gut, 32% oral), with profound implications for understanding and treating health conditions that manifest at the dyadic level. The methodological framework presented here provides researchers with comprehensive tools for investigating the couples' microbiome, from experimental design through advanced bioinformatic analysis. Future research directions should focus on longitudinal studies mapping microbial transmission dynamics, intervention trials targeting the couple unit, and integrating multi-omic data to elucidate mechanisms linking shared microbiomes to health outcomes.

Within the framework of research on couples' microbiomes and health outcomes, quantifying the convergence of microbial strains between partners across different body sites is a critical step. This protocol details the methodologies for measuring strain-sharing rates, a key metric for inferring microbial transmission between cohabiting individuals. The convergence of gut, oral, and skin microbiomes in couples is well-documented, with studies showing that cohabiting partners harbor more similar microbial communities than unrelated individuals [1]. This sharing arises from sustained close contact, a shared environment, and intimate behaviors, and has implications for understanding dyadic health outcomes [1] [9]. The following sections provide a structured quantitative overview, detailed experimental protocols, and a standardized workflow for quantifying this strain-sharing.

Strain-sharing rates vary significantly by body site, type of relationship, and behavioral factors. The tables below summarize key quantitative findings from recent large-scale studies.

Table 1: Strain-Sharing Rates by Relationship Type and Body Site

Relationship Type Median Gut Microbiome Strain-Sharing Rate Median Oral Microbiome Strain-Sharing Rate Key Context and Notes
Spouses/Partners 13.9% [10] ~32% [1] Highest strain-sharing observed; used as a baseline for other comparisons.
Same-Household 13.8% [10] Information Missing Includes familial and non-familial cohabitants.
Non-Kin, Different Households 7.8% [10] Information Missing Demonstrates sharing extends beyond the household via social networks.
Same Village (No Direct Tie) 4.0% [10] Information Missing Suggests background sharing from shared environments.
Different Villages 2.0% [10] Information Missing Serves as a baseline for minimal contact.

Table 2: Impact of Behavioral Factors on Strain-Sharing

Behavioral Factor Impact on Strain-Sharing Rate Key Context and Notes
Meal Sharing Frequency Increased sharing with higher frequency (Kruskal-Wallis test, χ² = 194.25, P < 2.2 × 10⁻¹⁶) [10] Effect holds even after excluding kin and cohabitation effects [10].
Time Spent Together Increased sharing with higher frequency (Kruskal-Wallis test, χ² = 105.45, P < 2.2 × 10⁻¹⁶) [10] A gradient is observed from daily to monthly interaction [10].
Greeting with a Kiss Median strain-sharing rate of 12.9% [10] Indicates the role of intimate physical contact in oral microbiome transmission [1] [10].

Experimental Protocols for Strain-Sharing Analysis

This section outlines a detailed, step-by-step protocol for a couple-level, multi-site microbiome analysis, adapted from current methodologies [1] [10].

Sample Collection and Metadata Acquisition

  • Participant Recruitment: Recruit couples (and other family members, if applicable), ensuring informed consent is obtained. Include detailed questionnaires to capture metadata.
  • Sample Collection: Collect samples from multiple body sites:
    • Gut: Fresh fecal samples, using standardized collection kits.
    • Oral: Saliva or buccal swabs.
    • Skin: Swabs from specific sites (e.g., forearms, feet).
  • Metadata Collection: Record comprehensive metadata for each participant and dyad:
    • Individual: Age, sex, diet, medication use (especially antibiotics), health status.
    • Dyadic: Relationship type (partner, sibling, etc.), cohabitation duration and status, frequency of physical contact (kissing, hand-holding), meal-sharing habits, greeting styles.

DNA Sequencing and Data Preprocessing

  • DNA Extraction: Perform microbial DNA extraction from all samples using a commercially available kit suitable for the specific sample type (e.g., soil kit for stool) to ensure broad lysis of microbial cells.
  • Library Preparation and Sequencing: Utilize shotgun metagenomic sequencing for strain-level resolution. Prepare libraries and sequence on a platform such as Illumina to a recommended depth of >10 million reads per sample.
  • Quality Control and Host Depletion:
    • Process raw sequencing reads (FASTQ files) through a quality control pipeline (e.g., FastQC).
    • Remove adapter sequences and low-quality reads (using tools like Trimmomatic or fastp).
    • Deplete host-derived reads using a alignment-based tool (e.g., Bowtie2) against a host genome (e.g., GRCh38) to enrich for microbial sequences [1] [11].

Metagenomic Profiling and Strain-Sharing Quantification

  • Taxonomic and Functional Profiling:
    • Profile the microbial community composition using a tool like MetaPhlAn 4 [1], which uses clade-specific marker genes to provide accurate taxonomic abundance estimates at the species level.
    • Perform functional profiling of metabolic pathways using HUMAnN 3 [1], which maps reads to a database of gene families (e.g., UniRef90) and then to metabolic pathways (e.g., MetaCyc).
  • Strain-Level Profiling and Sharing Quantification:
    • Identify and compare strains between samples using StrainPhlAn [10] or inStrain [1].
    • StrainPhlAn extracts and aligns marker genes from specific species present in multiple samples to build phylogenetic trees and assess strain-level relatedness.
    • Calculate the strain-sharing rate for each dyad. This metric is defined as the number of shared strains divided by the number of species with available strain profiles that are present in both samples [10]. Apply stringent thresholds for strain identity (e.g., Average Nucleotide Identity, ANI > 99.9%) and genome coverage to minimize false positives [1].

Statistical and Dyadic Analysis

  • Similarity Metrics: Calculate beta-diversity (community dissimilarity) using metrics like Bray-Curtis dissimilarity and Jaccard index from species-level relative abundances [10].
  • Dyadic Contrasts: Use permutation tests to compare beta-diversity and strain-sharing rates within couples against randomly assigned pairs from the same population [1] [10].
  • Modeling: Employ linear mixed-effects models to assess the association between strain-sharing and relationship ties, while adjusting for confounders such as diet, age, and medication use [10]. The unit of analysis is the dyad (couple).

Workflow for Strain-Sharing Quantification

The following diagram illustrates the end-to-end workflow for processing samples and quantifying strain sharing between individuals, integrating the protocols described above.

G Strain-Sharing Analysis Workflow cluster_1 1. Sample & Metadata Collection cluster_2 2. Laboratory Processing cluster_3 3. Bioinformatic Analysis cluster_4 4. Quantification & Statistics A Recruit Couples B Collect Samples: - Gut (Stool) - Oral (Saliva) - Skin (Swab) A->B C Gather Metadata: - Diet, Medications - Cohabitation Duration - Intimate Behaviors B->C D Microbial DNA Extraction C->D E Shotgun Metagenomic Sequencing D->E F Quality Control & Host Read Depletion E->F G Species Profiling (MetaPhlAn 4) F->G H Strain-Level Profiling (StrainPhlAn / inStrain) G->H I Calculate Strain-Sharing Rate: Shared Strains / Total Profiled Species H->I J Dyadic Analytics: Permutation Tests Mixed-Effects Models I->J K Output: Strain-Sharing Metrics & P-Values J->K

Research Reagent Solutions

The following table lists essential software and database resources required for implementing the strain-sharing analysis protocol.

Table 3: Essential Research Reagents and Computational Tools

Tool/Resource Name Function in Protocol Key Features
MetaPhlAn 4 [1] Taxonomic Profiling Uses clade-specific marker genes for precise species-level abundance estimation from metagenomic data.
StrainPhlAn [10] Strain-Level Profiling Infers strain-level genotypes and identifies shared strains across samples from marker gene sequences.
inStrain [1] Strain-Level Profiling Quantifies strain-level variation and compares population genetics (e.g., ANI) between sample pairs.
HUMAnN 3 [1] Functional Profiling Profiles the abundance of microbial metabolic pathways in a community from metagenomic data.
COBRA Toolbox & MicroMap [12] Metabolic Network Visualization Visualizes the metabolic capabilities of microbial communities and explores microbiome metabolism in a systems context.
AGORA2 Resource [12] Metabolic Modeling Provides a resource of curated, strain-level metabolic reconstructions of human gut microbes.
MicrobiomeAnalyst [13] Statistical Analysis & Visualization A user-friendly web platform for comprehensive statistical, functional, and visual analysis of microbiome data.

A growing body of evidence indicates that the gut microbiome may serve as a key biological mechanism linking social relationships to health outcomes [2]. Longitudinal studies, which collect data from the same subjects over extended periods, are particularly valuable for elucidating the dynamic interplay between social factors and the gut ecosystem. This Application Note synthesizes findings from key longitudinal research, with a specific focus on couples' microbiomes, and provides detailed experimental protocols for investigating these relationships. The content is framed within a broader thesis on analysis of couples' microbiomes and health outcomes protocol research, providing methodological guidance for researchers in this emerging field.

Key Quantitative Findings from Longitudinal Studies

Table 1: Summary of Key Quantitative Findings on Social Relationships and Gut Microbiota

Study Factor Measured Outcome Key Quantitative Result Statistical Significance Notes
Spousal Cohabitation [2] Microbiota similarity (vs. siblings/unrelated) Spouses showed significantly higher similarity and more shared bacterial taxa P-value reported as significant Held after controlling for dietary factors
Relationship Closeness [2] Gut microbial diversity & richness Highest diversity in couples reporting "close" relationships; no significant difference for "somewhat close" vs. unrelated Shannon P=0.005; Chao P=0.011 Linked to known health benefits of high-quality relationships
Marital Distress & Depression [14] Gut microbial diversity & richness Increase in depressive symptoms associated with a decrease in diversity and richness Longitudinal correlation Pathway from marital distress to health risk
Marital Distress [14] Gut permeability (Lipopolysaccharide-binding protein - LBP) Lower relationship satisfaction predicted increases in LBP Longitudinal correlation Reflects bacterial endotoxin translocation, fueling inflammation
Social Interactions (Non-cohabiting) [2] Gut microbial diversity & richness Socialness with family/friends predicted diversity Unweighted UniFrac P=0.0030; Shannon P=0.042 Weaker effect in already diverse microbiomes of cohabiting spouses

Detailed Experimental Protocols

Protocol 1: Investigating Couple Similarity in Gut Microbiota

This protocol is adapted from methodologies used in the Wisconsin Longitudinal Study (WLS) and other couple-based research [2] [1].

1. Research Question and Hypothesis:

  • Question: Do cohabiting spouses have more similar gut microbiota compositions than sibling pairs or unrelated individuals, independent of diet?
  • Null Hypothesis (H₀): There is no difference in gut microbiota similarity between spousal pairs, sibling pairs, and unrelated pairs.
  • Alternative Hypothesis (H₁): Spousal pairs have significantly more similar gut microbiota than sibling or unrelated pairs [2].

2. Experimental Design:

  • Design Type: Cross-sectional comparison with control for confounding variables.
  • Groups:
    • Target Pairs: Cohabiting spousal/partner pairs (N=94 pairs in WLS) [2].
    • Control Pairs 1: Sibling pairs (N=83 pairs in WLS) [2].
    • Control Pairs 2: Unrelated, non-cohabiting individuals (demographically matched).
  • Key Variables:
    • Independent Variable: Pair type (spouse, sibling, unrelated).
    • Dependent Variable: Gut microbiota similarity (Bray-Curtis dissimilarity, Jaccard index, Unweighted/Weighted UniFrac distance).
    • Covariates: Age, sex, dietary protein intake, antibiotic use, chronic conditions (e.g., diabetes, heart disease) [2].

3. Subject Recruitment and Sample Collection:

  • Recruitment: Utilize established longitudinal cohorts (e.g., WLS) or recruit community-based couples and siblings [2].
  • Inclusion/Exclusion: Exclude participants with recent antibiotic use (e.g., past 4-8 weeks), immune disorders, inflammatory bowel disease, and other major GI conditions [14].
  • Sample: Collect fecal samples from all participants using standardized home-collection kits, immediately frozen at -20°C or -80°C until processing.

4. Microbiome Profiling (16S rRNA Gene Sequencing):

  • DNA Extraction: Use a standardized kit (e.g., QIAGEN DNeasy PowerSoil Kit) for all samples.
  • Library Preparation: Amplify the V4 region of the 16S rRNA gene using primers (e.g., 515F/806R). Use a platform such as Illumina MiSeq.
  • Bioinformatics Processing:
    • Processing Pipeline: Use QIIME 2 or mothur.
    • Sequence Quality Control: Denoise, cluster sequences into Amplicon Sequence Variants (ASVs) or Operational Taxonomic Units (OTUs).
    • Taxonomy Assignment: Assign taxonomy using a reference database (e.g., SILVA or Greengenes).

5. Data Analysis:

  • Similarity Calculation: Calculate within-pair microbiota similarity for each group using Bray-Curtis, Jaccard, and UniFrac metrics.
  • Statistical Comparison: Use Permutational Multivariate Analysis of Variance (PERMANOVA) to test for significant similarity within spousal pairs versus other groups. Employ linear mixed-effects models to account for covariates and non-independence of pairs.
  • Diversity Analysis: Compare alpha diversity (Shannon, Chao1) between married and unmarried individuals using t-tests or linear models.

G start Define Cohort & Pairs recruit Participant Recruitment & Screening start->recruit collect Stool Sample Collection (Home Kit, -80°C Storage) recruit->collect dna DNA Extraction (PowerSoil Kit) collect->dna seq 16S rRNA Library Preperation & Sequencing (Illumina) dna->seq process Bioinformatic Processing (QIIME 2 / mothur) seq->process analyze Data Analysis: Similarity, Diversity, Statistical Testing process->analyze result Result: Couple Microbiome Similarity & Diversity analyze->result

Protocol 2: Longitudinal Analysis of Relationship Quality, Depression, and Gut Health

This protocol is based on a longitudinal study examining the impact of marital quality on gut microbiota and permeability [14].

1. Research Question and Hypothesis:

  • Question: Does lower marital quality predict increases in depressive symptoms, which in turn lead to decreases in gut microbial diversity and increases in gut permeability?
  • Hypothesis: Lower baseline relationship satisfaction will predict increases in depressive symptoms over time, and these increases will be associated with decreased gut microbial diversity/richness and increased gut permeability (LBP) [14].

2. Experimental Design:

  • Design Type: Longitudinal repeated-measures.
  • Timeline: Two or more assessment waves, approximately 3 months apart (e.g., M=90 days in source study) [14].
  • Key Variables:
    • Predictor: Baseline relationship satisfaction (Couples Satisfaction Index, CSI).
    • Mediator: Change in depressive symptoms (Center for Epidemiological Studies Depression Scale, CES-D).
    • Outcomes: Change in gut microbiota alpha diversity (Shannon, Richness) and change in gut permeability (serum LBP levels).

3. Subject Recruitment and Data Collection:

  • Recruitment: 143 couples (excluding same-sex couples for specific analytical models) [14].
  • Measures per Visit:
    • Questionnaires: CSI, CES-D, health behaviors (diet, alcohol, smoking, physical activity).
    • Biological Samples: Fecal sample for microbiome analysis, blood sample for LBP assay.

4. Laboratory Methods:

  • Microbiome Profiling: As described in Protocol 1, section 4.
  • Gut Permeability Assay: Measure Lipopolysaccharide-Binding Protein (LBP) in serum using a commercial enzyme-linked immunosorbent assay (ELISA) kit.

5. Statistical Analysis:

  • Primary Analysis: Use longitudinal mixed-effects models to test if baseline CSI predicts change in CES-D, and if change in CES-D predicts change in diversity/richness/LBP.
  • Mediation Analysis: Test the indirect effect of relationship satisfaction on gut outcomes via depressive symptoms.
  • Covariate Control: Control for age, sex, BMI, baseline health behaviors, and medication use (e.g., antidepressants).

G A Baseline: Low Relationship Satisfaction (CSI) B Follow-up: Increase in Depressive Symptoms (CES-D) A->B Longitudinal Prediction C Follow-up: Decreased Gut Microbiota Diversity & Richness B->C Consequential Change D Follow-up: Increased Gut Permeability (Serum LBP) B->D Consequential Change

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Materials and Reagents for Microbiome-Couple Studies

Item Name Function/Application Example Product/Specification
Fecal Sample Collection Kit Standardized at-home collection and stabilization of stool microbial community. OMNIgene•GUT (DNA Genotek) or similar with stabilizer.
DNA Extraction Kit High-yield, bias-minimized microbial genomic DNA extraction from stool. QIAGEN DNeasy PowerSoil Pro Kit or MoBio PowerSoil Kit.
16S rRNA PCR Primers Amplification of target hypervariable regions for taxonomic profiling. 515F (5'-GTGYCAGCMGCCGCGGTAA-3') / 806R (5'-GGACTACNVGGGTWTCTAAT-3') for V4 region.
High-Sensitivity ELISA Kit Quantification of gut permeability marker LBP in serum/plasma. Human LBP ELISA Kit (e.g., Hycult Biotech).
Next-Gen Sequencing Platform High-throughput sequencing of 16S rRNA amplicons. Illumina MiSeq System (for 16S).
Bioinformatics Software Processing, analyzing, and visualizing sequencing data. QIIME 2 (Quantitative Insights Into Microbial Ecology).
Validated Psychometric Scales Quantifying relationship quality and depressive symptoms. Couples Satisfaction Index (CSI), Center for Epidemiological Studies Depression Scale (CES-D).

The Interplay of Marital Dynamics, Shared Stress, and Health Behaviors on Microbiome Profiles

A growing body of evidence suggests that the gut microbiome serves as a crucial biological interface between social relationships and physical health. Married individuals generally experience better health outcomes and greater longevity than their unmarried counterparts, benefits historically attributed to psychosocial support and shared health behaviors [15]. However, emerging research indicates that cohabiting partners share more similar microbiomes across gut, oral, skin, and genital sites than unrelated individuals, with metagenomic studies demonstrating measurable strain sharing (median ~12% gut; ~32% oral) that scales with duration of cohabitation [1]. This microbial convergence creates a "social microbiome" with direct implications for reproductive, metabolic, and immune health outcomes within couples. This protocol outlines comprehensive methodologies for investigating how marital dynamics, shared stress, and coordinated health behaviors influence this shared microbial ecosystem, providing a framework for future therapeutic interventions.

Theoretical Framework and Key Evidence

The Dyadic Biobehavioral Stress Model

The Dyadic Biobehavioral Stress Model provides a conceptual framework for understanding how partners "get under each other's skin" to influence psychological, behavioral, and biological health [15]. This model posits that marital stress alters endocrine, cardiovascular, and immune function—key pathways connecting troubled relationships to poor health. The model further suggests that the way couples manage stress—rather than the stress itself—may confer health risks or benefits across the lifespan [15]. Within this model, the microbiome represents a novel biological pathway through which dyadic stress processes become biologically embedded.

Empirical Evidence for Microbial Sharing in Couples

Recent studies have quantified the extent of microbial similarity between cohabiting partners, demonstrating that intimate relationships significantly influence microbial composition and diversity.

Table 1: Quantitative Evidence of Microbial Similarity in Couples

Body Site Similarity Metric Effect Size/Findings Reference
Gut Strain Sharing Median ~12% shared strains [1]
Oral Strain Sharing Median ~32% shared strains [1]
Skin Identification Accuracy ~86% accuracy in identifying couples based on skin microbiome [1]
Gut Diversity Married individuals show greater microbial diversity and richness than those living alone [2]
Gut Relationship Quality Closer marital relationships associated with greatest microbial diversity [2]
Feet Microbial Similarity Most pronounced similarity due to shared environments [1]

Analysis of spouse and sibling pairs within the Wisconsin Longitudinal Study revealed that spouses have more similar microbiota and more bacterial taxa in common than siblings, with these differences persisting even after accounting for dietary factors [2]. Notably, the differences between unrelated individuals and married couples were driven entirely by couples reporting close relationships; couples reporting somewhat close relationships showed no significant differences in microbial similarity compared to unrelated individuals [2].

Experimental Protocols

Comprehensive Multi-Site Microbiome Sampling Protocol

Objective: To characterize microbial composition across multiple body sites in couples, accounting for relationship dynamics and health behaviors.

Sample Collection Materials:

  • Sterile fecal collection tubes (DNA/RNA shield)
  • Copan FLOQSwabs for vaginal/oral/skin sampling
  • DNA/RNA preservation solution
  • Barcoded cryovials for tissue biopsies (endometrial)
  • Standardized dietary and stress questionnaires
  • Cold chain packaging for transport

Procedure:

  • Participant Recruitment: Recruit couples meeting inclusion criteria (cohabitation >1 year, age 25-65). Include detailed assessment of relationship quality using standardized metrics (Dyadic Adjustment Scale).
  • Simultaneous Sampling: Collect samples from both partners within 2-hour window to control for diurnal variation.
  • Multi-site Collection:
    • Fecal: Participants collect first-morning stool using DNA-stabilizing collection kit
    • Oral: Swab subgingival and buccal mucosa for 30 seconds each
    • Vaginal: Swab mid-vaginal wall avoiding cervical mucus
    • Skin: Swab predetermined 4cm² area of forehead and volar forearm
    • Endometrial: (Clinic visit) Collect biopsy using Pipelle catheter during window of implantation
  • Questionnaire Administration: Administer comprehensive surveys assessing:
    • Perceived Stress Scale (PSS)
    • Dyadic Coping Inventory
    • Health Behavior Inventory (diet, exercise, sleep)
    • Recent antibiotic/probiotic use
  • Sample Processing: Immediately freeze samples at -80°C with aliquoting for different analyses (DNA, RNA, metabolomics).
Metagenomic Sequencing and Analysis Workflow

Objective: To process and analyze microbiome samples for taxonomic and functional profiling.

G A Raw Samples B DNA Extraction A->B C Quality Control B->C D Library Prep C->D E Shotgun Sequencing D->E F Bioinformatic Analysis E->F G Statistical Analysis F->G H Integration G->H

Sequencing Protocol:

  • DNA Extraction: Use MoBio PowerSoil DNA Isolation Kit with bead-beating step for mechanical lysis. Include extraction controls.
  • Quality Assessment: Verify DNA quality via fluorometry (Qubit) and fragment analysis (Bioanalyzer).
  • Library Preparation: Utilize Illumina DNA Prep kit with 350bp insert size. Amplify with dual-index barcodes.
  • Sequencing: Perform 2x150bp paired-end sequencing on Illumina NovaSeq platform targeting 20 million reads per sample.
  • Bioinformatic Processing:
    • Quality Filtering: Remove adapters and low-quality reads using Trimmomatic
    • Host Depletion: Map reads to human genome (hg38) using BWA and remove matching sequences
    • Taxonomic Profiling: Use MetaPhlAn 4 for species-level identification
    • Strain-Level Analysis: Apply StrainPhlAn for tracking shared strains between partners
    • Functional Profiling: Utilize HUMAnN 3 for pathway abundance analysis
  • Statistical Analysis:
    • Calculate alpha diversity (Shannon, Chao1) and beta diversity (Bray-Curtis, UniFrac)
    • Apply PERMANOVA for group differences
    • Use DESeq2 for differential abundance testing
    • Implement SPIEC-EASI for microbial network inference
Dyadic Statistical Analysis Framework

Objective: To model actor-partner effects in microbial similarity and health outcomes.

The Actor-Partner Interdependence Model (APIM) provides the statistical framework for examining how one partner's relationship experiences, health behaviors, and stress levels affect their own microbial composition (actor effects) and their partner's microbial composition (partner effects) [15]. This model accounts for the non-independence of data from couples and allows researchers to:

  • Test whether partners' microbial similarity predicts health outcomes
  • Examine whether relationship quality moderates microbial convergence
  • Investigate whether shared health behaviors mediate partner effects on microbial composition

Analysis should control for potential confounders including age, sex, antibiotics, dietary protein, and chronic health conditions [2].

The Scientist's Toolkit

Table 2: Essential Research Reagent Solutions for Couples Microbiome Studies

Category Specific Tool/Reagent Function/Application Key Features
Sequencing Technology Illumina Shotgun Sequencing Untargeted sequencing of all microbial genomes Enables species-level classification and functional profiling [16]
Bioinformatic Tools QIIME 2 / DADA2 Processing of marker gene (16S) data Quality filtering, OTU/ASV picking, taxonomy assignment [16]
Bioinformatic Tools MetaPhlAn 4 Profiling microbial composition from shotgun data Uses clade-specific marker genes for taxonomic assignment [1]
Bioinformatic Tools HUMAnN 3 Metabolic pathway reconstruction Quantifies abundance of microbial metabolic pathways [1]
Statistical Analysis MicrobiomeAnalyst Comprehensive statistical analysis platform User-friendly web interface for diverse microbiome analyses [13]
Statistical Methods DESeq2 / edgeR Differential abundance analysis Accounts for compositionality and overdispersion of microbiome data [17]
Statistical Methods Actor-Partner Interdependence Model Dyadic data analysis Models interdependence between partners' data [15]
Sample Collection DNA/RNA Shield Preservation Tubes Stabilizes microbial community during storage Preserves microbial composition without immediate freezing

Data Visualization and Interpretation Framework

Multi-Modal Data Integration Workflow

G A Microbiome Data E Multi-Omics Integration A->E B Relationship Metrics B->E C Health Behaviors C->E D Physiological Stress D->E F Pathway Analysis E->F G Network Modeling F->G H Health Outcomes G->H

Key Outcome Measures and Analytical Approaches

Table 3: Core Outcome Measures and Analytical Methods

Domain Primary Outcomes Analytical Methods Interpretation Focus
Microbial Composition Alpha/Beta diversity, Strain sharing rates, Taxonomic profiles PERMANOVA, DESeq2, StrainPhlAn Similarity between partners, association with relationship quality
Microbial Function Metabolic pathway abundance, Gene family representation HUMAnN 3, KEGG pathway analysis Functional convergence in couples, links to health phenotypes
Relationship Factors Marital satisfaction, Dyadic coping, Conflict frequency APIM, Mixed-effects models Actor and partner effects on microbial metrics
Health Behaviors Diet quality, Sleep synchrony, Physical activity Correlation analysis, Mediation models Behavioral pathways for microbial transmission
Health Outcomes Inflammatory markers, Metabolic parameters, Mental health Regression models, Network analysis Microbiome as mediator between relationships and health

Application Notes

Special Considerations for Couples Research
  • Temporal Dynamics: Sample couples during periods of high and low stress to capture dynamic changes in microbial synchrony
  • Confounding Control: Carefully document shared environmental exposures (pets, home environment) that may contribute to microbial similarity independent of relationship factors
  • Recruitment Strategy: Oversample discordant couples (high vs. low relationship quality) to enhance statistical power for detecting relationship-quality interactions
  • Ethical Considerations: Develop protocols for handling incidental findings of health relevance, particularly when one partner's results may have implications for the other
Translational Applications

The findings generated through these protocols have direct translational applications:

  • Couples-based interventions for microbiome-related conditions (e.g., bacterial vaginosis recurrence prevention) [1]
  • Dyadic approaches to weight management and metabolic health
  • Relationship-centered pre-conception care to optimize reproductive outcomes
  • Personalized probiotic and prebiotic strategies targeting the couple as a unit

This comprehensive protocol provides researchers with the methodological foundation to investigate the complex interplay between marital dynamics, shared stress, health behaviors, and couple-level microbiome profiles, advancing our understanding of the microbial pathways through which intimate relationships influence health.

The concept of the "social microbiome" has emerged as a critical factor in understanding shared health trajectories within close relationships. Cohabiting partners share more similar microbiomes across gut, oral, skin, and genital sites than unrelated individuals, creating a biological link that influences disease risk synchronization [1]. Modern metagenomic studies demonstrate that cohabiting partners exchange and maintain similar microbial strains, with median strain sharing of approximately 12% in the gut and 32% in the oral microbiome [1]. This microbial convergence scales with duration of cohabitation and intimacy levels, with algorithms able to identify couples with ~86% accuracy based solely on skin microbiome similarity [1]. This protocol outlines comprehensive methodologies for investigating how this microbial sharing contributes to correlated disease risks, with particular emphasis on metabolic and reproductive health outcomes.

Quantitative Evidence of Microbial Sharing and Health Associations

Table 1: Documented Microbial Similarity Between Cohabiting Partners Across Body Sites

Body Site Similarity Metric Magnitude Health Implications Citation
Gut Strain Sharing ~12% median Synchronized metabolic profiles, energy harvest [1]
Oral Strain Sharing ~32% median Synchronized salivary metabolome, periodontal health [1]
Skin Overall Similarity 86% couple identification accuracy Shared dermatological conditions, immune exposure [1]
Genital Microbial Convergence Significant BV recurrence, reproductive tract health [1] [18]

Table 2: Documented Health Correlations in Couples with Shared Microbiomes

Health Domain Observed Correlation Proposed Microbial Mechanism Evidence Level
Metabolic Health Correlated weight gain, insulin resistance Shared energy harvest efficiency, SCFA profiles Human observational studies [1] [19]
Reproductive Health BV recurrence, infertility synchrony Shared genital microbiota, reinfection cycles Clinical trials [1] [18]
Inflammation Markers Synchronized inflammatory tones Shared immune modulation, LPS translocation Human and animal studies [18] [2]
Mental Health Correlated stress responses Gut-brain axis metabolites, neurotransmitter production Emerging human data [20] [21]

Experimental Protocols for Couples' Microbiome Analysis

Sample Collection and Metadata Documentation

Protocol: Multi-site Longitudinal Sampling for Dyadic Analysis

  • Sample Collection Sites: Fecal (gut), saliva (oral), vaginal/penile swabs (genital), forearm/shin skin swabs (skin)
  • Collection Frequency: Baseline, 3-month, and 12-month intervals to assess temporal dynamics
  • Storage Conditions: Immediate freezing at -80°C in DNA/RNA shield buffer
  • Critical Metadata Documentation:
    • Cohabitation duration and intimacy behaviors (kissing frequency, sexual activity)
    • Shared dietary patterns and meal timing
    • Household characteristics (pets, cleaning products, living space square footage)
    • Health outcomes (weight, BMI, metabolic panels, reproductive health markers)
    • Medication use (particularly antibiotics, proton pump inhibitors) [1] [5]

Microbiome Profiling and Bioinformatics Workflow

Protocol: Multi-omics Integration for Couple-Level Analysis

  • DNA Extraction: Use MoBio PowerSoil DNA Isolation Kit with bead-beating step for mechanical lysis
  • Sequencing Approach:
    • 16S rRNA gene sequencing (V4 region) for community profiling
    • Shotgun metagenomics for strain-level resolution and functional potential
    • Metatranscriptomics for active community assessment (optional)
  • Bioinformatic Processing:
    • Quality control with FastQC and Trimmomatic
    • 16S analysis: DADA2 pipeline in QIIME 2 for ASV table generation
    • Shotgun analysis: KneadData for host depletion, MetaPhlAn 4 for taxonomic profiling, HUMAnN 3 for pathway abundance
    • Strain sharing: StrainPhlAn 3 and inStrain with stringent thresholds (ANI >99.5%, breadth >80%) [1]

Dyadic Statistical Analytics Framework

Protocol: Partner Similarity Quantification and Health Association Testing

  • Similarity Metrics:
    • Bray-Curtis dissimilarity for community structure
    • Jaccard similarity for shared taxa presence/absence
    • Pearson correlation for abundance patterns of specific taxa
  • Statistical Models:
    • Permutation tests for partner vs. non-partor similarity contrasts
    • Linear mixed-effects models accounting for household clustering
    • Actor-Partner Interdependence Models (APIM) for dyadic data analysis
    • Cross-lagged panel models for longitudinal directional influence [1] [2]

G cluster_0 Sample Types cluster_1 Analytical Approaches Sample Collection Sample Collection DNA Extraction DNA Extraction Sample Collection->DNA Extraction Multi-site samples Sequencing Sequencing DNA Extraction->Sequencing High-quality DNA Bioinformatics Bioinformatics Sequencing->Bioinformatics Raw sequences Statistical Analysis Statistical Analysis Bioinformatics->Statistical Analysis Processed data Strain Sharing Strain Sharing Bioinformatics->Strain Sharing Beta Diversity Beta Diversity Bioinformatics->Beta Diversity Pathway Analysis Pathway Analysis Bioinformatics->Pathway Analysis Network Modeling Network Modeling Bioinformatics->Network Modeling Interpretation Interpretation Statistical Analysis->Interpretation Statistical results Fecal Fecal Fecal->Sample Collection Saliva Saliva Saliva->Sample Collection Skin Swabs Skin Swabs Skin Swabs->Sample Collection Genital Swabs Genital Swabs Genital Swabs->Sample Collection

Diagram 1: Comprehensive Workflow for Couples' Microbiome Analysis. This workflow outlines the integrated multi-omics approach from sample collection through statistical interpretation for analyzing couples' microbiomes.

Mechanistic Pathways Linking Shared Microbiomes to Disease Risk

Metabolic Syndrome Pathways

Protocol: Assessing Gut-Reproductive Axis in Metabolic Dysregulation

The gut-reproductive axis represents a critical pathway through which shared microbiomes influence synchronized metabolic risks. Key mechanistic assessments include:

  • Short-Chain Fatty Acid (SCFA) Profiling:

    • Quantify acetate, propionate, and butyrate via GC-MS from fecal samples
    • Measure SCFA receptor expression (GPR41, GPR43) in peripheral blood mononuclear cells
    • Correlate SCFA levels with HPG axis hormone measurements (GnRH, FSH, LH) [18]
  • Intestinal Permeability Assessment:

    • Serum zonulin measurements as permeability marker
    • LPS-binding protein (LBP) quantification for metabolic endotoxemia
    • In vitro transepithelial electrical resistance (TEER) assays with couple-derived microbiota [18] [19]
  • Estrobolome Function Assay:

    • Quantify fecal β-glucuronidase activity via fluorescence-based assays
    • Measure estrogen metabolites (E1, E2, E3) in serum and feces
    • Correlate estrobolome activity with anthropometric measures and metabolic panels [18]

Reproductive Health Pathways

Protocol: Evaluating Bidirectional Influences on Reproductive Outcomes

  • Vaginal-Penile Microbial Exchange:

    • Strain tracking of Gardnerella, Prevotella spp. between partners
    • Anti-microbial resistance gene sharing assessment via metagenomics
    • In vitro biofilm formation assays with partner-derived isolates [1] [5]
  • Sperm Microbiome Analysis:

    • 16S sequencing of washed sperm samples
    • Correlation with sperm motility, morphology, and DNA fragmentation
    • Immunofluorescence localization of bacteria-sperm interactions [21]
  • Endometrial Microenvironment:

    • Endometrial fluid collection and cytokine profiling (IL-6, TNF-α, IL-10)
    • Microbiome-metabolome integration with LC-MS
    • Correlation with implantation success in fertility treatments [5] [21]

G cluster_0 Microbiome-Mediated Mechanisms Shared Gut Microbiome Shared Gut Microbiome SCFA Production SCFA Production Shared Gut Microbiome->SCFA Production Intestinal Permeability Intestinal Permeability Shared Gut Microbiome->Intestinal Permeability Estrobolome Activity Estrobolome Activity Shared Gut Microbiome->Estrobolome Activity Inflammatory Tone Inflammatory Tone Shared Gut Microbiome->Inflammatory Tone Metabolic Syndrome Metabolic Syndrome SCFA Production->Metabolic Syndrome Altered energy harvest Reproductive Dysfunction Reproductive Dysfunction SCFA Production->Reproductive Dysfunction HPG axis modulation Intestinal Permeability->Inflammatory Tone LPS translocation Estrobolome Activity->Metabolic Syndrome Estrogen disruption Estrobolome Activity->Reproductive Dysfunction Hormone imbalance Inflammatory Tone->Metabolic Syndrome Insulin resistance Inflammatory Tone->Reproductive Dysfunction Ovarian/testicular inflammation

Diagram 2: Gut-Reproductive Axis in Shared Disease Risk. This diagram illustrates the key mechanistic pathways through which shared gut microbiomes influence both metabolic and reproductive health outcomes in couples.

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Research Reagents for Couples' Microbiome Studies

Reagent/Kit Application Key Features Protocol Considerations
MoBio PowerSoil DNA Isolation Kit Microbial DNA extraction Efficient lysis of Gram-positive bacteria, inhibitor removal Include positive extraction controls; process partner samples in same batch
ZymoBIOMICS Microbial Community Standard Sequencing controls Defined bacterial composition, quality control Include in each sequencing run to assess technical variability
HUMAnN 3 Software Metabolic pathway analysis Quantifies molecular pathways from metagenomic data Normalize by copies per million for cross-sample comparison
StrainPhlAn 3 Strain-level profiling Identifies conspecific strains across samples Use default parameters then apply stringent filtering (ANI>99.5%)
Custom SCFA Standards (Sigma) Metabolite quantification GC-MS calibration for acetate, propionate, butyrate Derivatize samples immediately after collection
Zonulin ELISA Kit (Immundiagnostik) Intestinal permeability Quantifies human zonulin in serum Process samples within 2 hours of collection

  • Experimental Notes: Always process paired couple samples simultaneously to minimize batch effects. Include extraction blanks and positive controls in each processing batch. For longitudinal studies, maintain identical reagent lots across timepoints where possible.

Application to Therapeutic Development and Precision Medicine

Couple-Focused Intervention Strategies

Protocol: Designing Dyadic Microbiome-Targeted Interventions

  • Preconception Optimization:

    • Synchronized probiotic regimens (Lactobacillus, Bifidobacterium strains) for both partners
    • Shared dietary interventions targeting microbial diversity increase
    • FMT synchronization for couples with severe dysbiosis [21] [19]
  • Metabolic Health Synchronization:

    • Partner-inclusive Mediterranean diet implementation
    • Synchronized physical activity regimens to modulate microbial rhythms
    • Dual-targeted prebiotic (inulin-type fructans) supplementation [20] [19]
  • Breaking Cycles of Reinfection:

    • Concurrent antibiotic treatment for conditions like bacterial vaginosis
    • Partner-inclusive topical microbiome restoration therapies
    • Household environment modification to reshape shared microbial reservoirs [1] [18]

Pharmacomicrobiomics Considerations for Couples

Protocol: Assessing Microbiome-Mediated Drug Response in Dyads

  • Drug-Microbiome Interaction Screening:

    • In vitro incubation of partner-derived microbiota with target therapeutics
    • Quantification of microbial biotransformation products via LC-MS/MS
    • Assessment of microbial β-glucuronidase, β-lyase activities toward drugs [22] [23]
  • Personalized Dosing Adjustments:

    • Account for shared microbial metabolic capacity in drug prescribing
    • Consider couple-level microbiome profiles for medication selection
    • Monitor therapeutic drug levels in both partners when using highly microbiome-dependent drugs [22] [23]

Table 4: Drugs with Documented Microbiome-Mediated Metabolism Relevant to Couples' Health

Drug Therapeutic Class Microbial Biotransformation Clinical Impact
Sulfasalazine Anti-inflammatory (IBD) Azo-reduction to 5-ASA Activation requires specific gut bacteria [22]
Levodopa Anti-Parkinson Dehydroxylation, decarboxylation Reduced bioavailability [22]
Digoxin Cardiac glycoside Reduction by Eggerthella lenta Inactivation, reduced efficacy [22]
Acetaminophen Analgesic Competitive sulfonation Altered metabolism, hepatotoxicity risk [22]
Irinotecan Chemotherapeutic Deconjugation of SN-38G Severe diarrhea, dose-limiting toxicity [22]

The study of couples' microbiomes represents a paradigm shift in understanding shared disease risks and developing targeted interventions. The protocols outlined here provide a comprehensive framework for investigating microbial sharing and its health implications, with particular relevance for metabolic and reproductive conditions. Future research directions should include:

  • Development of couple-specific microbial health indices
  • Longitudinal studies across relationship transitions (cohabitation, parenthood, separation)
  • Investigation of microbiome-mediated emotional and behavioral synchrony
  • Clinical trials of dyadic microbiome-targeted interventions for chronic conditions

By adopting a couples-focused approach to microbiome research, we advance toward more effective strategies for preventing and managing interconnected health risks within close relationships.

A Rigorous Workflow for Couple-Level Multi-Site Microbiome Analysis

The study of couples' microbiomes represents a paradigm shift in microbial ecology, transitioning from individual-focused analyses to a dyadic framework that acknowledges the significant microbial exchange between cohabiting partners. Cohabiting partners share more similar microbiomes across gut, oral, skin, and genital sites than unrelated individuals, with measurable strain sharing (median ~12% gut; ~32% oral) that scales with duration of cohabitation [1]. This "social microbiome" forms through sustained close contact, shared environments, and intimate behaviors, potentially influencing reproductive, metabolic, and child health outcomes [1]. This protocol outlines a comprehensive framework for leveraging public datasets through rigorous data harmonization approaches to enable robust dyadic analytics that can advance hypotheses on person-to-person microbial transmission, co-adaptation, and their relevance for clinical applications including preconception care and fertility optimization [1].

Retrospective Harmonization Framework

Retrospective harmonization synthesizes already-collected information from heterogeneous public datasets when prospective harmonization at the study design phase is not feasible [24]. This approach involves defining a core set of variables, assessing compatibility of existing data, and creating harmonized variables through systematic processing strategies [24]. The success of this method depends on extensive data cleaning, management, and variable transformation processes to generate comparable datasets across different study populations and methodologies [24].

Table: Data Harmonization Approaches for Couples' Microbiome Studies

Harmonization Type Implementation Phase Key Characteristics Applicability to Public Data
Prospective Study design phase Standardized protocols and variables agreed upon before data collection Limited applicability to existing datasets
Retrospective After data collection Flexible approach targeting synthesis of existing information; variable transformation required High applicability; enables pooling of diverse public datasets
Construct-based Variable definition phase Focuses on conceptual equivalence of measured constructs across studies Essential for ensuring measured variables represent same biological/social constructs

Variable Assessment and Harmonization Strategies

Variables from public datasets must be evaluated across multiple features to determine harmonization potential. Completely matching variables across datasets can be pooled directly, while partially matching variables require transformation to common formats, response options, measurement timing, and coding features [24].

Table: Quantitative Metrics of Couples' Microbiome Similarity from Harmonized Studies

Body Site Similarity Metric Reported Effect Size Statistical Significance Key Influencing Factors
Gut Strain sharing Median ~12% [1] P < 0.001 [2] Cohabitation duration, diet, antibiotic use
Oral Strain sharing Median ~32% [1] P < 0.001 [1] Intimate kissing frequency, shared oral hygiene
Skin Community similarity Partners identifiable with ~86% accuracy [1] P < 0.001 [1] Body site (highest on feet), shared living environment
Genital BV-associated bacteria 35% vs 63% BV recurrence with partner treatment [1] P < 0.01 [1] Sexual behavior, treatment of both partners

The harmonization process involves meticulous assessment of variables including: (a) the construct measured; (b) question asked and response options; (c) measurement scale used; (d) frequency of measurement; (e) timing of measurement; and (f) coding features [24]. Continuous variables like maternal age may require only missing value standardization, while categorical variables like marital status need recoding to align response categories across datasets [24].

Experimental Protocols and Analytical Workflows

Microbiome Profiling and Bioinformatics

Sample Processing and Sequencing: Public microbiome data typically derives from 16S rRNA gene sequencing or shotgun metagenomics. The protocol standardizes reprocessing of amplicon reads with a uniform QIIME 2/DADA2 pipeline to minimize batch effects [1]. For metagenomic data, the workflow includes host DNA depletion, species profiling using MetaPhlAn 4, and functional pathway profiling with HUMAnN 3 [1].

Strain-Level Analysis: Strain sharing is quantified with StrainPhlAn and inStrain across prioritized taxa using stringent ANI (Average Nucleotide Identity) and breadth thresholds to reduce false positives [1]. This strain-resolved approach enables precise tracking of microbial transmission between partners.

G Microbiome Data Processing Workflow From Raw Sequences to Dyadic Analytics cluster_raw Raw Data Processing cluster_analysis Advanced Analytics cluster_dyadic Dyadic Analytics RawSequences Raw Sequencing Data (16S rRNA/Shotgun) QC Quality Control & Filtering RawSequences->QC ASV ASV/OTU Picking (QIIME 2/DADA2) QC->ASV Taxonomic Taxonomic Classification ASV->Taxonomic Strain Strain-Level Analysis (StrainPhlAn/inStrain) Taxonomic->Strain Functional Functional Profiling (HUMAnN 3) Taxonomic->Functional Diversity Diversity Metrics (Alpha/Beta Diversity) Taxonomic->Diversity Networks Transmission Networks & Co-occurrence Strain->Networks Functional->Networks Similarity Partner Similarity Metrics Diversity->Similarity Networks->Similarity Models Mixed-Effects Models & APIM Similarity->Models Outcomes Health Outcome Association Models->Outcomes

Dyadic Statistical Analytics

Similarity Metrics: Partner microbiome similarity is quantified through beta-diversity contrasts (Bray-Curtis, UniFrac distances), permutation tests, and calculation of shared taxa/strains [1]. These metrics are contrasted against non-partner pairs to establish significance of cohabitation effects.

Actor-Partner Interdependence Models (APIM): APIM accounts for the non-independence of couple data and tests how one partner's microbiome characteristics may influence the other's health outcomes [1]. These models incorporate fixed and random effects for both partners simultaneously.

Longitudinal Analysis: For datasets with temporal components, mixed-effects models evaluate how microbiome convergence changes with relationship duration, shared behaviors, and life events [1].

G Dyadic Analytical Framework for Couples' Microbiome Data cluster_inputs Input Data cluster_methods Analytical Methods cluster_outputs Output Applications Microbiome Microbiome Features (Species, Strains, Pathways) Similarity Similarity Analysis (Beta-diversity, Strain Sharing) Microbiome->Similarity Metadata Partner Metadata (Demographics, Behaviors, Health) Metadata->Similarity Contextual Contextual Factors (Diet, Environment, Medications) Contextual->Similarity Regression Dyadic Regression (APIM, Mixed-Effects) Similarity->Regression Network Network Analysis (Transmission Patterns) Regression->Network Longitudinal Longitudinal Models (Convergence Over Time) Network->Longitudinal Transmission Microbial Transmission Dynamics Longitudinal->Transmission Health Couple-Level Health Implications Transmission->Health Clinical Clinical Applications (Joint Treatment Strategies) Health->Clinical

The Scientist's Toolkit: Research Reagent Solutions

Table: Essential Research Tools for Couples' Microbiome Studies

Tool/Category Specific Solutions Function/Application Protocol Considerations
Bioinformatics Pipelines QIIME 2, DADA2, MetaPhlAn 4, HUMAnN 3 Processing raw sequencing data; species and functional profiling Standardize parameters across datasets; account for batch effects [1]
Strain Tracking StrainPhlAn, inStrain Quantifying strain sharing between partners Use stringent ANI/breadth thresholds (≥99% ANI) to reduce false positives [1]
Statistical Frameworks R/Phyloseq, APIM, mixed-effects models Dyadic data analysis; accounting for non-independence Implement permutation tests for partner vs. non-partner comparisons [1]
Data Harmonization Custom scripting (R/Python) Retrospective variable alignment across studies Assess construct validity; transform variables to common formats [24]
Reporting Standards STORMS checklist Comprehensive study reporting Adapt STROBE guidelines for microbiome-specific elements [25]

Reporting and Interpretation Guidelines

Effective reporting of couples' microbiome studies requires adherence to specialized guidelines. The STORMS checklist (Strengthening The Organization and Reporting of Microbiome Studies) provides a 17-item framework organized into six sections corresponding to standard publication format [25]. This includes detailed reporting of participant characteristics, laboratory processing, bioinformatics, statistical analyses, and results specific to microbiome studies.

For dyadic analyses, reporting should explicitly describe: the unit of analysis (couple versus individual); methods for handling non-independence; similarity metrics and their statistical evaluation; and interpretation of results in the context of bidirectional influence between partners [1] [25]. This framework ensures reproducibility and facilitates comparative analysis across studies, advancing our understanding of the couple as an integrated microbial unit.

The study of couples' microbiomes represents a paradigm shift in microbial ecology, positioning the couple as the fundamental unit of analysis rather than the individual. Cohabiting partners share significantly more similar microbiomes across gut, oral, skin, and genital sites than unrelated individuals, with metagenomic studies demonstrating measurable strain sharing (median ~12% gut; ~32% oral) that scales with duration of cohabitation [1]. This "social microbiome" forms through sustained close contact, shared environments, and intimate behaviors, creating a microbial ecosystem that may profoundly influence reproductive, metabolic, and child health outcomes [1]. The ability to identify couples with ~86% accuracy based solely on skin microbiome similarity underscores the profound microbial convergence that occurs through partnership [1]. This protocol establishes a standardized framework for designing studies that capture these partner linkages, enabling researchers to investigate how microbial transmission between partners contributes to health and disease states, including fertility optimization, bacterial vaginosis recurrence prevention, and early-life microbiome seeding [1].

Sampling Protocol Design

Multi-Site Sampling Strategy

Comprehensive couples' microbiome research requires synchronized sampling across multiple body sites to capture the full spectrum of microbial exchange. The protocol mandates collection from gut, oral, skin, and genital sites simultaneously from both partners, with timing coordinated to account for temporal variations [1] [5]. Sample integrity must be maintained through immediate preservation or freezing at -80°C until processing. For genital microbiome sampling in particular, careful timing relative to menstrual cycle phase is essential, as the vaginal microbiome demonstrates fluctuations throughout the cycle [5].

Table 1: Minimum Sample Collection Requirements for Couples' Microbiome Studies

Body Site Sample Type Collection Method Storage Conditions Processing Priority
Gut Stool Commercially available collection kit -80°C High (labile communities)
Oral Saliva Salivette or passive drool -80°C Medium
Skin Swabs Sterile synthetic swab with moistened tip -80°C Medium
Vaginal Swabs Sterile synthetic swab -80°C High (for reproductive health studies)
Endometrial Biopsy Medical procedure by clinician -80°C Situation-dependent
Semen Ejaculate Sterile container -80°C Medium

Temporal Sampling Considerations

Longitudinal study designs are strongly recommended to capture the dynamics of microbial sharing and convergence. For studies investigating reproductive outcomes, sampling should occur at critical timepoints: pre-conception, each trimester during pregnancy, and post-partum for both partners [5]. In menstrual cycle studies, sampling should cover minimum three timepoints: early follicular phase, peri-ovulatory phase, and mid-luteal phase to account for hormonal influences on the microbiome [5]. The duration of cohabitation should be recorded as a continuous variable, as microbiome similarity scales with time shared [1].

Metadata Collection Framework

Comprehensive metadata collection is essential for interpreting couples' microbiome data. The STORMS (Strengthening The Organization and Reporting of Microbiome Studies) guidelines provide a framework for standardized metadata documentation [26]. All metadata should be formatted according to the MixS standards developed by the Genome Standards Consortium [27].

Table 2: Essential Metadata Categories for Couples' Microbiome Studies

Metadata Category Specific Variables Collection Method Level of Importance
Demographic & Anthropometric Age, sex, BMI, ethnicity, education, socioeconomic status Structured questionnaire Essential
Relationship Dynamics Duration of cohabitation (months/years), relationship satisfaction, intimacy frequency Validated relationship scales Essential for couple studies
Behavioral & Lifestyle Dietary patterns, alcohol/tobacco use, exercise frequency, sleep quality, stress levels Food frequency questionnaire, lifestyle survey Essential
Medical & Medication History Antibiotic use (timing/duration), hormonal contraception, chronic conditions, reproductive history Medical interview and verification Critical (exclusion criterion)
Household Environment Home type, pet ownership, cleaning product use, water source Environmental questionnaire Recommended
Site-Specific Behaviors Oral: kissing frequency, oral hygiene; Skin: showering frequency, cosmetic use Targeted questionnaire Situation-dependent

Partner Linkage Documentation

The core innovation of this protocol is the systematic documentation of partner linkages in metadata. Each participant should have a unique household identifier that links them to their partner, plus an individual participant code. Additionally, researchers should record the timing of partnership formation relative to the study period, and document separation histories for previously cohabiting couples, as shared microbial strains gradually wane when cohabitation ends [1]. For complex family structures, include relationship type (spouses, cohabiting partners, same-sex couples) to enable analysis of how different relationship dynamics influence microbial sharing [1].

Experimental Workflow and Quality Control

Sample Processing Pipeline

The following workflow diagram outlines the complete experimental process from participant recruitment to data analysis, specifically designed for couples' microbiome studies:

CouplesMicrobiomeWorkflow cluster_0 Participant Recruitment & Sampling cluster_1 Laboratory Processing cluster_2 Bioinformatics cluster_3 Statistical Analysis Recruitment Recruitment EligibilityScreening EligibilityScreening Recruitment->EligibilityScreening InformedConsent InformedConsent EligibilityScreening->InformedConsent BaselineMetadata BaselineMetadata InformedConsent->BaselineMetadata MultiSiteSampling MultiSiteSampling BaselineMetadata->MultiSiteSampling DNAExtraction DNAExtraction MultiSiteSampling->DNAExtraction QCQuantification QCQuantification DNAExtraction->QCQuantification LibraryPrep LibraryPrep QCQuantification->LibraryPrep Sequencing Sequencing LibraryPrep->Sequencing QualityFiltering QualityFiltering Sequencing->QualityFiltering HostDepletion HostDepletion QualityFiltering->HostDepletion TaxonomicProfiling TaxonomicProfiling HostDepletion->TaxonomicProfiling StrainAnalysis StrainAnalysis TaxonomicProfiling->StrainAnalysis DyadicModeling DyadicModeling StrainAnalysis->DyadicModeling SimilarityQuantification SimilarityQuantification DyadicModeling->SimilarityQuantification NetworkAnalysis NetworkAnalysis SimilarityQuantification->NetworkAnalysis HealthCorrelations HealthCorrelations NetworkAnalysis->HealthCorrelations

Quality Control and Experimental Controls

Rigorous quality control is essential for generating reliable couples' microbiome data. The protocol mandates inclusion of experimental controls at multiple stages: sampling controls (blank swabs), extraction controls (no template), and amplification controls [27]. For low-biomass samples (e.g., skin, endometrium), include mock communities as positive controls to confirm sensitivity and specificity [27]. Batch effects must be minimized by processing partner samples simultaneously in randomized order, and including technical replicates for a subset of samples to quantify technical variability [26]. All sequence data must meet minimum quality thresholds (Q-score >30 for shotgun metagenomics) before inclusion in analysis [1].

Data Analysis Framework

Dyadic Statistical Models

The analysis of couples' microbiome data requires specialized statistical approaches that account for the non-independence of partners' data. Actor-Partner Interdependence Models (APIM) are recommended for assessing how one partner's microbiome characteristics influence the other's health outcomes [1]. Mixed-effects models should include random effects for household to account for shared environmental factors [1]. Partner similarity can be quantified using beta-diversity contrasts (comparing within-couple distances to between-couple distances) with permutation tests to establish statistical significance [1]. For longitudinal studies, time-series analyses should model microbial convergence as a function of cohabitation duration while controlling for shared diet and environmental exposures [1].

Strain-Sharing Analysis

Strain-level resolution is critical for confirming microbial transmission between partners. The protocol recommends using StrainPhlAn or inStrain tools with stringent thresholds (ANI >99.9%, breadth >90%) to minimize false positives in strain sharing detection [1]. Analysis should prioritize highly transmitted taxa previously identified in household studies, including specific Bifidobacterium and Bacteroides strains that efficiently spread between cohabitants [1]. The proportion of shared strains should be calculated for each body site and correlated with behavioral factors (kissing frequency for oral strains, sexual practices for genital strains) [1].

Table 3: Core Bioinformatics Tools for Couples' Microbiome Analysis

Tool Category Software/Tool Primary Function Key Parameters
Sequence Processing QIIME 2/DADA2 (16S) Denoising, ASV/OTU calling --p-trunc-len, --p-max-ee
Metagenomic Profiling MetaPhlAn 4 Taxonomic profiling --bowtie2db, --stat_q
Functional Profiling HUMAnN 3 Pathway abundance analysis --pathways, --taxonomic-profile
Strain Analysis StrainPhlAn Strain-level tracking --markerinclade, --samplewithn_markers
Strain Analysis inStrain Strain population genetics --minreadqual, --min_mapq
Network Analysis SPIEC-EASI Microbial association networks --method, --pulsar.select

The Scientist's Toolkit: Research Reagent Solutions

Table 4: Essential Research Reagents and Materials for Couples' Microbiome Studies

Reagent/Material Function/Application Specifications/Alternatives
DNA/RNA Shield Preserves nucleic acids during sample storage and transport Compatible with most extraction kits
DNeasy PowerSoil Pro Kit Gold-standard DNA extraction for difficult samples (stool, soil) Includes inhibitor removal technology
ZymoBIOMICS Microbial Community Standards Mock communities for quality control Contains defined ratios of microbial species
KAPA HyperPrep Kit Library preparation for shotgun metagenomics Compatible with low-input samples
Illumina DNA Prep Library preparation for Illumina platforms Integrated tagmentation workflow
MetaPhlAn 4 Database Reference database for taxonomic profiling Includes ~1M unique clade-specific markers
UNITE Database Reference database for fungal ITS sequencing Essential for mycobiome studies
HUMAnN 3 Pathway Databases Reference for metabolic pathway profiling Includes MetaCyc and UniRef mappings

Data Reporting and Reproducibility

STORMS-Compliant Reporting

All studies should adhere to the STORMS guidelines (Strengthening The Organization and Reporting of Microbiome Studies) to ensure complete and reproducible reporting [26]. The 17-item STORMS checklist covers six sections: abstract, introduction, methods, results, discussion, and other information [26]. Manuscripts must explicitly describe participant eligibility criteria, including any exclusion for recent antibiotic use (typically within 3 months) [26]. The methods section should detail all statistical approaches used for handling compositional data and correcting for multiple comparisons [26] [27].

Data Sharing and Documentation

Following community standards, all raw sequence data must be deposited in public repositories (e.g., SRA, ENA) with appropriate accession numbers prior to publication [27]. All analysis scripts (R, Python, etc.) should be shared as knitr files, iPython Notebooks, or similar formats to enable complete reproducibility [27]. Couple and household identifiers must be preserved in metadata while maintaining participant confidentiality through appropriate de-identification strategies [26]. The MiMARKS checklist should be completed for all samples to ensure standardized metadata reporting [26] [27].

The analysis of microbial communities through shotgun metagenomics provides a comprehensive view of the taxonomic and functional potential of complex ecosystems. When framed within the context of couples' microbiome and health outcomes research, this approach becomes a powerful tool for investigating microbial transmission, strain sharing, and functional convergence between partners. Cohabiting partners have been shown to share more similar microbiomes across gut, oral, skin, and genital sites than unrelated individuals, with metagenomic studies demonstrating measurable strain sharing (median ~12% gut; ~32% oral) that scales with cohabitation duration [1]. This "social microbiome" may influence reproductive, metabolic, and child health outcomes, making sophisticated analytical pipelines like QIIME 2 and its dedicated shotgun metagenomics toolkit, MOSHPIT, essential for researchers in this field [28] [29].

Unlike amplicon-based approaches (e.g., 16S rRNA sequencing) that primarily profile taxonomic composition, shotgun metagenomics sequences all DNA fragments from a sample, enabling simultaneous characterization of community membership and biological functions encoded in the collective metagenome [30]. This is particularly valuable for couples' microbiome studies, where understanding the functional implications of shared microbes—such as antibiotic resistance genes, metabolic pathways, or virulence factors—can illuminate mechanisms linking microbial sharing to health outcomes [1].

Experimental Workflow: From Sample to Data

The journey from biological sample to analyzable data involves a series of critical wet-lab and computational steps, each with specific quality control checkpoints as shown in the workflow below.

Wet-Lab Procedures: Sample Preparation and Sequencing

Sample Collection and DNA Extraction

  • Body Site Sampling: For couples' microbiome studies, collect samples from relevant body sites (e.g., gut via stool, oral via saliva, skin via swabs, genital via vaginal/penile swabs) using standardized collection kits. Maintain consistent collection protocols across both partners to minimize technical variation.
  • DNA Extraction: Use high-yield DNA extraction kits designed for microbial cell lysis (e.g., MoBio PowerSoil Kit for environmental samples, QIAamp DNA Stool Mini Kit for fecal samples). Include negative extraction controls to detect contamination.
  • DNA Quality Assessment: Quantify DNA using fluorometric methods (e.g., Qubit dsDNA HS Assay) and assess purity via spectrophotometry (A260/A280 ratio ~1.8-2.0). Verify DNA integrity by agarose gel electrophoresis.

Library Preparation and Sequencing

  • Library Construction: Prepare sequencing libraries using Illumina-compatible kits (e.g., Nextera XT DNA Library Preparation Kit) with dual indexing to enable sample multiplexing. This step fragments DNA and adds adapter sequences compatible with sequencing platforms.
  • Quality Control: Validate library quality using Bioanalyzer or TapeStation to confirm appropriate fragment size distribution (~300-800 bp). Quantify libraries via qPCR for accurate pooling.
  • Sequencing: Perform shotgun sequencing on Illumina platforms (e.g., NovaSeq 6000) to generate paired-end reads (2×150 bp or 2×250 bp). Aim for 10-50 million reads per sample depending on community complexity and desired depth.

Table 1: Key Research Reagents for Wet-Lab Procedures

Reagent/Kit Function Application in Couples' Microbiome Studies
MoBio PowerSoil DNA Isolation Kit Extracts microbial DNA from complex samples Standardized extraction across partner samples from different body sites
Nextera XT DNA Library Preparation Kit Prepares sequencing libraries with dual indexes Enables multiplexing of partner samples in a single sequencing run
Qubit dsDNA HS Assay Kit Accurately quantifies double-stranded DNA Quality control before expensive sequencing steps
Illumina Sequencing Reagents Enables high-throughput sequencing Generates raw sequence data for downstream bioinformatic analysis

In-Silico Analysis: Computational Processing with MOSHPIT/QIIME 2

The computational workflow for analyzing shotgun metagenomic data involves multiple steps for quality control, assembly, and annotation, now streamlined through the MOSHPIT toolkit within the QIIME 2 framework [29].

G cluster_0 MOSHPIT/QIIME 2 Processing Stages A Raw Sequencing Reads (FASTQ files) B Quality Control & Host Read Filtering A->B C Metagenome Assembly B->C D Taxonomic Profiling (MetaPhlAn 4) C->D E Functional Profiling (HUMAnN 3) C->E F Strain-Level Analysis (StrainPhlAn/inStrain) C->F G Statistical Analysis & Visualization D->G E->G F->G H Couples-Specific Analyses (Partner similarity, strain sharing) G->H

Detailed Methodologies for Key Experiments

Taxonomic and Functional Profiling Protocol

Step 1: Data Import and Quality Control

  • Import Sequences: Use QIIME 2's import tools to bring shotgun sequencing data into the analysis environment. For paired-end reads, specify the appropriate import type:

  • Quality Control: Generate interactive quality reports to assess read quality and determine appropriate trimming parameters:

  • Host Read Filtration: For host-associated samples (e.g., from human swabs), implement host DNA removal using alignment-based tools prior to downstream analysis to increase microbial sequence yield [30].

Step 2: Taxonomic Profiling with MetaPhlAn 4 MetaPhlAn 4 uses clade-specific marker genes to provide accurate taxonomic profiling at the species level, which is essential for detecting microbial sharing between partners [1].

  • Run MetaPhlAn 4:

  • Visualize Results: Create interactive bar plots and phylogenetic trees to compare taxonomic profiles across partner samples and body sites.

Step 3: Functional Profiling with HUMAnN 3 HUMAnN 3 characterizes the abundance of microbial pathways in a community, enabling functional comparisons between partners' microbiomes.

  • Execute HUMAnN 3:

  • Normalize Data: Convert pathway abundances to copies per million (CPM) for cross-sample comparability.

Table 2: Key Parameters for Shotgun Metagenomic Processing

Analysis Step Critical Parameters Recommended Settings Impact on Results
Quality Control Trimming quality score, Minimum length Q20, 50 bp Removes low-quality reads, reduces errors
Taxonomic Profiling Database version, Minimum read alignment MetaPhlAn 4 DB, 80% identity Affects species detection sensitivity
Functional Profiling Pathway database, Normalization method UniRef90, CPM normalization Influences pathway abundance accuracy
Strain Tracking ANI threshold, Minimum breadth 99% ANI, 50% breadth Controls strain sharing detection stringency

Strain-Level Analysis for Detecting Microbial Transmission

Strain-level analysis is particularly valuable in couples' microbiome studies as it enables direct detection of microbial transmission between partners [1]. The protocol below outlines the steps for identifying shared bacterial strains.

Step 1: Strain Profiling with StrainPhlAn StrainPhlAn extracts species-specific marker sequences from metagenomic samples to identify strain-level variants.

  • Run StrainPhlAn:

  • Select Target Species: Prioritize highly transmitted species identified in couples' studies, such as specific Bifidobacterium and Bacteroides strains [1].

Step 2: Strain Comparison with inStrain inStrain provides genome-wide analysis of population diversity and strain sharing through comparison of single-nucleotide variants (SNVs).

  • Execute inStrain:

  • Calculate Strain Sharing: Use the inStrain compare function to quantify the proportion of shared strains between partner samples versus unrelated individuals.

Step 3: Statistical Analysis of Strain Sharing

  • Quantify Sharing Rates: Calculate the percentage of shared strains between partners across different body sites using stringent thresholds (e.g., ≥99% average nucleotide identity).
  • Perform Permutation Tests: Use random resampling to determine if observed strain sharing between partners exceeds chance expectation.
  • Model Covariates: Apply mixed-effects models to assess how cohabitation duration, intimate behaviors, and shared environment influence strain sharing rates.

Data Analysis and Couples-Specific Analytical Approaches

Comparative Analysis of Partners' Microbiomes

Beta-Diversity Analysis

  • Calculate Dissimilarities: Generate Bray-Curtis dissimilarity matrices from taxonomic and functional profiles to quantify overall microbiome differences between samples.
  • Perform PERMANOVA: Test whether partners' microbiomes are significantly more similar than those of unrelated individuals using permutation-based multivariate analysis of variance.
  • Visualize with PCoA: Create principal coordinates plots to visualize clustering of partner samples versus controls.

Dyadic Data Analysis

  • Actor-Partner Interdependence Models: Apply specialized statistical models that account for the non-independence of data from partnered individuals.
  • Longitudinal Analysis: For studies with multiple timepoints, use QIIME 2's longitudinal plugin to track changes in microbiome similarity over time [31]:

Visualization and Interpretation

Effective visualization is crucial for interpreting the complex relationships in couples' microbiome data. The following diagram illustrates the key analytical approaches and their interrelationships.

G cluster_0 Input Data Types cluster_1 Analytical Methods cluster_2 Key Findings in Couples A Taxonomic Profiles (Species abundance) D Beta-Diversity Analysis (Partner similarity assessment) A->D B Functional Profiles (Pathway abundance) B->D E Differential Abundance (Tests between couples vs. controls) B->E C Strain Profiles (SNV patterns) F Strain Sharing Quantification (ANI-based comparison) C->F G Partner Similarity Confirmation D->G H Functional Convergence Detection E->H I Microbial Transmission Evidence F->I

Table 3: Expected Results in Couples' Microbiome Studies

Analytical Domain Expected Finding Health Implication Statistical Approach
Taxonomic Composition Elevated similarity in gut/oral microbiomes Potential shared disease risk PERMANOVA, Mantel tests
Strain Sharing 12-32% strain sharing depending on body site Evidence of direct microbial transmission Proportion tests, ANOVA
Functional Potential Convergence in metabolic pathways Shared metabolic phenotypes Linear mixed-effects models
Antimicrobial Resistance Shared resistome patterns Coordinated antibiotic response Correlation analysis, network models

The integration of QIIME 2 and MOSHPIT provides a robust, reproducible framework for analyzing shotgun metagenomic data in couples' microbiome studies. The standardized workflows enable detection of microbial sharing and functional convergence that may underlie health outcomes shared between partners. This protocol operationalizes the couple as the analytical unit, advancing hypotheses on person-to-person microbial transmission and its relevance for preconception care, bacterial vaginosis recurrence prevention, fertility optimization, and early-life microbiome seeding [1]. As metagenomic technologies continue evolving, these methodologies will become increasingly accessible for exploring the complex interplay between shared microbial ecosystems and dyadic health outcomes.

Strain-resolved metagenomic analysis represents a pivotal advancement over traditional species-level profiling, enabling researchers to discern genetic variation within bacterial species. This high-resolution approach is crucial for investigating microbiome transmission dynamics, such as those between couples, tracking pathogenic strains, and understanding microevolution in host-associated ecosystems. Unlike 16S rRNA gene sequencing, which cannot reliably differentiate strains, shotgun metagenomics, when coupled with sophisticated computational tools, can reveal strain-level differences that often underlie important phenotypic variations [32]. This protocol focuses on two powerful tools for strain-level analysis: StrainPhlAn 3, which uses species-specific marker genes for phylogenetic strain tracking, and inStrain, which employs microdiversity-aware, whole-genome comparisons for population-genetic analysis [33] [34]. The implementation of stringent thresholds is emphasized throughout to ensure accurate identification of strain sharing events, a critical consideration when studying close contact pairs like couples where microbial transmission is anticipated.

Tool Selection and Comparative Performance

Selecting the appropriate tool is foundational to the success of a strain-resolved study. StrainPhlAn and inStrain operate on distinct principles and offer complementary strengths. The table below summarizes their key characteristics and performance metrics based on benchmark studies.

Table 1: Comparison of Strain-Resolved Metagenomic Analysis Tools

Feature StrainPhlAn 3 inStrain
Core Methodology Phylogenetic inference from species-specific marker genes Microdiversity-aware whole-genome comparison (popANI)
Genetic Resolution Consensus sequences of marker genes (~0.3% of genome) [34] Population-level analysis across >99.7% of genome [34]
Key Metric Marker gene identity Population ANI (popANI) & Consensus ANI (conANI)
Sensitivity (Strain Sharing) Lower sensitivity in complex communities [35] High sensitivity; identifies more shared strains in genuine communities [35]
Stringency Threshold ~99.97% ANI (≈1307 years divergence) [35] 99.999% popANI (Recommended) (≈2.2 years divergence) [35] [36]
Reference Dependency Relies on MetaPhlAn database markers Uses representative genomes (de novo assembled or from database)
Best Application Rapid strain tracking across large sample sets for well-characterized species High-stringency strain comparison and population genetic analysis

Benchmarking reveals that inStrain provides superior stringency for detecting identical strains. In analyses of defined microbial communities (ZymoBIOMICS Standard), inStrain reported an average popANI of 99.999998%, with the lowest comparison at 99.99996% [35]. This translates to a detection threshold capable of identifying strains that have diverged for only about 2.2 years, assuming a mutation rate of 0.9 single nucleotide substitutions (SNSs) per genome per year [35]. In contrast, StrainPhlAn's minimum reported ANI in the same benchmark was 99.97% (≈1307 years divergence) [35]. This high stringency makes inStrain particularly valuable for confirming recent strain sharing events in couples' microbiome studies.

Workflow Implementation

The following diagram illustrates the comprehensive workflow for a strain-resolved analysis of couples' microbiomes, from sample collection to biological interpretation.

G cluster_1 Core Computational Steps Longitudinal Sample Collection (Both Partners) Longitudinal Sample Collection (Both Partners) DNA Extraction & WGS Sequencing DNA Extraction & WGS Sequencing Longitudinal Sample Collection (Both Partners)->DNA Extraction & WGS Sequencing Quality Control & Host DNA Removal Quality Control & Host DNA Removal DNA Extraction & WGS Sequencing->Quality Control & Host DNA Removal Parallel Strain Analysis Parallel Strain Analysis Quality Control & Host DNA Removal->Parallel Strain Analysis StrainPhlAn 3 Pipeline StrainPhlAn 3 Pipeline Parallel Strain Analysis->StrainPhlAn 3 Pipeline  For marker-based profiling inStrain Pipeline inStrain Pipeline Parallel Strain Analysis->inStrain Pipeline  For population genomics Strain Sharing & Phylogenetics Strain Sharing & Phylogenetics StrainPhlAn 3 Pipeline->Strain Sharing & Phylogenetics inStrain Pipeline->Strain Sharing & Phylogenetics Integration with Health Outcomes Integration with Health Outcomes Strain Sharing & Phylogenetics->Integration with Health Outcomes Biological Interpretation (Transmission, Health Links) Biological Interpretation (Transmission, Health Links) Integration with Health Outcomes->Biological Interpretation (Transmission, Health Links)

StrainPhlAn 3 Protocol

StrainPhlAn 3 infers strain-level phylogenies by reconstructing consensus sequences from species-specific marker genes. The following workflow details its implementation.

G cluster_1 Key Optimization for Low Biomass Input: Quality-Controlled Metagenomic Reads Input: Quality-Controlled Metagenomic Reads MetaPhlAn 3 Profiling MetaPhlAn 3 Profiling Input: Quality-Controlled Metagenomic Reads->MetaPhlAn 3 Profiling Species Selection for Strain-Level Analysis Species Selection for Strain-Level Analysis MetaPhlAn 3 Profiling->Species Selection for Strain-Level Analysis StrainPhlAn 3: Extract Marker Reads StrainPhlAn 3: Extract Marker Reads Species Selection for Strain-Level Analysis->StrainPhlAn 3: Extract Marker Reads Parameter Optimization (--read_min_len, --sample_with_stats) Parameter Optimization (--read_min_len, --sample_with_stats) Species Selection for Strain-Level Analysis->Parameter Optimization (--read_min_len, --sample_with_stats) StrainPhlAn 3: Build Marker MSA StrainPhlAn 3: Build Marker MSA StrainPhlAn 3: Extract Marker Reads->StrainPhlAn 3: Build Marker MSA StrainPhlAn 3: Infer Phylogenetic Tree StrainPhlAn 3: Infer Phylogenetic Tree StrainPhlAn 3: Build Marker MSA->StrainPhlAn 3: Infer Phylogenetic Tree Output: Strain Trees & Newick Files Output: Strain Trees & Newick Files StrainPhlAn 3: Infer Phylogenetic Tree->Output: Strain Trees & Newick Files Parameter Optimization (--read_min_len, --sample_with_stats)->StrainPhlAn 3: Extract Marker Reads Benchmark with Culture Data (if available) Benchmark with Culture Data (if available) Benchmark with Culture Data (if available)->Parameter Optimization (--read_min_len, --sample_with_stats)

Detailed Step-by-Step Protocol:

  • Prerequisite: Taxonomic Profiling

    • Run MetaPhlAn 3 on all metagenomic samples to obtain species-level abundances and identify candidate species for strain-level analysis.
    • Example command:

  • Strain-Level Profiling

    • Execute StrainPhlAn 3 using the MetaPhlAn 3 output to generate multiple sequence alignments (MSAs) and phylogenetic trees for each species of interest.
    • Example command:

    • For samples with lower microbial biomass (e.g., oral or skin swabs), optimize parameters like --read_min_len to improve sensitivity [33].
  • Strain Sharing Analysis

    • Interpret the resulting phylogenetic trees (Newick format) to identify clusters where strains from partners in a couple have identical or nearly identical marker gene sequences.
    • Calculate the proportion of shared strains between partners compared to unrelated individuals to establish significance.

inStrain Protocol

inStrain provides a microdiversity-aware approach for strain comparison by calculating population ANI (popANI) across entire genomes. Its workflow for a couples' microbiome study is as follows.

G cluster_1 Critical Step: Genome Database Creation Input: Metagenomic Reads + Representative Genomes Input: Metagenomic Reads + Representative Genomes Read Mapping (Bowtie2) Read Mapping (Bowtie2) Input: Metagenomic Reads + Representative Genomes->Read Mapping (Bowtie2) inStrain profile (Sample-wise) inStrain profile (Sample-wise) Read Mapping (Bowtie2)->inStrain profile (Sample-wise) Competitive Mapping to Dereplicated Genome Database Competitive Mapping to Dereplicated Genome Database Read Mapping (Bowtie2)->Competitive Mapping to Dereplicated Genome Database  Reduces mis-mapping inStrain compare (Cross-sample) inStrain compare (Cross-sample) inStrain profile (Sample-wise)->inStrain compare (Cross-sample) Filtering: min_cov 5x, mapQ 2, min_read_ani 0.97 Filtering: min_cov 5x, mapQ 2, min_read_ani 0.97 inStrain profile (Sample-wise)->Filtering: min_cov 5x, mapQ 2, min_read_ani 0.97  Stringent thresholds Output: popANI, conANI, SNP Data Output: popANI, conANI, SNP Data inStrain compare (Cross-sample)->Output: popANI, conANI, SNP Data Competitive Mapping to Dereplicated Genome Database->inStrain profile (Sample-wise) Microdiversity Metrics (Nucleotide Diversity, SNVs) Microdiversity Metrics (Nucleotide Diversity, SNVs) Filtering: min_cov 5x, mapQ 2, min_read_ani 0.97->Microdiversity Metrics (Nucleotide Diversity, SNVs) Microdiversity Metrics (Nucleotide Diversity, SNVs)->inStrain compare (Cross-sample) De Novo Assembly & Binning (per sample) De Novo Assembly & Binning (per sample) Dereplication at 95-99% ANI (dRep) Dereplication at 95-99% ANI (dRep) De Novo Assembly & Binning (per sample)->Dereplication at 95-99% ANI (dRep) Create Scaffold-to-Bin File Create Scaffold-to-Bin File Dereplication at 95-99% ANI (dRep)->Create Scaffold-to-Bin File Representative Genome Database Representative Genome Database Create Scaffold-to-Bin File->Representative Genome Database Representative Genome Database->Input: Metagenomic Reads + Representative Genomes

Detailed Step-by-Step Protocol:

  • Create a Representative Genome Database

    • Perform de novo assembly (e.g., using metaSPAdes or MEGAHIT) and binning (e.g., using MetaBAT2) on each metagenomic sample to reconstruct genomes [37] [32].
    • Dereplicate all genomes across all samples using dRep at 95-99% Average Nucleotide Identity (ANI) to create a non-redundant set of representative genomes [38] [37]. This step is crucial to avoid read mis-mapping.
    • Create a scaffold-to-bin file that links contigs to their respective genomes using scripts like parse_stb.py [37].
  • Read Mapping and Profiling

    • Map reads from all samples competitively against the dereplicated genome database using Bowtie 2. Competitive mapping significantly reduces mis-mapped reads [38] [37].
    • Example command for creating the database and mapping:

    • Run inStrain profile on each BAM file to calculate microdiversity metrics.
    • Example command with stringent filters:

  • Strain Comparison

    • Run inStrain compare on all inStrain profiles to calculate popANI and conANI between samples for each genome.
    • Example command:

  • Identify Shared Strains

    • Apply the 99.999% popANI threshold to define strain sharing events between samples [35] [36]. This stringent threshold ensures only recently shared strains are considered.

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 2: Key Research Reagents and Computational Tools for Strain-Resolved Analysis

Item Name Function/Application Specifications/Notes
DNeasy PowerSoil Pro Kit (Qiagen) DNA extraction from stool/sample Maximizes yield from complex samples; used in referenced studies [39] [36]
Illumina DNA Prep (M) Tagmentation Kit Library preparation for WGS Standardized protocol for metagenomic sequencing [36]
NovaSeq 6000 System High-throughput sequencing Enables deep sequencing (e.g., 10+ Gb/sample) for sufficient strain coverage [33] [39]
ZymoBIOMICS Microbial Community Standard Benchmarking and validation Defined bacterial community to validate strain-tracking accuracy [35] [34]
Unified Human Gastrointestinal Genome (UHGG) Reference genome database Comprehensive database of gut microbes; can be used for mapping [39] [36]
Bowtie 2 Read alignment Standard for mapping metagenomic reads to reference genomes [38] [37]
metaSPAdes / MEGAHIT De novo metagenomic assembly Assembles short reads into contigs for MAG generation [37] [32]
MetaBAT2 Binning of assembled contigs Groups contigs into draft genomes (MAGs) from assembly [37]
dRep Genome dereplication Clusters MAGs at specified ANI (e.g., 95-99%) to create non-redundant sets [38] [37]
Prodigal Gene prediction Annotates open reading frames on contigs for functional analysis [37]

Data Interpretation and Integration in Couples' Studies

Defining Strain Sharing with Stringent Thresholds

Applying the correct thresholds is critical for meaningful biological interpretation in couples' research. The recommended 99.999% popANI threshold in inStrain corresponds to strains that have diverged for only approximately 2.2 years, making it highly suitable for detecting recent transmission between partners [35]. In contrast, StrainPhlAn's typical thresholds correspond to much longer divergence times (~1307 years), which may be less specific for confirming partner transmission [35]. For species without sufficient coverage for popANI calculation, conANI can serve as a secondary, though less sensitive, metric.

Analytical Considerations for Couples' Microbiome Research

When designing a couples' microbiome study, several factors require careful consideration:

  • Longitudinal Sampling: Strain sharing rates are most informative when analyzed over time. Sample pairs collected closely in time show more reliable strain sharing signals [36].
  • Shared Environment vs. Transmission: Elevated strain sharing between partners can result from either direct transmission or parallel acquisition from a shared environment (e.g., diet, household) [36]. Study design and statistical models must account for this.
  • Species-Specific Dynamics: Strain retention and transmission potential vary by species. Analyze abundant, common species separately from low-abundance or rare taxa.

Implementing StrainPhlAn 3 and inStrain with stringent thresholds provides a powerful, complementary framework for conducting strain-resolved analysis of couples' microbiomes. StrainPhlAn 3 offers a rapid, marker-based approach for initial strain tracking across large sample sets and numerous species. inStrain delivers high-resolution, microdiversity-aware comparisons with superior stringency for confirming recent strain sharing events. The protocols outlined herein, emphasizing optimized workflows and stringent thresholds, will enable researchers to rigorously investigate strain-level microbial transmission between partners and its potential impact on health outcomes. This methodological approach lays the foundation for advancing our understanding of the intricate connections between shared microbial strains and coupled health.

Functional profiling of microbial communities answers a critical question in microbiome research: "What are the microbes in my community-of-interest doing (or capable of doing)?" [40]. HUMAnN 3.0 (The HMP Unified Metabolic Analysis Network) is a pivotal computational tool designed to address this question by efficiently and accurately profiling the abundance of microbial metabolic pathways and other molecular functions from metagenomic or metatranscriptomic sequencing data [41]. This capability is fundamental to moving beyond taxonomic census (determining "who is there") to understanding the functional capacity and metabolic potential of microbial communities, including those inhabiting the human gut [42].

Within the specific research context of couples' microbiome and health outcomes, HUMAnN 3 enables the systematic comparison of community metabolic potential. It can identify whether partners share similar microbial metabolic pathways, which may provide insights into shared environmental exposures, dietary habits, and their collective influence on health. The tool achieves this by leveraging an extensive knowledge base, including UniProt/UniRef sequences for gene families and MetaCyc for pathway definitions, to quantify the presence and abundance of metabolic pathways in a community [41] [40]. Its integration with the broader bioBakery 3 platform, particularly the taxonomic profiler MetaPhlAn 3, ensures that functional profiles can be accurately stratified by contributing organisms, providing a layered understanding of community metabolism [42].

Key Updates and Technical Specifications of HUMAnN 3

HUMAnN 3 represents a significant evolution from its predecessors, incorporating major updates that enhance its accuracy, scope, and performance. A primary advancement is its design in tandem with MetaPhlAn 3.0, which uses a marker database that also includes viral markers [41] [43]. This synergy allows for more precise organism-specific functional profiling. The underlying databases have been substantially expanded; HUMAnN 3 is based on the UniProt/UniRef 2019_01 sequence set and incorporates MetaCyc v24.0 pathway definitions. This has resulted in a pangenome database containing twice as many species and three times more gene families compared to HUMAnN 2.0 [41]. From a performance perspective, the algorithm has been re-tuned across all search steps, and a more stringent default reporting threshold requires that pangenome sequences must be covered at >50% of sites to be included [41].

Independent evaluations within the bioBakery 3 platform have demonstrated that these updates yield tangible improvements. As shown in Table 1, HUMAnN 3 produces more accurate estimates of enzyme commission (EC) abundances and identifies a higher number of true positive species compared to HUMAnN 2 and other tools like Carnelian [43]. Subsequent minor releases (e.g., versions 3.1, 3.5, 3.6) have further refined the pangenome catalog, ensured compatibility with newer versions of MetaPhlAn, and resolved critical software dependency issues, ensuring the pipeline's robustness and currency [41].

Table 1: Key Updates in HUMAnN 3.0 Compared to HUMAnN 2.0

Feature HUMAnN 2.0 HUMAnN 3.0 Impact
Reference Database Older UniProt/UniRef UniProt/UniRef 2019_01 More contemporary gene family definitions
Pangenome Scope Baseline 2x more species, 3x more gene families Increased profiling sensitivity and coverage
Pathway Database Older MetaCyc MetaCyc v24.0 Updated metabolic pathway definitions
Taxonomic Profiling MetaPhlAn 2 MetaPhlAn 3 Improved taxonomic accuracy for stratified profiling
Reported Coverage Not specified >50% of pangenome sites (tunable) More stringent and accurate gene presence/absence calls

Installation and Database Configuration

Software Installation

HUMAnN 3 can be installed via two primary methods: package managers like Conda or from source via PyPI. The Conda method is recommended for most users as it simplifies dependency management.

  • Installation via Conda: First, create and activate a new Conda environment: conda create --name biobakery3 python=3.7 and conda activate biobakery3. After configuring the channels (defaults, bioconda, conda-forge, and biobakery in that order), install HUMAnN with the command: conda install humann -c biobakery [41]. This will automatically install HUMAnN 3 along with its critical dependencies, including MetaPhlAn 3, Bowtie2, and DIAMOND [41].
  • Installation via PyPI: Alternatively, installation from source can be performed using pip: pip install humann --no-binary :all: [41]. The --no-binary parameter ensures the package is installed from source, which also triggers the installation of required dependencies like Bowtie2 and DIAMOND [40].

Following installation, it is crucial to verify the setup by running the unit tests with the command humann_test [41] [40]. A successful installation can be further validated by executing a demo analysis on provided example data: humann -i demo.fastq -o sample_results [41].

Database Setup

The standard installation includes small demonstration databases. For production-level analysis, such as processing human gut metagenomes, downloading full-scale databases is mandatory [40]. The following commands download the necessary comprehensive databases and update the software configuration accordingly:

  • ChocoPhlAn Pangenome Database: humann_databases --download chocophlan full /path/to/databases --update-config yes
  • UniRef Protein Database: humann_databases --download uniref uniref90_diamond /path/to/databases --update-config yes
  • Utility Mapping Database: humann_databases --download utility_mapping full /path/to/databases --update-config yes [41]

These databases underpin the various stages of the HUMAnN 3 workflow, from nucleotide-level alignment to translated search and functional annotation.

Core Workflow and Protocol for Metabolic Profiling

The HUMAnN 3 pipeline is designed for ease of use, typically requiring a single command to initiate a complete analysis from quality-controlled sequencing reads. The primary input can be a FASTA or FASTQ file (File Type 1) [40]. The foundational workflow for analyzing a metagenomic sample is illustrated below, highlighting the key steps and their relationships.

humann_workflow Start Input Metagenome (FASTQ/FASTA) TaxoProfile Taxonomic Profiling (MetaPhlAn 3) Start->TaxoProfile NucleoDB Build Custom Nucleotide DB TaxoProfile->NucleoDB NucleoAlign Nucleotide Alignment (Bowtie2) NucleoDB->NucleoAlign TranslatedSearch Translated Search (DIAMOND vs. UniRef) NucleoAlign->TranslatedSearch Unmapped reads GeneFamilies Quantify Gene Families (UniRef) TranslatedSearch->GeneFamilies PathwayCoverage Compute Pathway Coverage & Abundance GeneFamilies->PathwayCoverage End Stratified & Unstratified Pathway Abundance Tables PathwayCoverage->End

Figure 1. Core HUMAnN 3 workflow for functional profiling from metagenomic reads.

Step-by-Step Protocol

  • Input Preparation: Begin with quality-controlled metagenomic or metatranscriptomic reads in FASTA or FASTQ format. Quality control can be performed using tools like KneadData from the bioBakery suite [42].
  • Basic Execution: The core analysis is launched with a single command: humann --input sample_reads.fastq --output sample_results This command executes the full workflow shown in Figure 1 [41].
  • Taxonomic Profiling and Nucleotide Alignment: The pipeline first uses MetaPhlAn 3 to identify the microbial species present in the sample and their relative abundances [42] [40]. It then constructs a customized pangenome database comprising the genomes of the detected species. Reads are aligned against this database using the nucleotide aligner Bowtie2. Reads that align are assigned to their respective gene families.
  • Translated Search: Reads not mapped in the nucleotide search are subjected to a translated search using DIAMOND, which aligns the nucleotide reads to the UniRef90 protein database at the amino acid level. This step is critical for capturing gene families from novel or low-abundance organisms not fully represented in the pangenome database [40].
  • Gene Family and Pathway Quantification: The results from both alignment steps are integrated to produce a quantitative table of UniRef90 gene families in the community. HUMAnN 3 then maps these gene families to metabolic pathways using the MetaCyc database. For each pathway, it computes two key metrics: Pathway Coverage (the fraction of pathway steps with detected genes) and Pathway Abundance (a quantitative estimate of its abundance, based on the geometric mean of its gene abundances) [40].
  • Output Generation: The primary outputs are:
    • Gene Families File: Abundance of UniRef90 gene families.
    • Pathway Abundance File: Abundance of MetaCyc pathways.
    • Pathway Coverage File: Coverage of MetaCyc pathways. Each of these is produced in both stratified (showing the contribution of individual species) and unstratified (showing the total community abundance) formats [40].

Advanced Workflow Options

HUMAnN 3 offers flexibility for non-standard analyses through several "bypass" modes, which allow the workflow to be started from intermediate points if the user has pre-computed results [40]. For instance, providing a pre-computed taxonomic profile (--taxonomic-profile file.tsv) bypasses the MetaPhlAn step, and providing alignment files (SAM/BAM or BLAST-like TSV) allows the user to skip the respective alignment steps. The --resume option is particularly useful for efficiently re-running parts of a analysis with modified parameters, as it bypasses steps where valid output already exists [40].

Output Interpretation and Application in Microbiome Research

Data Normalization and Stratification

The raw output from HUMAnN 3 (Copies Per Million) is not suitable for direct cross-sample comparison, as it is influenced by sequencing depth. Therefore, normalization is an essential post-processing step. HUMAnN includes the humann_renorm_table utility to normalize gene family and pathway abundances to relative abundance (default) or counts per million (CPM).

A powerful feature of HUMAnN 3 is the generation of stratified pathway abundances. This output breaks down the total abundance of a pathway into contributions from individual microbial taxa. For example, in a couples' microbiome study, if the pathway for L-tryptophan biosynthesis is elevated in both partners, stratification can reveal whether the same bacterial species is responsible in both individuals or if different species are contributing to the same metabolic function in each person. This can provide deeper insights into functional redundancy or specialization within partners' microbiomes.

Linking Metabolic Potential to Health Outcomes

In the context of couples' health research, the identified metabolic pathways can be linked to specific health outcomes. For instance, studies have shown that gut microbiomes can display an enhanced capacity for the production of specific metabolites like tryptophan and the short-chain fatty acid (SCFA) butyrate [44]. These molecules are known to promote intestinal barrier function and modulate host immune responses [44]. HUMAnN 3 can be used to quantify the abundance of pathways related to the biosynthesis of these key metabolites in each partner's microbiome.

Table 2: Key Metabolic Pathways Relevant to Gut Health and Their Potential Interpretation

Pathway / Metabolic Route Key Metabolite Potential Health Relevance Interpretation in Couples' Study
L-Tryptophan Biosynthesis Tryptophan Precursor to serotonin; promotes intestinal barrier function [44] Assess shared potential for neuroimmune modulation.
Butyrate Synthesis I/II Butyrate Primary energy source for colonocytes; anti-inflammatory [44] [45] Compare SCFA production potential as a shared health marker.
Manno-oligosaccharide degradation MOS-derived SCFAs Prebiotic fermentation linked to beneficial gut bacteria [45] Relate to shared dietary habits (e.g., fiber intake).

As shown in Table 2, differences or similarities in these pathways between partners can form the basis for hypotheses about shared environmental factors, dietary patterns, and their collective influence on health. An example from research demonstrated the use of integrative metagenomics to identify predominant bacterial species and their metabolic routes involved in cooperative networks for SCFA biosynthesis after a dietary intervention [45]. This approach can be directly adapted to compare the metabolic synergy within couples' microbiomes.

The Scientist's Toolkit: Essential Research Reagents and Materials

Successful functional profiling with HUMAnN 3 relies on a combination of software, databases, and computational resources. The following table details the essential components of the pipeline.

Table 3: Research Reagent Solutions for HUMAnN 3 Analysis

Item / Resource Type Function / Purpose Installation Source / Reference
HUMAnN 3 Software Software Pipeline Core tool for inferring gene family and pathway abundance from metagenomic data. Conda (biobakery channel) or PyPI [41]
ChocoPhlAn Pangenome DB Reference Database Species-specific pangenomes for rapid nucleotide alignment. Downloaded via humann_databases [41]
UniRef90 Database Reference Database Non-redundant protein database for comprehensive translated search. Downloaded via humann_databases [41]
MetaCyc Database Biochemical Database Curated database of metabolic pathways and enzymes for functional annotation. Bundled with HUMAnN 3 [41]
MetaPhlAn 3 Software Tool High-resolution taxonomic profiler; used by HUMAnN for organism stratification. Installed automatically as a dependency [41] [42]
DIAMOND Software Tool Accelerated sequence aligner for fast translated search against protein databases. Installed automatically as a dependency [41] [40]
Bowtie2 Software Tool Ultrafast, memory-efficient nucleotide sequence aligner. Installed automatically as a dependency [41] [40]

Troubleshooting and Best Practices

Even with a correctly installed pipeline, users may encounter specific issues. A common point of confusion is the detection of "engineered pathways" from human gut microbiome data. These are pathways defined in MetaCyc that were constructed in a lab setting and do not naturally occur in any known organism. Their appearance in results is typically an artifact of the pathway inference process and does not indicate a problem with the data or mapping. It is recommended to filter out these pathways (e.g., those with names containing "engineered" or "biosynthesis") during downstream analysis [46].

For optimal performance, ensure your system meets the recommended requirements of at least 16 GB of RAM and 15 GB of disk space for the comprehensive databases [40]. When running large cohorts, such as multiple samples from couples, it is efficient to run jobs in parallel. Always inspect the log files generated by HUMAnN to verify that each step completed successfully and to identify the specific point of failure if an error occurs.

The study of couples' microbiomes represents a paradigm shift from individual-focused analyses to a dyadic framework that acknowledges the profound interpersonal influences on microbial composition and function. Dyadic data analysis provides a sophisticated statistical toolkit for investigating the interdependence between two linked individuals, such as romantic partners or spouses [47]. In the context of microbiome research, this approach is particularly valuable because cohabiting partners have been shown to share more similar microbiomes across gut, oral, skin, and genital sites than unrelated individuals, with measurable strain sharing (median ~12% gut; ~32% oral) that scales with duration of cohabitation [1]. This "social microbiome" forms through sustained close contact, shared environments, and intimate behaviors, potentially influencing reproductive, metabolic, and child health outcomes [1].

The core challenge in analyzing dyadic data is the violation of the independence assumption inherent in traditional statistical methods, as responses from dyad members are typically correlated [47] [48]. The Actor-Partner Interdependence Model (APIM) has emerged as the most widely used analytical framework for dyadic data in epidemiological and behavioral research [47]. APIM simultaneously models both actor effects (the effect of an individual's predictor on their own outcome) and partner effects (the effect of the partner's predictor on the individual's outcome), thereby explaining the interdependence of outcome errors within a dyad [47]. This model is particularly suited to microbiome research because it can quantify bidirectional influences in microbial transmission, convergence, and associated health outcomes within couples.

Theoretical Foundations of Dyadic Analysis

The Actor-Partner Interdependence Model (APIM)

The APIM framework conceptualizes dyadic relationships through distinguishable and indistinguishable dyads. Distinguishable dyads have a characteristic that differentiates members within each dyad (e.g., gender in heterosexual couples), while indistinguishable dyads have no such characteristic (e.g., same-sex couples or identical twins) [47]. This distinction is critical for determining the appropriate analytical approach.

The basic APIM equation for continuous outcomes takes the form: [ Y = \beta0 + \beta1(actor_x) + \beta2(partner_x) + \epsilon ] where *actorx* represents the actor effect for variable x, and partner_x represents the partner effect for variable x [47]. For microbiome studies, X could represent microbial diversity, specific taxon abundance, or functional potential, while Y could represent health outcomes like psychological well-being, metabolic parameters, or inflammatory markers.

APIM enables researchers to test four distinctive dyadic patterns using the parameter k method, where k represents the ratio of the partner effect to the actor effect (p/a) [48]:

  • Couple pattern (k = 1): Actor and partner effects are identical
  • Contrast pattern (k = -1): Actor and partner effects have equivalent magnitude but opposite directions
  • Actor-only pattern (k = 0): Only the actor effect is significant
  • Partner-only pattern (k = ∞): Only the partner effect is significant [48]

Distinguishability in Dyadic Analysis

Determining distinguishability is a crucial first step in APIM implementation. Kenny et al. recommend empirical testing for distinguishability, while Gonzalez and Griffin argue that theoretically distinguishable dyads should be treated as such without empirical testing [47]. For microbiome studies involving heterosexual couples, gender typically serves as the distinguishing variable, while same-sex couples would be treated as indistinguishable.

Analytical approaches differ for distinguishable versus indistinguishable dyads:

  • Indistinguishable dyads: Analyzed using multilevel modeling (MLM) with random intercepts or repeated measures models with compound symmetry covariance structure [47]
  • Distinguishable dyads: Analyzed using the two-intercept approach or interaction models that account for heterogeneous variances across dyad members [47]

Application to Couples' Microbiome Research

Empirical Evidence of Microbiome Sharing in Couples

A growing body of evidence demonstrates that intimate partners share significant microbial communities. Research integrating microbiota data into the Wisconsin Longitudinal Study found that spouses had significantly more similar gut microbiota compositions and shared more bacterial taxa than either siblings or random unrelated pairs [2]. Notably, spouses' microbiomes were more alike than those of siblings, despite siblings sharing genetics and upbringing, and these similarities persisted after adjusting for diet [2]. Married individuals also harbored greater gut microbial diversity and richness relative to those living alone, with the highest diversity seen in individuals reporting very close marital relationships [2].

The skin microbiome shows particularly strong partner influence. One study found partners' skin microbiomes were much more similar than expected by chance, with the most pronounced resemblance on the feet [1]. Algorithms could even identify couples with ~86% accuracy based solely on skin microbiome similarity [1]. Oral microbiota also demonstrates significant sharing between partners. Research indicates that a 10-second intimate kiss can transfer approximately 80 million bacteria between partners, and frequent kissing leads to couples developing a shared salivary microbiome over time [49]. However, the tongue microbiota of long-term partners shows greater similarity than that of random individuals independent of recent kissing, suggesting convergence due to shared lifestyle, environment, or host genetic factors [49].

Modern metagenomic studies using strain-level analysis have confirmed that cohabiting partners share specific microbial strains. A large-scale analysis of person-to-person microbiome transmission found that within-household adults share significantly more gut bacterial strains with each other than with outsiders, with strain sharing between cohabiting partners on par with that between parents and children [1]. Certain bacterial species, including specific Bifidobacterium and Bacteroides strains, were identified as "highly transmitted" within households [1].

Health Implications of Couples' Shared Microbiome

The convergence of microbiomes in couples has important health implications. The observed higher microbial diversity in married individuals may contribute to the well-documented "marriage protection" effect, where married people tend to have better health outcomes and longevity than singles [2]. A recent meta-analysis found that both microbial diversity and taxonomic abundance were positively associated with psychological well-being, with diversity emerging as the stronger predictor [50].

Conversely, microbiome sharing can facilitate the transmission of dysbiotic conditions. A striking example is bacterial vaginosis (BV), where male partners can harbor BV-associated bacteria on their penis and reintroduce them to the female partner after treatment [1]. A randomized trial demonstrated that treating the male partner with antibiotics alongside the female greatly reduced BV recurrence (35% vs 63% recurrence within 12 weeks when only the woman was treated) [1], highlighting the importance of couple-level interventions for certain microbiome-mediated conditions.

Partners also frequently exhibit correlated weights and metabolic profiles, which could partly stem from shared microbiome composition and function. The gut microbiota affects energy harvest and metabolism, potentially allowing dysbiosis in one partner to influence obesity risk or metabolic disease in the other [1].

Table 1: Key Findings from Couples' Microbiome Studies

Body Site Similarity Measure Key Finding Health Implication
Gut Strain sharing Median ~12% strain sharing between partners [1] Potential shared risk for metabolic conditions
Oral Strain sharing Median ~32% strain sharing between partners [1] Shared risk profiles for oral-systemic diseases
Skin Community similarity Partners' skin microbiomes significantly more similar than unrelated individuals [1] Potential for shared dermatological conditions
Gut Diversity Married individuals show greater microbial diversity than those living alone [2] Possible mechanism for marriage protection effect
Vaginal Condition transmission BV recurrence reduced when male partners receive treatment [1] Highlights need for couple-level interventions

Methodological Protocols for Dyadic Microbiome Analysis

Study Design and Data Collection

Participant Recruitment and Ethical Considerations

  • Recruit couples based on specific inclusion criteria (e.g., cohabitation duration, age range, health status)
  • Obtain informed consent from both partners, explicitly addressing the dyadic nature of the study and potential implications of findings for both individuals
  • Collect comprehensive metadata including relationship quality measures, intimacy behaviors, cohabitation duration, dietary patterns, and health history from both partners

Sample Collection and Processing

  • Collect multi-site samples (gut, oral, skin, genital) from both partners simultaneously to account for temporal variation
  • For gut microbiome: collect fecal samples using standardized collection kits with stabilizers
  • For oral microbiome: collect saliva and tongue dorsum samples using standardized swabbing techniques
  • For skin microbiome: collect samples from multiple body sites (e.g., forearms, feet, thighs) using standardized protocols
  • Process samples using either 16S rRNA gene sequencing for community profiling or shotgun metagenomics for strain-level resolution and functional analysis [1]

Bioinformatics Processing Pipeline

Data Generation and Quality Control

  • Process amplicon reads with a uniform QIIME 2/DADA2 pipeline to generate amplicon sequence variants (ASVs) [1]
  • For metagenomic data: perform host depletion, followed by species profiling using MetaPhlAn 4 and pathway profiling using HUMAnN 3 [1]
  • Implement rigorous quality control measures including removal of low-depth samples, contamination checks, and batch effect correction

Strain-Level Analysis

  • Quantify strain sharing with StrainPhlAn or inStrain across prioritized taxa using stringent ANI (Average Nucleotide Identity) and breadth thresholds to reduce false positives [1]
  • Identify single-nucleotide variants (SNVs) to distinguish transmitted strains from those acquired from common environmental sources
  • Determine directionality of transmission where possible through longitudinal sampling and phylogenetic analysis

Statistical Analysis Framework

Data Preparation for Dyadic Analysis

  • Structure data in pairwise format where each dyad has two rows (one for each partner) with linked identifiers [47]
  • Create variables for actor and partner effects for each predictor of interest
  • For distinguishable dyads (e.g., heterosexual couples), code distinguishing variable (e.g., gender)
  • Address missing data using appropriate imputation techniques or maximum likelihood estimation

Partner-vs-Non-Partner Contrasts

  • Calculate within-couple similarity metrics (e.g., Bray-Curtis, Jaccard, UniFrac distances)
  • Compare within-couple similarity to between-couple similarity using permutation tests (e.g., PERMANOVA)
  • Implement similarity-based approaches such as determining if partners can be identified based on microbial profiles using machine learning classifiers [1]

Actor-Partner Interdependence Modeling

  • Specify APIM models based on distinguishability of dyads:
    • For indistinguishable dyads: Use multilevel modeling with random intercepts or repeated measures with compound symmetry [47]
    • For distinguishable dyads: Use the two-intercept approach to obtain separate estimates for each type of partner [47]
  • Test dyadic patterns using the parameter k method or alternative approaches (new-variable approach or χ² difference test) [48]
  • For binary outcomes (e.g., disease presence/absence), use generalized estimating equations (GEE) or logistic APIM extensions

Advanced Analytical Extensions

  • Incorporate longitudinal designs to examine microbial convergence over time
  • Integrate multi-omics data (e.g., metabolomics, immunologic measures) to explore mechanisms linking dyadic microbial patterns to health outcomes
  • Implement moderated APIM to examine whether relationship quality, intimacy behaviors, or cohabitation duration moderate actor and partner effects

Table 2: Analytical Methods for Dyadic Microbiome Data

Analytical Goal Recommended Method Key Considerations Software Implementation
Partner Similarity Beta-diversity contrasts with permutation tests Account for sex differences when comparing similarity across body sites QIIME 2, R vegan package
Strain Sharing StrainPhlAn, inStrain Use stringent thresholds to minimize false positives; requires metagenomic data StrainPhlAn, inStrain
APIM for continuous outcomes Multilevel modeling or repeated measures Choose based on distinguishability of dyads SAS PROC MIXED, R lme4, Mplus
APIM for binary outcomes Generalized estimating equations Binary extensions of APIM are computationally intensive SAS PROC GENMOD, R gee package
Dyadic pattern testing Parameter k method, new-variable approach, or χ² difference test New-variable approach performs well without convergence issues [48] Mplus, R lavaan

Experimental Workflow and Signaling Pathways

The following diagram illustrates the comprehensive workflow for dyadic microbiome analysis, from study design through interpretation:

G cluster_0 Experimental Phase cluster_1 Analytical Phase Start Study Design & Couple Recruitment SC Sample Collection (Multi-site from both partners) Start->SC Seq Sequencing & Bioinformatics Processing SC->Seq DC Data Curation & Pairwise Dataset Creation Seq->DC Dist Distinguishability Assessment DC->Dist SIM Similarity Analysis (Partner vs Non-partner) Dist->SIM APIM APIM Implementation SIM->APIM HC Health Correlation & Mechanistic Exploration APIM->HC Int Interpretation & Couple-Level Insights HC->Int

Diagram 1: Comprehensive Workflow for Dyadic Microbiome Analysis. This diagram outlines the key stages in conducting dyadic analysis of couples' microbiomes, from initial study design through final interpretation.

The following diagram illustrates the conceptual framework of the Actor-Partner Interdependence Model (APIM) as applied to microbiome research:

G P1_M Partner 1 Microbiome P1_H Partner 1 Health Outcome P1_M->P1_H Actor Effect (a1) P2_M Partner 2 Microbiome P2_H Partner 2 Health Outcome P1_M->P2_H Partner Effect (p21) Cov Covariance P1_H->Cov P2_M->P1_H Partner Effect (p12) P2_M->P2_H Actor Effect (a2) P2_H->Cov A1 Actor Effect (a1) P12 Partner Effect (p12) A2 Actor Effect (a2) P21 Partner Effect (p21)

Diagram 2: Actor-Partner Interdependence Model (APIM) for Microbiome Studies. This diagram visualizes the core APIM structure where each partner's microbiome influences both their own health (actor effects) and their partner's health (partner effects), with correlated outcomes accounting for shared environmental or lifestyle factors.

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 3: Essential Research Reagents and Computational Tools for Dyadic Microbiome Studies

Category Item Specification/Version Application in Dyadic Studies
Wet Lab Supplies DNA/RNA Shield Stabilizer Zymo Research R1100 Preserves microbial composition during storage and transport
Stool Collection Kit OMNIgene•GUT OMR-200 Standardized fecal sample collection from both partners
Copan FLOQSwabs 502CS01 Consistent mucosal sampling (oral, vaginal)
DNeasy PowerSoil Pro Kit Qiagen 47014 High-quality DNA extraction challenging samples
Sequencing Reagents 16S rRNA Amplification Primers 515F/806R Bacterial community profiling for similarity analysis
Shotgun Metagenomic Library Prep Illumina DNA Prep Strain-level resolution for transmission studies
Sequencing Reagents Illumina NovaSeq 6000 S4 High-depth sequencing for strain variant detection
Bioinformatics Tools QIIME 2 2023.9 Amplicon data processing for community similarity
MetaPhlAn 4.0 Species-level profiling from metagenomic data
HUMAnN 3.6 Functional pathway analysis for mechanistic insights
StrainPhlAn 4.0 Strain tracking to confirm microbial transmission
Statistical Software R with lavaan package 4.3.1 APIM implementation and dyadic pattern testing
Mplus 8.10 Structural equation modeling for complex APIM
SAS PROC MIXED 9.4 Mixed models for distinguishable dyads

Advanced dyadic analytics, particularly partner-vs-non-partner contrasts and Actor-Partner Interdependence Models, provide a powerful framework for understanding how couples' microbiomes interact and influence health outcomes. By accounting for the inherent interdependence between partners, these methods offer more nuanced insights than individual-focused approaches alone.

The application of APIM in microbiome research is still nascent but holds tremendous promise for elucidating the interpersonal dimensions of microbial ecology and its health implications. Future research should focus on longitudinal designs to track microbial convergence and transmission dynamics over time, integration of multi-omics data to uncover mechanisms linking dyadic microbial patterns to health, and the development of specialized statistical tools for complex dyadic microbiome data.

As evidence accumulates for the significance of couple-level microbial dynamics in health and disease, dyadic analytics will play an increasingly important role in designing targeted interventions that consider both partners. This approach represents a crucial advancement toward more comprehensive and effective strategies for modulating the microbiome to improve health outcomes.

Ensuring Reproducibility: Tackling Contamination, Data Policy, and Model Selection

Adhering to Data Release Policies and MIxS Standards for Metadata

In contemporary studies of couples' microbiomes, the reliability and reproducibility of research findings are paramount. Adhering to established data release policies and metadata standards is not merely an administrative task but a fundamental scientific responsibility. Metadata—the contextual data describing the 'who', 'what', 'when', 'where', and 'why' of your experimental samples—provides the essential framework that makes microbiome data interpretable, reusable, and shareable across the scientific community. For researchers investigating the intricate relationships between couples' microbiomes and health outcomes, consistent application of the Minimum Information about any (x) Sequence (MIxS) standards developed by the Genomics Standards Consortium (GSC) ensures that complex datasets can be integrated and compared across studies, thereby accelerating discovery [51] [27] [52].

Journals such as Microbiome enforce a strict data release policy, requiring that all datasets underlying a paper's conclusions be made publicly available at the time of publication. This policy includes not only raw sequence data but also the accompanying metadata formatted according to MIxS standards and the analytical scripts used for processing [27]. This comprehensive approach to data sharing is critical for studies of couples' microbiomes, where the interplay between host genetics, shared environment, and microbial transfer creates complex data ecosystems requiring meticulous documentation.

Core Metadata Standards: MIxS and Beyond

The MIxS Framework

The MIxS standard provides a unified framework for describing the contextual information about the sampling and sequencing of genomic sequences. It consists of a standardized data dictionary of sample descriptors organized into checklists and environmental packages that address three fundamental questions about any sequence: what is its source, in what environment was the sample collected, and what methods were used to process it [52]. The MIxS standard is modular by design, comprising several components:

  • Checklists: These include required, recommended, and optional metadata fields for specific types of genomic sequences. Key checklists relevant to couples' microbiome research include:
    • MIMS (Minimum Information about a Metagenome Sequence)
    • MIMARKS (Minimum Information about a Marker Gene Sequence) for marker gene studies (e.g., 16S rRNA gene sequencing) [52] [53]
  • Environmental Extensions: These include terms that describe specific environments from which a sample was collected. For human microbiome studies, the host-associated package is particularly relevant [52] [53].
  • Combinations: Researchers can create MIxS Combinations by mixing and matching any genomic checklist with terms from any environmental extension to precisely suit their study design [52].
Associated Standards and Ontologies

Beyond the core MIxS framework, several complementary systems enhance metadata consistency:

  • Genomes OnLine Database (GOLD) Ecosystem Classification: This five-level path (Ecosystem → Ecosystem Category → Ecosystem Type → Ecosystem Subtype → Specific Ecosystem) provides a structured vocabulary for describing sample environments. For human microbiome studies, the classification would typically follow a host-associated path [53].
  • Environment Ontology (EnvO): EnvO provides a community-led ontology of environmental entities with unique, resolvable identifiers. Its greatest relevance to MIxS compliance lies in the "MIxS triad" of terms, which are recommended to be populated with EnvO terms [53]:
    • env_broad_scale (Biome): The major environmental system (e.g., human-associated biome [ENVO:01001053]).
    • env_local_scale (Feature): The direct local vicinity of the sample (e.g., human skin [ENVO:01062824] or human oral cavity [ENVO:01001739]).
    • env_medium (Material): The environmental material immediately surrounding the sample (e.g., skin microbiome [ENVO:05890036]) [53].

Table 1: Essential MIxS Checklists and Environmental Packages for Couples' Microbiome Research

Standard Type Name Scope and Relevance Key Application in Couples' Studies
Checklist MIMARKS (Marker Gene) Specifies minimum information for marker gene sequences (e.g., 16S rRNA) [52]. Documenting 16S rRNA sequencing of skin, oral, or gut samples from partners.
Checklist MIMS (Metagenome) Specifies minimum information for metagenome sequences [52]. Documenting shotgun metagenomic sequencing of samples.
Environmental Package Host-associated Describes samples associated with a host organism [53]. Core package for all human sample collections; captures host details.
Environmental Package Human-associated Specialization of the host-associated package for human hosts. Providing specific details like host sex, age, health status, and diet.

Data Release Policies and Repository Submission

Journal and Funder Requirements

Leading scientific journals have implemented stringent data policies to enhance reproducibility. For instance, the journal Microbiome requires that:

  • All datasets supporting a paper's conclusions must be available to reviewers at submission and publicly available upon publication [27].
  • Metadata must be formatted according to MIxS standards, with sample identifiers in the repository matching those used in the manuscript [27].
  • Authors must make their analysis code/scripts available (e.g., as knitr files or iPython Notebooks) to ensure complete transparency and reproducibility [27].

Furthermore, funding agencies often stipulate specific data timelines. The NOAA Omics Data Management Guide, for example, suggests a deadline of one year after the project end date for intramural principal investigators, or before a paper is published, whichever is sooner [51].

Selecting Appropriate Repositories

Submitting data to the correct public repository is a critical step in the data release process. The choice of repository depends on the data type, as outlined below.

Table 2: Data Repository Selection Guide for Microbiome Research

Data Type Primary Repository Alternative/Specialized Repositories Key Considerations
Raw Sequence Data (16S, metagenomes) NCBI SRA (Sequence Read Archive) ENA (European Nucleotide Archive), DDBJ Mandatory for most journals; links to BioSample metadata [51] [27].
Biodiversity Data (ASV/OTU Tables) OBIS/GBIF NCEI (for smaller datasets) OBIS/GBIF are global biodiversity repositories actively seeking eDNA data [51].
Metabolomics/ Proteomics Data Specialized Repositories (e.g., MetaboLights) NCEI (if environmental context) NCEI can curate datasets <20GB but lacks interactive querying features of 'omics-tailored repositories [51].
Analysis Scripts/Code GitHub, GitLab, Zenodo As supplementary files with the manuscript Zenodo provides a DOI for code snapshots; journals like Microbiome require script availability [27].

Experimental Protocol: Implementing MIxS Standards in a Couples' Microbiome Study

Metadata Collection and Management Workflow

The following workflow, developed from NOAA Omics and NMDC guidelines, provides a step-by-step protocol for managing metadata in a couples' microbiome study [51] [53].

G Start Start Project Plan Plan Metadata (Select MIxS Checklists) Start->Plan Template Use Standardized Template Plan->Template Collect Collect Metadata (Primary Sources) Digitize Digitize & Validate Collect->Digitize Template->Collect Standardize Standardize Terms (Ontologies) Digitize->Standardize Submit Submit to Repositories Standardize->Submit Publish Publish Study Submit->Publish

Metadata Management Workflow

Step 1: Pre-Sample Collection Planning

  • Action: Before collecting the first sample, select the appropriate MIxS checklists (MIMARKS for 16S sequencing; MIMS for shotgun metagenomics) and the host-associated environmental package [52] [53].
  • Protocol: Create a project-specific data dictionary in a spreadsheet. Define all attributes (columns), their formats, and permissible values (e.g., using EnvO terms for the MIxS triad). This serves as a single source of truth for all researchers involved in the project [51].

Step 2: Concurrent Metadata Collection

  • Action: Associate metadata with sample IDs as soon as samples are collected [51].
  • Protocol: For each participant in the couples' study, record a minimum set of core attributes at collection. Use mobile data entry forms or standardized paper sheets to minimize transcription errors. Immediately backup primary sources [51].

Step 3: Metadata Digitization and Validation

  • Action: Transfer metadata from primary sources to a centralized digital template.
  • Protocol: Use the MIxS spreadsheet templates available from the GSC GitHub repository [52]. Validate data for potential errors (e.g., out-of-range values for host age, missing geolocation data) and follow up with the original collector to resolve discrepancies promptly [51].

Step 4: Standardization and Ontology Mapping

  • Action: Refine metadata to a standard format with well-defined attributes [51].
  • Protocol: Standardize the data in each column consistently. For the MIxS triad (env_broad_scale, env_local_scale, env_medium), use the precise EnvO terms and their unique identifiers (e.g., human skin [ENVO:01062824]) [53]. For missing data that cannot be recovered, use the INSDC standardized missing value reporting language (e.g., "not collected," "not applicable") [51].

Step 5: Repository Submission

  • Action: Submit metadata and sequence data to appropriate repositories.
  • Protocol:
    • NCBI BioSample: Create and submit sample metadata using the MIxS-compliant checklist.
    • Sequence Read Archive (SRA): Submit raw sequence data, linking to the BioSample records.
    • Biodiversity Data: Processed ASV/OTU tables with associated taxonomic assignments can be submitted to OBIS/GBIF using tools like the edna2obis Python workflow [51].
    • Persistent Identifiers: Once accessions are obtained (e.g., BioSample SAMNXXXXXX), include them in the manuscript's "Availability of Data and Materials" section [27].
The Scientist's Toolkit: Essential Research Reagent Solutions

Table 3: Key Research Reagents and Materials for Couples' Microbiome Studies

Item/Category Function/Application Implementation Notes
Sample Collection Kits (e.g., fecal, saliva, skin swabs) Standardized procurement of biological material from both members of a couple. Use kits with stabilizers to preserve microbial DNA/RNA integrity during transport.
DNA/RNA Extraction Kits Isolation of high-quality, inhibitor-free nucleic acids for sequencing. Critical for protocol reproducibility; document brand and version in investigation type metadata [27].
PCR Primers (e.g., 16S V4 region) Amplification of target marker genes for sequencing. Specify primer sequences and conditions in pcr primers MIxS field [27] [52].
Mock Community Controls Serve as positive controls to assess sequencing accuracy and bioinformatic pipeline performance. Required by journals like Microbiome for low-biomass studies; sequence and report data alongside samples [27].
Negative Extraction Controls Control for contamination introduced during laboratory processing. Include in every extraction batch; sequence and analyze to identify potential contaminants [27].
Standardized MIxS Templates Ensure consistent, complete, and standards-compliant metadata capture. Use templates from the GSC GitHub [52] or NMDC [53] to structure project metadata.

Adherence to MIxS standards and data release policies is a critical component of rigorous couples' microbiome research. By implementing the protocols outlined in this document—from meticulous metadata collection using standardized templates to deposition in appropriate repositories—researchers significantly enhance the reproducibility, discoverability, and long-term value of their work. This disciplined approach to data management ensures that complex datasets investigating the links between couples' microbiomes and health outcomes can be reliably interpreted, independently verified, and meaningfully integrated into the broader scientific knowledge base, ultimately accelerating progress in the field.

Implementing Essential Experimental Controls for Low-Biomass Samples

The analysis of low-biomass microbial environments—such as specific human tissues, biological samples from couples' microbiome studies, and various built environments—presents unique challenges that distinguish it from higher-biomass microbiome research. In these samples, where microbial biomass approaches the limits of detection for standard DNA-based sequencing approaches, the inevitable introduction of external microbial DNA contaminants can disproportionately impact results and lead to spurious biological conclusions [54]. The research community has witnessed several high-profile controversies, such as debates surrounding the placental microbiome and tumor microbiomes, which underscore the critical importance of implementing robust experimental controls to distinguish true signal from contamination [54] [55]. This protocol outlines essential strategies for preventing, identifying, and accounting for contamination throughout the experimental workflow, with particular emphasis on studies investigating couples' microbiomes and their relationship to health outcomes.

In low-biomass microbiome research, contaminants can be introduced from various sources throughout the experimental workflow. Understanding these sources is the first step toward implementing effective controls.

  • Human Operators: Microbial DNA from researchers' skin, hair, or breath can contaminate samples during collection or processing [54].
  • Sampling Equipment: Collection kits, swabs, and other tools can introduce contaminating DNA unless properly decontaminated [54] [55].
  • Laboratory Reagents: DNA extraction kits, PCR reagents, and water often contain trace amounts of microbial DNA that become significant in low-biomass contexts [55].
  • Laboratory Environments: Airborne particles and surfaces in laboratory spaces harbor microbial communities that can contaminate samples [54].
  • Cross-Contamination (Well-to-Well Leakage): DNA transfer between adjacent samples on multi-well plates during processing can compromise sample integrity [54] [55].

Table 1: Common Contamination Sources and Their Impact in Low-Biomass Studies

Contamination Source Description Potential Impact on Data
Human Operators DNA from skin, hair, aerosols from breathing Introduction of human-associated taxa (e.g., Cutibacterium, Staphylococcus)
Laboratory Reagents Microbial DNA in extraction kits, enzymes, water Consistent background community across samples (e.g., Comamonadaceae, Burkholderiales)
Sampling Equipment Swabs, collection tubes, preservatives Introduction of environmental taxa depending on manufacturing and storage
Cross-Contamination Well-to-well leakage on plates during PCR/library prep Artificial similarity between spatially adjacent samples
Host DNA Misclassification Incorrect taxonomic assignment of host sequences False positive microbial signals, particularly in metagenomic studies [55]

Comprehensive Experimental Design Strategy

Pre-Sampling Planning and Decontamination

Before sample collection begins, researchers must implement rigorous decontamination protocols:

  • Equipment Sterilization: Use single-use, DNA-free collection materials where possible. For re-usable equipment, implement a two-step decontamination process: (1) treatment with 80% ethanol to kill contaminating organisms, followed by (2) a nucleic acid degrading solution (e.g., sodium hypochlorite/bleach, UV-C exposure, or commercial DNA removal solutions) to remove residual DNA [54].
  • Personal Protective Equipment (PPE): Researchers should wear appropriate PPE—including gloves, masks, cleanroom suits, and shoe covers—to minimize contamination from human sources [54].
  • Reagent Validation: Test all reagents (e.g., preservation solutions, extraction kits) for background microbial DNA through blank controls before study initiation [54].
Strategic Control Selection and Implementation

The inclusion of appropriate process controls is essential for identifying contamination sources and informing subsequent computational decontamination. We recommend implementing a multi-layered control strategy:

Table 2: Essential Process Controls for Low-Biomass Microbiome Studies

Control Type Collection Method Purpose When to Include
Negative Extraction Control Empty tube taken through DNA extraction process Identifies contamination from extraction reagents and process Every extraction batch [55]
No-Template Control (NTC) PCR reaction with water instead of DNA template Detects contamination in PCR/master mix reagents Every PCR batch [55]
Sample Collection Control Empty collection vessel handled like a sample Identifies contamination from collection materials Every sampling batch [54]
Environmental Control Swab of air, surfaces, or PPE in sampling environment Characterizes background environmental contamination During sample collection [54]
Mock Community DNA from known microbial strains in defined ratios Assesses technical bias and sequencing accuracy Each sequencing batch [55]
Batch Design and Randomization

To prevent batch effects from confounding results, carefully consider sample organization:

  • Avoid Batch Confounding: Ensure phenotypes and covariates of interest (e.g., health status, couple pairing) are not confounded with processing batches. Actively balance batches using tools like BalanceIT rather than relying solely on randomization [55].
  • Distribute Controls: Include controls in every processing batch (extraction, PCR, sequencing) to capture batch-specific contamination profiles [55].
  • Spatial Randomization: When using multi-well plates, randomize sample positions to avoid systematic spatial biases and place negative controls strategically to detect well-to-well leakage [54] [55].

Detailed Protocols for Key Experimental Stages

Sample Collection Protocol for Couples' Microbiome Studies

This protocol is specifically adapted for collecting low-biomass samples in a couples' microbiome study, which might include skin, oral, or other specialized samples.

Materials Required:

  • DNA-free swabs or collection kits
  • Personal protective equipment (gloves, mask, clean suit)
  • Nucleic acid preservation solution
  • Pre-labeled collection tubes
  • Environmental control swabs

Procedure:

  • Preparation: Decontaminate work surfaces with DNA-degrading solution. All personnel should don appropriate PPE.
  • Control Collection: Before sample collection, prepare and seal negative controls including:
    • An empty collection tube
    • A swab exposed to the sampling environment air
    • A swab of glove surfaces
  • Sample Collection: Using aseptic technique, collect the target sample (e.g., skin swab) with minimal handling.
  • Preservation: Immediately place the sample in appropriate preservation solution and store at recommended temperature (typically -80°C for long-term storage).
  • Documentation: Record all sample handling information and potential deviations from protocol.
DNA Extraction and Library Preparation Protocol

Materials Required:

  • DNA extraction kit (validated for low-biomass)
  • Molecular biology grade water
  • Filtered pipette tips
  • Negative extraction controls
  • Mock community controls

Procedure:

  • Workspace Preparation: Clean all surfaces and equipment with DNA-degrading solution. Use dedicated workspace for pre- and post-PCR activities if possible.
  • DNA Extraction: Process samples alongside negative extraction controls and mock communities using manufacturer's protocol with modifications for low biomass:
    • Include bead-beating step for comprehensive cell lysis
    • Use larger sample input volumes when possible
    • Include carrier RNA if recommended for low biomass recovery
  • Quality Control: Quantify DNA yield using fluorometric methods sensitive to low concentrations (e.g., Qubit).
  • Library Preparation: Use minimal-cycle PCR protocols to minimize amplification bias. Include no-template controls at this stage.
  • Pooling and Cleanup: Normalize libraries based on quantitative measurements and include appropriate balance of controls in final sequencing pool.

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 3: Essential Research Reagent Solutions for Low-Biomass Studies

Item Function Application Notes
DNA-free Swabs Sample collection without introducing contaminants Verify DNA-free status by manufacturer certification or in-house testing
Nucleic Acid Preservation Solution Stabilizes microbial DNA/RNA at time of collection Prevents microbial growth and degradation between collection and processing
DNA Degradation Solution Removes contaminating DNA from surfaces and equipment Sodium hypochlorite (0.5-1%) or commercial DNA removal solutions
Low-Biomass DNA Extraction Kit Efficiently recovers minimal microbial DNA Select kits with demonstrated high efficiency for low cell numbers
Molecular Biology Grade Water DNA-free water for molecular reactions Test batches for background microbial DNA
Mock Microbial Communities Control for technical bias and quantification accuracy Use defined mixtures of known microbial strains
Filtered Pipette Tips Prevents aerosol contamination during liquid handling Essential for all molecular steps to prevent cross-contamination

Visualizing Experimental Workflows and Contamination Pathways

Low-Biomass Experimental Workflow with Critical Control Points

G cluster_controls Control Implementation Points Planning Planning Sampling Sampling Planning->Sampling  Define control strategy Extraction Extraction Sampling->Extraction  Include collection controls EnvironmentalControls Environmental Controls Sampling->EnvironmentalControls Sequencing Sequencing Extraction->Sequencing  Include extraction controls ExtractionControls Extraction Blanks Extraction->ExtractionControls PCRControls No-Template Controls Extraction->PCRControls MockCommunities Mock Communities Extraction->MockCommunities Analysis Analysis Sequencing->Analysis  Include sequencing controls

G HumanOperator Human Operator PPE Proper PPE Usage HumanOperator->PPE Mitigates SamplingEquipment Sampling Equipment EquipmentDecontamination Equipment Decontamination SamplingEquipment->EquipmentDecontamination Mitigates LabReagents Laboratory Reagents ReagentScreening Reagent Screening LabReagents->ReagentScreening Mitigates CrossContamination Cross-Contamination SpatialRandomization Spatial Randomization CrossContamination->SpatialRandomization Mitigates

Data Analysis Considerations for Controlled Studies

While comprehensive data analysis protocols extend beyond experimental controls, several key considerations directly relate to control implementation:

  • Control-Informed Decontamination: Utilize data from process controls to inform computational decontamination using established tools (e.g., Decontam, SourceTracker). However, note that well-to-well leakage into contamination controls can violate the assumptions of some decontamination methods [55].
  • Batch Effect Correction: Account for processing batches in statistical models, even when using balanced designs.
  • Reporting Standards: Clearly document all controls used, their results, and any decontamination steps applied in publications to enhance reproducibility and transparency [54].

Implementing comprehensive experimental controls is not merely a technical formality in low-biomass microbiome research—it is a fundamental requirement for generating biologically valid and interpretable data. This is particularly critical in couples' microbiome studies investigating health outcomes, where subtle microbial signals may have important clinical implications. The protocols outlined here provide a framework for systematically addressing contamination challenges through rigorous pre-sampling planning, strategic control implementation, and appropriate analytical approaches. By adopting these practices, researchers can significantly enhance the reliability and interpretability of their low-biomass microbiome studies, advancing our understanding of these complex microbial systems while avoiding the pitfalls that have challenged the field.

Optimizing Bioinformatics Parameters to Minimize False Positive Strain Sharing

Strain-level analysis of microbiome data provides unprecedented resolution for investigating microbial transmission between hosts, such as couples in health outcomes research. However, inferring transmission from strain sharing data is complicated by shared environmental and demographic factors that can confound results. This application note details a standardized protocol for optimizing key bioinformatics parameters to minimize false positives in strain sharing inference, with specific application to studies of couples' microbiomes. We provide step-by-step methodologies for parameter selection, validation strategies using positive and negative controls, and implementation workflows to enhance the reliability of transmission analysis in dyadic microbiome studies.

The inference of microbial transmission through strain-resolved metagenomics has become a powerful tool for understanding microbiome dynamics in closely linked individuals, such as couples. However, recent evidence demonstrates that shared environments and host characteristics can complicate transmission inference, as strain sharing may result from parallel acquisition rather than direct transmission [36]. In couples' microbiome studies, where partners share living environments, diets, and lifestyles, distinguishing true transmission from spurious sharing is particularly challenging.

Bioinformatics pipelines for strain detection involve multiple parameter choices that significantly impact sensitivity and specificity. Parameters governing sequence similarity thresholds, genome coverage requirements, and read mapping stringency directly influence false positive rates in strain sharing detection. Without careful optimization, these parameters can lead to both overestimation of transmission events and failure to detect true biological sharing. This protocol addresses these challenges through systematic parameter validation and controlled analysis strategies specific to couples' research designs.

Core Parameter Optimization

Critical Bioinformatics Parameters

Optimizing strain sharing analysis requires careful adjustment of several bioinformatics parameters that directly impact false positive rates. The table below summarizes key parameters, their typical value ranges, and optimization criteria.

Table 1: Key Bioinformatics Parameters for Strain Sharing Analysis

Parameter Category Specific Parameter Recommended Range Optimization Criteria Impact on False Positives
Sequence Similarity Average Nucleotide Identity (ANI) Threshold 99.99% - 99.999% Balance between strain discrimination and technical variability Higher thresholds reduce false positives but may miss true transmission
Genome Coverage Minimum breadth of coverage 25% - 50% Retain sufficient genomic representation while controlling for false positives Lower coverage increases false positives from partial genomes
Read Mapping Minimum read depth 5× - 10× Ensure sufficient sequencing depth for accurate variant calling Lower depth increases stochastic errors in similarity estimation
Variant Calling Minor allele frequency threshold 10% - 20% Filter low-frequency variants that may represent sequencing errors Lower thresholds increase noise in strain discrimination
Strain Presence Detection threshold across samples 25% - 50% genome representation at 5× coverage Balance sensitivity for rare strains with specificity [36] Lower thresholds increase cross-talk between samples
Validation Strategies for Parameter Selection

Implement the following validation approaches to guide parameter selection:

  • Positive Controls: Use known strain sharing events (e.g., technical replicates, sample splits) to establish true positive rates across parameter combinations.

  • Negative Controls: Include samples from individuals with non-overlapping lifetimes or geographical separation where transmission is impossible [36].

  • Parameter Sweeps: Systematically test parameter combinations using grid search approaches while monitoring performance metrics.

  • Background Estimation: Quantify strain sharing rates between biologically unrelated individuals to establish baseline sharing rates.

Experimental Protocol for Couples' Microbiome Studies

Sample Collection and Sequencing
  • Sample Collection: Collect fecal samples from both partners simultaneously using standardized collection kits containing 95% ethanol preservative [36].
  • Storage Conditions: Store samples at 4°C for no more than 2 weeks before processing, then transfer to -80°C for long-term storage.
  • DNA Extraction: Use the DNeasy PowerSoil Pro Kit (Qiagen) or equivalent with bead-beating step for mechanical lysis.
  • Library Preparation: Prepare libraries using Illumina DNA Prep Tagmentation kit with 350bp insert size.
  • Sequencing: Sequence on Illumina NovaSeq 6000 platform targeting 20-50 million 2×150bp read pairs per sample.
Bioinformatics Processing
  • Quality Control: Process raw reads with Trimmomatic requiring minimum length of 70bp and quality score of 20 within a 4bp sliding window [36].
  • Host Read Removal: Align reads to host reference genome (e.g., hg38) and remove matching sequences.
  • Metagenomic Assembly: Perform co-assembly of reads from all couple samples using MEGAHIT with default parameters.
  • Strain Profiling: Profile strains using inStrain software with parameters optimized as described in Section 2.
Strain Sharing Analysis
  • Strain Detection: Consider a strain "present" in a sample when at least 25% of its genome is represented with minimum 5× coverage in both samples being compared [36].
  • Similarity Calculation: Calculate Average Nucleotide Identity (ANI) using a microdiversity-aware approach that calls substitutions only when no alleles are shared between samples.
  • Sharing Definition: Define strain sharing as ANI ≥ 99.999% between samples from different individuals.
  • Transmission Inference: Apply conservative filtering to exclude strains that are widespread in the population or present in environmental samples.

The Scientist's Toolkit

Table 2: Essential Research Reagents and Computational Tools

Category Item Specification/Version Function/Purpose
Wet Lab Reagents DNeasy PowerSoil Pro Kit Qiagen High-quality DNA extraction from fecal samples
Illumina DNA Prep Tagmentation Kit (M) Tagmentation Library preparation for shotgun metagenomics
Ethanol (95%) Molecular biology grade Sample preservation at collection
Bioinformatics Tools Trimmomatic v0.39 Read quality control and adapter removal
bowtie2 v2.4.2 Read alignment to reference genomes
inStrain v1.5.7 Strain-level population genetic analysis [36]
MEGAHIT v1.2.9 Metagenomic assembly
Reference Databases Unified Human Gastrointestinal Genome UHGG v1.0 Species-representative microbial genomes [36]
Human Reference Genome hg38 Host sequence removal

Implementation Workflows

Strain Sharing Analysis Pipeline

StrainSharingWorkflow RawReads Raw Sequencing Reads QC Quality Control (Trimmomatic) RawReads->QC HostRemoval Host Read Removal QC->HostRemoval Alignment Align to Reference (bowtie2) HostRemoval->Alignment StrainProfiling Strain Profiling (inStrain) Alignment->StrainProfiling ParameterOpt Parameter Optimization StrainProfiling->ParameterOpt SharingAnalysis Strain Sharing Analysis ParameterOpt->SharingAnalysis Validation Result Validation SharingAnalysis->Validation

Parameter Optimization Strategy

ParameterOptimization Start Define Parameter Space Controls Establish Controls (Positive & Negative) Start->Controls GridSearch Parameter Grid Search Controls->GridSearch Metrics Calculate Performance Metrics GridSearch->Metrics SelectParams Select Optimal Parameters Metrics->SelectParams Validate Cross-Validation SelectParams->Validate

Discussion

Optimizing bioinformatics parameters for strain sharing analysis in couples' microbiome studies requires a balanced approach that considers both technical and biological factors. The stringent parameters recommended in this protocol (99.999% ANI threshold, 25% minimum genome coverage, and 5× read depth) provide a conservative foundation for minimizing false positives while maintaining sensitivity to true transmission events. Implementation of proper negative controls is particularly crucial in couples' studies, where shared environments can create spurious signals of transmission that must be distinguished from direct microbial exchange.

Future methodological developments should focus on integrating temporal sampling designs and accounting for host-specific factors that influence strain retention. The protocols described here provide a robust foundation for investigating microbial transmission in couples' microbiome studies while minimizing false positive inferences that could lead to incorrect conclusions about transmission dynamics and their relationship to health outcomes.

In the study of couples' microbiomes and their association with health outcomes, a major challenge lies in disentangling the effects of shared exposures from the true influence of the microbiome itself. Factors such as diet, medication use, and co-habitation duration act as potent confounders, capable of creating spurious associations or masking real effects. The inherent characteristics of microbiome data—including its compositional nature, high dimensionality, and sparsity—further complicate statistical analysis [17] [56]. This document provides detailed application notes and protocols for the robust statistical adjustment of these key confounders, ensuring that inferences drawn in couples' microbiome research are both valid and reliable.

Key Confounding Factors in Couples' Microbiome Research

In microbiome studies involving couples, several factors can significantly influence microbial community composition and must be accounted for as confounders. These factors can be technical, biological, or behavioral in nature.

Table 1: Key Confounding Factors in Couples' Microbiome Studies

Confounder Category Specific Variables Impact on Microbiome Adjustment Methods
Diet Protein intake, fruit/vegetable consumption, overall dietary patterns Strongly shapes gut microbiota composition; couples often share diets [57] [2]. Include as covariates in statistical models; use dietary indices or specific nutrient measures.
Medication Antibiotics, proton pump inhibitors, antipsychotics, other prescription drugs Dramatically alters microbial diversity and abundance [57] [58]. Document use carefully; exclude recently medicated participants or include as binary/categorical covariates.
Co-habitation & Social Dynamics Duration of cohabitation, relationship quality, physical contact Leads to microbial convergence between partners [2]. Measure and include as continuous or categorical variables in models.
Demographics & Lifestyle Age, sex, pet ownership, geography Fundamental determinants of microbial community structure [57]. Standard covariates in all models; ensure matched study designs where possible.
Technical Factors DNA extraction kit batch, storage conditions, sequencing run Introduces non-biological variation that can obscure true signals [57] [58]. Standardize protocols; include batch as random effect in models; use positive and negative controls.

The Special Case of Co-habitation

Research has demonstrated that married couples and cohabiting partners harbor more similar gut microbiota than unrelated individuals, an effect driven entirely by couples reporting close relationships [2]. This similarity is likely mediated by shared living environments, physical contact, and common behavioral patterns. Consequently, the duration and intensity of co-habitation must be measured and statistically controlled for when comparing microbial communities between couples or against external control groups. Furthermore, studies have shown that married individuals living with a partner possess microbial communities of greater diversity and richness compared to those living alone, which is a significant health-related outcome in its own right [2].

Statistical Analysis Framework

Characteristics of Microbiome Data

Microbiome data presents unique analytical challenges that must be considered when selecting statistical approaches:

  • Compositional: Data represents relative, not absolute, abundances, making relationships between features dependent [56] [59].
  • Sparse and Zero-Inflated: Typically contains a high proportion of zeros (often up to 90%), arising from both biological absence and technical limitations [17] [56].
  • Over-Dispersed: Variance often exceeds the mean [17].
  • High-Dimensional: Far more microbial features (p) than samples (n), creating the "large p, small n" problem [17] [56].
  • Hierarchically Structured: Taxonomic features are related through phylogenetic trees [56].

Normalization Methods for Microbiome Data

Normalization is a critical preprocessing step to address uneven sampling depth and other technical artifacts before differential abundance testing.

Table 2: Common Normalization Methods for Microbiome Data

Method Category Procedure Notes
Rarefying Ecology-based Subsampling to an even depth without replacement [56]. Controversial; can reduce power but useful for some methods like LEfSe.
Total Sum Scaling (TSS) Traditional Convert counts to relative abundances by dividing by total reads per sample [17]. Simple but sensitive to sampling depth.
Cumulative Sum Scaling (CSS) Microbiome-based Implemented in metagenomeSeq; mitigates bias from highly abundant features [17]. Good for zero-inflated data.
Centered Log-Ratio (CLR) Compositional Uses geometric mean of sample as denominator; addresses compositionality [17] [59]. Used by ALDEx2; requires careful handling of zeros.
Trimmed Mean of M-values (TMM) RNA-seq-based Implemented in edgeR; trims extreme log fold-changes and library sizes [17]. Robust to highly differential features.

Differential Abundance Testing Methods

Multiple methods exist for identifying differentially abundant taxa between groups, each with different strengths and weaknesses.

Table 3: Selected Differential Abundance Analysis Methods

Method Underlying Model / Approach Key Features Implementation in R
ALDEx2 Compositional (CLR transformation) Accounts for compositionality; robust to false positives; lower power [17] [59]. ALDEx2 package
ANCOM(-II) Compositional (Additive log-ratio) Accounts for compositionality; consistent results across studies [17] [59]. ANCOMBC package
DESeq2 Negative binomial distribution Adopted from RNA-seq; handles overdispersion; sensitive to compositionality [17] [59]. DESeq2 package
edgeR Negative binomial distribution Adopted from RNA-seq; good power; can have high FDR [17] [59]. edgeR package
metagenomeSeq Zero-inflated Gaussian Designed for sparse microbiome data; uses CSS normalization [17]. metagenomeSeq package
corncob Beta-binomial distribution Models both abundance and dispersion; good for accounting for library size bias [17]. corncob package

A comprehensive comparison of 14 differential abundance methods across 38 datasets revealed that these tools identify drastically different numbers and sets of significant taxa [59]. The number of features identified often correlated with aspects of the data such as sample size, sequencing depth, and effect size. Given this variability, a consensus approach based on multiple differential abundance methods is recommended to ensure robust biological interpretations [59].

Incorporating Confounders into Statistical Models

To adjust for confounders like diet, medication, and co-habitation duration, several statistical modeling approaches are available:

  • Linear and Linear Mixed Models: Suitable for normalized or transformed data, allowing inclusion of continuous and categorical confounders as fixed effects. Mixed models can account for non-independence of couples with random effects [17].
  • Generalized Linear Models (GLMs): Extend linear models to handle non-normally distributed data (e.g., negative binomial for count data). Tools like edgeR, DESeq2, and corncob use GLM frameworks [17].
  • Model-Based Standardization: When using methods that don't easily accommodate covariates (e.g., some non-parametric tests), stratification or model-based standardization can be applied.

The following diagram illustrates the recommended statistical workflow for addressing confounders:

Start Start: Raw Microbiome Data Norm Data Normalization (Select from Table 2) Start->Norm DA Differential Abundance Testing (Select from Table 3) Norm->DA Model Include Confounders in Statistical Model DA->Model Result Confounder-Adjusted Results Model->Result Confounders Key Confounders: - Diet - Medication - Co-habitation Duration - Age/Sex - Technical Batch Confounders->Model

Experimental Protocol for Couples' Microbiome Studies

Sample Collection and Storage Protocol

Materials Needed:

  • Standardized stool collection kits (e.g., OMNIgene Gut kit for field collection)
  • Cryovials and permanent labels
  • -80°C freezer for long-term storage
  • Personal protective equipment (gloves, lab coat)

Procedure:

  • Kit Preparation: Use standardized collection kits with DNA stabilizers if immediate freezing at -80°C is not possible [57]. For fecal samples, the OMNIgene Gut kit, 95% ethanol, or FTA cards are acceptable preservation methods [57].
  • Sample Collection: Collect samples from both partners simultaneously to control for temporal variation. Document exact time of collection.
  • Short-term Storage: If unable to immediately freeze, store samples on ice for no more than 24 hours if studying bacterial communities [57].
  • Long-term Storage: Transfer samples to -80°C freezer within 24 hours of collection. Maintain consistent storage conditions for all samples in a study [57].
  • Documentation: Record any deviations from protocol, including delays in freezing or temperature excursions.

DNA Extraction and Sequencing Protocol

Materials Needed:

  • DNA extraction kit (select one and use the same batch for all samples)
  • Positive control (e.g., mock microbial community)
  • Negative control (extraction reagents only)
  • Quality control equipment (Nanodrop, Qubit, gel electrophoresis)
  • 16S rRNA gene primers or shotgun metagenomic library preparation kit

Procedure:

  • DNA Extraction:
    • Use the same DNA extraction kit lot for all samples to minimize technical variation [57] [58].
    • Process cases and controls randomly to avoid batch effects.
    • Include both positive controls (mock communities) and negative controls (reagent blanks) to monitor contamination and technical variability [57].
  • Quality Control:
    • Quantify DNA concentration using fluorometric methods (e.g., Qubit).
    • Assess DNA quality via spectrophotometry (A260/A280 ratios) and/or gel electrophoresis.
  • Library Preparation:
    • For 16S rRNA gene sequencing: Amplify the V4 region using dual-indexed primers [57].
    • For shotgun metagenomic sequencing: Use standardized library preparation kits.
    • Pool libraries at equimolar concentrations.
  • Sequencing:
    • Sequence on Illumina platform (e.g., MiSeq for 16S, HiSeq for shotgun).
    • Include PhiX control to improve base calling.

Confounder Data Collection Protocol

Comprehensive metadata collection is essential for adequate statistical adjustment of confounders.

Dietary Assessment:

  • Administer validated food frequency questionnaires (FFQ) to both partners.
  • Focus on dietary components known to influence microbiome: protein, fiber, fruits, vegetables [2].
  • Assess both individual consumption and shared meals.

Medication Documentation:

  • Record all prescription medications, especially antibiotics, proton pump inhibitors, and psychotropics [57] [58].
  • Document medication history for the past 3-6 months, with specific attention to antibiotics in the past 30 days.
  • Note dosage, frequency, and duration of use.

Co-habitation and Social Dynamics:

  • Record duration of co-habitation in months/years.
  • Assess relationship quality using validated instruments (e.g., marital satisfaction scales) [2].
  • Document frequency of physical contact and shared activities.

Additional Covariates:

  • Collect basic demographics: age, sex, education, income.
  • Document pet ownership [57].
  • Record smoking status and alcohol consumption.
  • Measure height and weight for BMI calculation.

The Scientist's Toolkit

Table 4: Essential Research Reagent Solutions for Couples' Microbiome Studies

Item Function Example Products/Protocols
Sample Collection & Preservation Maintains microbial integrity between collection and processing OMNIgene Gut kit, 95% ethanol, FTA cards, RNAlater [57]
DNA Extraction Kits Isolates high-quality microbial DNA from complex samples QIAamp PowerFecal Pro DNA Kit, DNeasy PowerSoil Kit, MO BIO PowerSoil DNA Isolation Kit [57] [58]
Positive Controls Monitors technical performance and identifies contamination Mock microbial communities (e.g., ZymoBIOMICS Microbial Community Standards) [57]
Negative Controls Identifies reagent and environmental contamination Extraction blanks (reagents only), PCR water [57]
16S rRNA Primers Amplifies target variable region for bacterial identification 515F/806R for V4 region [57]
Sequencing Standards Calibrates sequencing runs and improves base calling PhiX Control v3 [57]
Bioinformatic Pipelines Processes raw sequences into analyzed data DADA2, QIIME 2, MOTHUR for 16S data; KneadData, HUMAnN2 for shotgun data [17]

Integrated Workflow Diagram

The following diagram summarizes the complete experimental and analytical workflow for a couples' microbiome study, from initial design through confounder-adjusted analysis:

cluster_confounders Confounder Data Collection Design Study Design Recruit couples, define case/control status Collect Sample & Metadata Collection Design->Collect DNA DNA Extraction & Quality Control Collect->DNA Seq Library Prep & Sequencing DNA->Seq Bioinf Bioinformatic Processing Seq->Bioinf Norm Data Normalization Bioinf->Norm DA Differential Abundance Analysis with Confounders Norm->DA Interp Biological Interpretation DA->Interp Diet Dietary Assessment Diet->DA Meds Medication History Meds->DA Cohab Co-habitation Duration & Relationship Quality Cohab->DA Demo Demographics & Lifestyle Factors Demo->DA

Robust statistical adjustment for confounders such as diet, medication, and co-habitation duration is essential for drawing valid conclusions in couples' microbiome research. This requires meticulous study design, comprehensive metadata collection, appropriate normalization methods, and careful selection of differential abundance testing frameworks that can incorporate these confounding variables. No single differential abundance method consistently outperforms all others across all scenarios [59], so employing a consensus approach that integrates results from multiple complementary methods provides the most reliable foundation for biological interpretation. By implementing the protocols and application notes outlined in this document, researchers can significantly enhance the rigor, reproducibility, and translational impact of their investigations into couples' microbiomes and health outcomes.

Troubleshooting Common Pitfalls in Mixed-Effects and Network Analysis Models

Research on couples' microbiomes presents unique analytical challenges due to its inherent hierarchical data structure. Observations from partners are non-independent, and data is often clustered by couple, body site, and time point. Mixed-effects models are the statistical method of choice for analyzing such data, as they can partition variance between these different levels and account for non-independence. However, several common pitfalls can compromise their validity and lead to incorrect biological interpretations. This application note provides a structured guide to identifying, troubleshooting, and avoiding these critical pitfalls, with specific examples drawn from the context of couples' microbiome and health outcomes research.

Common Pitfalls in Mixed-Effects Modeling

The application of mixed models to couples' microbiome data requires careful consideration of model specification. The table below summarizes the primary pitfalls, their consequences, and recommended solutions.

Table 1: Key Pitfalls in Mixed-Effects Models for Microbiome Research

Pitfall Description Consequences Recommended Solutions
Anticonservative Tests at Low Sample Size [60] Using Wald-like tests with few replicates (e.g., few couples). Inflated Type I error rates (false positives). Use Kenward-Roger or Satterthwaite corrections; consider Bayesian approaches for credibility statements [60].
Pseudoreplication with Group-Level Predictors [60] Testing a partner-level effect (e.g., maternal trait) with individual-level replicates (e.g., offspring) without correct specification. Increased Type I error. Ensure the model structure reflects the true level of replication (e.g., partner-level predictor should be nested correctly) [60].
Too Few Random Effect Levels [60] Fitting a variable with very few levels (e.g., "Sex" with 2 levels) as a random effect. Model degeneracy, biased variance estimation. Fit the variable as a fixed effect instead, or use Bayesian models with strong priors [60].
Ignoring Random Slopes [60] Fitting only random intercepts when the effect of a predictor (e.g., diet) varies between couples. Increased Type I error rate if the slope variation is correlated with the fixed effect. Use a random slopes model that allows the relationship to vary across groups [60].
Including Candidate Marker in GRM (Genetics) [61] In MLMA, using all genetic markers to build the genetic relationship matrix (GRM) without excluding the candidate marker being tested. "Proximal contamination"; substantial loss of power to detect associations. Use MLM with the candidate marker excluded (MLMe) for association testing [61].
Confounding by Cluster [60] A group-level (e.g., couple-level) characteristic is correlated with both the outcome and the random effect structure. Biased estimates of both fixed and random effect parameters. Use within-group mean centering for level-1 predictors alongside group-level covariates [60].
Power and Sample Size Considerations

The power of mixed model association (MLMA) methods is significantly influenced by the ratio of sample size (N) to the number of markers (M). When the candidate marker is incorrectly included in the GRM (MLMi), it leads to a systematic loss of power compared to the correct approach (MLMe) or standard linear regression (LR). The following table illustrates this power loss in a quantitative trait simulation without sample structure.

Table 2: Power Implications of MLM Model Specification (Simulated Data) [61]

# Samples (N) # Markers (M) Linear Regression (LR) MLMi (Candidate in GRM) MLMe (Candidate Excluded)
10,000 10,000 10.93 (Baseline) Reduced Power Increased Power vs. LR
10,000 100,000 10.93 (Baseline) Slightly Reduced Power Slightly Increased Power vs. LR

Experimental Protocols for Robust Modeling

Protocol 1: Model Specification and Workflow for Dyadic Microbiome Data

Objective: To establish a standardized workflow for building and validating a mixed-effects model analyzing microbial similarity between partners in relation to a health outcome (e.g., recurrent pregnancy loss).

Materials and Reagents:

  • Software: R statistical environment (v4.3.0+) or Python with relevant libraries.
  • Key R Packages: lme4, lmerTest, performance, ggplot2, MuMIn.
  • Input Data: A data frame containing microbial diversity indices (e.g., Shannon Diversity) or species abundances for each partner, couple ID, and relevant metadata (health outcome, diet, cohabitation duration, etc.).

Procedure:

  • Exploratory Data Analysis: Visualize the distribution of the response variable and its relationship with potential fixed effects. Check for outliers.
  • Define Model Structure:
    • Fixed Effects: Select variables of primary interest (e.g., Health_Status, Cohabitation_Duration).
    • Random Effects: Identify grouping factors. For couples' data, Couple_ID is a fundamental random intercept to account for non-independence of partners. Consider random slopes if the effect of a predictor (e.g., Time) is expected to vary by couple.
  • Model Fitting: Fit the model using lmer() (for LMM) or glmer() (for GLMM). Start with a maximal model and simplify if necessary to aid convergence.
    • Example: lmer(Shannon_Diversity ~ Health_Status + Cohabitation_Duration + (1 | Couple_ID), data = microbiome_data)
  • Model Validation:
    • Check Normality: Plot quantile-quantile (Q-Q) plots of the random effects and residuals.
    • Check Homoscedasticity: Plot residuals versus fitted values.
    • Check for Multicollinearity: Calculate Variance Inflation Factors (VIFs) for fixed effects.
  • Inference and Interpretation: Report estimated coefficients for fixed effects with confidence intervals and p-values (using lmerTest for Satterthwaite df). Report variance explained by random effects (conditional R²) and fixed effects (marginal R²) using MuMIn::r.squaredGLMM().
Protocol 2: Diagnosing and Correcting for Proximal Contamination in MLMA

Objective: To prevent loss of power in genetic association studies within family-based microbiome genomics by correctly specifying the genetic relationship matrix.

Materials and Reagents:

  • Software: PLINK, GCTA, FaST-LMM, or GEMMA.
  • Input Data: Genotype data (e.g., VCF file), phenotype data (e.g., microbial taxon abundance).

Procedure:

  • Data Preparation: Quality control of genotype and phenotype data. Prune SNPs for linkage disequilibrium.
  • GRM Calculation: Compute the Genetic Relationship Matrix using all autosomal SNPs.
  • Association Testing:
    • Incorrect (MLMi): Run association analysis for each SNP using the full GRM (including the candidate SNP).
    • Correct (MLMe): For each candidate SNP, calculate a new GRM using all SNPs except the candidate SNP, then run the association test. (This is implemented efficiently in tools like FaST-LMM).
  • Result Comparison: Compare the resulting Manhattan plots and p-value distributions from both methods. Expect a systematic deflation of test statistics in the MLMi approach, particularly for studies with large N/M ratio [61].

The Scientist's Toolkit

Table 3: Essential Reagents and Tools for Analysis

Item Name Function/Application Example/Note
lme4 R Package [62] Fits linear and generalized linear mixed-effects models. The primary tool for implementing (G)LMMs in R. lmerTest adds p-values.
StrainPhlAn [1] Tools for strain-level analysis of microbial communities from metagenomic data. Essential for quantifying strain sharing between partners in couples' microbiome studies.
GCTA Software [61] Tool for Genome-wide Complex Trait Analysis. Used for estimating variance explained by SNPs and for MLMA, supporting the MLMe method.
MetaPhlAn [1] Profiler for microbial community composition from metagenomic data. Generates the species-level abundance profiles that often serve as input for statistical models.
Source of Truth (SoT) [63] An authoritative repository for all network data and policies. In network analysis, a SoT like NetBox is critical for maintaining consistent, accurate data for modeling.
Dyadic Data Analysis Framework [1] Statistical methods (e.g., Actor-Partner Interdependence Model - APIM) for analyzing data from dyads. APIM can be implemented within a mixed-model framework to distinguish within-couple from between-couple effects.

Workflow Visualization

The following diagram illustrates the logical workflow for building, validating, and troubleshooting a mixed-effects model in the context of couples' microbiome research.

workflow cluster_pitfalls Common Pitfalls to Check Start Start: Define Research Question & Data EDA Exploratory Data Analysis Start->EDA Spec Specify Model: Fixed & Random Effects EDA->Spec Fit Fit Model Spec->Fit Validate Validate Model Assumptions Fit->Validate PitfallCheck Pitfall Check Validate->PitfallCheck PitfallCheck->Spec Issues Identified Interpret Interpret Results & Draw Conclusions PitfallCheck->Interpret No Issues Found P1 Too few random effect levels? P2 Random slopes needed? P3 Pseudoreplication present? P4 Sample size sufficient? P5 Candidate in GRM? (Genetics)

Figure 1: A workflow for building and validating mixed-effects models, integrating checks for common pitfalls.

Benchmarking and Validating Couple-Specific Microbiome Signatures

In the study of couples' microbiomes and their influence on health outcomes, establishing robust analytical protocols is paramount. A core challenge in this research is ensuring that findings from one study cohort are not isolated incidents but are representative and reproducible across different populations. Validation against established cohorts through benchmarking similarity metrics provides a critical framework for this process. This protocol outlines detailed methodologies for assessing the cross-cohort performance of microbial community analyses, enabling researchers to distinguish consistent biological signals from cohort-specific noise. Within couples' microbiome research, this approach is indispensable for identifying microbial signatures that truly correlate with health outcomes versus those influenced by shared environmental confounders, thereby enhancing the translational potential of research findings for therapeutic development.

Core Concepts and Quantitative Benchmarks

The fundamental goal of cross-cohort validation is to test whether microbial biomarkers or classifiers derived from one study population maintain their predictive power in an independent population. This process is a key indicator of a finding's generalizability and robustness.

Performance is typically quantified using the Area Under the Receiver Operating Characteristic Curve (AUC), which measures the classifier's ability to distinguish between cases and controls [64]. Recent large-scale benchmarking efforts across 20 different diseases and 83 cohorts have established baseline expectations for cross-cohort validation performance, revealing significant variation depending on the disease type and methodology [64].

Table 1: Cross-Cohort Validation Performance of Gut Microbiome-Based Classifiers by Disease Category [64]

Disease Category Number of Diseases Typical Cross-Cohort AUC Key Observations
Intestinal Diseases 7 (e.g., CD, UC, CRC) ~0.73 AUC Highest cross-cohort reproducibility; most suitable for diagnostic applications.
Non-Intestinal Diseases 13 (e.g., T2D, PD, ASD) Lower than intestinal diseases Performance improves significantly with combined-cohort training.
Metabolic Diseases 3 (e.g., T2D, Obesity) Variable; often confounded Drug effects (e.g., metformin) can dominate microbial signals.
Autoimmune Diseases 4 (e.g., RA, MS) Variable Inflammatory signatures may show consistency.
Mental/Nervous System 5 (e.g., AD, PD, ASD) Variable Lower performance, but potential for improvement with larger samples.

Several factors determine the success of cross-cohort validation [64] [65]:

  • Disease Type: Intestinal diseases like Crohn's disease (CD) and Colorectal Cancer (CRC) show more consistent microbial alterations across geographies, resulting in higher validation AUCs.
  • Sequencing Technology: Classifiers built on whole-metagenome sequencing (mNGS) data generally outperform those based on 16S rRNA amplicon sequencing (16S), due to higher taxonomic and functional resolution [64].
  • Cohort Size and Combined-Cohort Modeling: For many non-intestinal diseases, building a classifier on a single cohort often leads to poor cross-cohort performance. Creating a combined-cohort classifier by pooling data from multiple studies during training dramatically improves validation accuracy [64].
  • Confounding Factors: Systematic differences in medication, diet, stool quality, and geography between case and control groups can create spurious associations. Accounting for these confounders in the model is critical [65].

Experimental Protocols

Protocol for Benchmarking Similarity Metrics and Classifier Performance

This protocol describes a systematic approach for evaluating the cross-cohort consistency of microbial findings, adapted from large-scale benchmarking studies [64].

I. Cohort Selection and Data Curation

  • Selection Criteria: Identify at least two independent case-control cohorts for the disease or condition of interest. Each cohort should have a minimum of 15 samples per group (case/control) and metadata on key confounders (e.g., age, BMI, medication) [64].
  • Data Harmonization: Obtain raw sequencing data (16S or mNGS). Process all datasets through the same bioinformatics pipeline (e.g., QIIME 2, mothur, or HUMAnN2) to generate unified taxonomic and/or functional profiles.
  • Confounder Adjustment: Test for significant differences in the distribution of confounders (e.g., age, gender) between case and control groups within each cohort. For any confounder with a p-value < 0.05, adjust the microbial composition data using batch effect correction tools like the removeBatchEffect function from the 'limma' R package or the adjust_batch function from the 'MMUPHin' R package [64].

II. Model Training and Intra-Cohort Validation

  • Feature Preparation: Use taxonomic abundances (e.g., genus or species-level) as features. Consider agglomerating or filtering features to manage sparsity.
  • Classifier Training: Train a machine learning classifier (e.g., Lasso Logistic Regression or Random Forest) on a single "discovery" cohort using these features to distinguish cases from controls.
  • Performance Assessment: Evaluate the classifier's performance on held-out samples from the same discovery cohort using a 5-fold cross-validation repeated 3 times. Record the mean AUC [64].

III. Cross-Cohort Validation

  • Application: Apply the classifier trained on the discovery cohort directly to the holdout "validation" cohort(s) without any retraining or parameter tuning.
  • Performance Calculation: Generate predictions for each sample in the validation cohort and calculate the AUC.
  • Interpretation: An AUC significantly above 0.5 indicates that the microbial signature generalizes. The benchmarks in Table 1 can be used for comparison.

IV. Advanced Analysis: Combined-Cohort Modeling

  • Data Pooling: To improve performance for non-intestinal diseases, combine samples from multiple cohorts into a single training set. Apply cross-cohort batch effect correction (e.g., with MMUPHin) before pooling.
  • Training and Validation: Train a new classifier on the combined dataset. Validate its performance using leave-one-cohort-out cross-validation, where the model is trained on all but one cohort and tested on the left-out cohort [64].

Protocol for Differential Abundance (DA) Testing with Confounder Adjustment

This protocol focuses on identifying individual microbial taxa that differ consistently between groups across cohorts, which is a foundation for building classifiers.

I. Realistic Signal Implantation for Benchmarking To benchmark DA methods, a realistic simulation is crucial. The following signal implantation approach preserves the characteristics of real data [65]:

  • Baseline Data: Start with a real microbial abundance dataset from a healthy cohort.
  • Define Ground Truth: Randomly assign samples to "case" and "control" groups.
  • Implant Signals: Select a small number of microbial features to be differentially abundant.
    • Abundance Scaling: Multiply the counts of a selected feature in the "case" group by a constant factor (e.g., 2 to 10).
    • Prevalence Shift: Randomly shuffle a percentage (e.g., 20-50%) of the non-zero observations for a feature from the control group to the case group, or vice versa.
  • Validate Realism: Compare the effect sizes (fold-change, prevalence difference) of the implanted signals to those observed in real disease association studies (e.g., from CRC or CD meta-analyses) to ensure they are biologically plausible [65].

II. Benchmarking DA Methods

  • Method Selection: Select a range of DA methods from different categories: classical statistics (t-test, Wilcoxon), RNA-seq adapted methods (DESeq2, edgeR), and microbiome-specific methods (ANCOM, LEfSe).
  • Application and Evaluation: Apply each method to multiple simulated datasets with a known ground truth. Calculate the False Discovery Rate (FDR) and sensitivity for each method. Methods that control the FDR below 0.05 while maintaining high sensitivity are preferable [65].
  • Confounder-Adjusted Testing: On simulations that include a confounder (e.g., a medication that affects the microbiome and is imbalanced between case/control groups), repeat the benchmarking using methods that allow for covariate adjustment (e.g., linear models with the confounder as a covariate).

Visualization of Experimental Workflows

Cross-Cohort Validation Workflow

CrossCohortValidation Start Start: Multiple Independent Cohorts DataHarmonization Data Harmonization & Confounder Adjustment Start->DataHarmonization ModelTraining Train Classifier on Discovery Cohort DataHarmonization->ModelTraining IntraValidation Intra-Cohort Validation (5-Fold CV) ModelTraining->IntraValidation CrossValidation Apply Model to Validation Cohort(s) IntraValidation->CrossValidation Eval1 Evaluation: Cross-Cohort AUC CrossValidation->Eval1 CombinedModeling Combined-Cohort Modeling (Pooled Training Data) Eval2 Evaluation: Leave-One-Cohort-Out AUC CombinedModeling->Eval2 Eval1->CombinedModeling Low/Medium AUC Result Result: Generalizable Microbial Signature Eval1->Result High AUC Eval2->Result

Diagram Title: Cross-Cohort Validation and Modeling Workflow

Differential Abundance Benchmarking

DABenchmarking StartDA Start: Real Baseline Dataset ImplantSignal Implant DA Signals (Abundance Scaling & Prevalence Shift) StartDA->ImplantSignal ApplyMethods Apply Multiple DA Testing Methods ImplantSignal->ApplyMethods CompareFDR Compare FDR Control and Sensitivity ApplyMethods->CompareFDR TestConfounders Test with Simulated Confounders (e.g., Medication) CompareFDR->TestConfounders CompareAdjusted Compare Adjusted vs. Unadjusted Models TestConfounders->CompareAdjusted Recommendation Recommendation: Optimal DA Method CompareAdjusted->Recommendation

Diagram Title: Differential Abundance Method Benchmarking Process

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Tools and Databases for Cross-Cohort Microbiome Analysis

Tool/Resource Name Type Primary Function in Validation Key Features
GMrepo v2 [64] Data Repository Cohort selection and data sourcing A database of consistently re-analyized, manually curated case-control gut microbiome studies.
MMUPHin [64] R Package Statistical Analysis Performs cross-cohort batch effect correction and meta-analysis of microbiome studies.
limma [64] R Package Statistical Analysis Adjusts for batch effects and confounders within a single cohort using the removeBatchEffect function.
Lasso Logistic Regression [64] Machine Learning Algorithm Classifier Training Resists overfitting via feature selection; works well with high-dimensional microbiome data.
Random Forest [64] Machine Learning Algorithm Classifier Training Handles complex interactions; provides feature importance rankings.
sparseDOSSA [65] Simulation Tool Benchmarking Parametrically simulates synthetic microbial community data for method testing.
ANCOM-BC / fastANCOM [64] [65] Statistical Tool Differential Abundance Testing Methods designed specifically for microbiome data's compositionality and sparsity.
Zeevi WGS Dataset [65] Reference Dataset Benchmarking Baseline A shotgun metagenomic dataset from healthy adults, often used as a baseline for realistic simulations.

Within the framework of a broader thesis on couples' microbiome and health outcomes, this protocol provides a detailed methodology for conducting a comparative analysis of microbiome similarity across different family relationships. A growing body of evidence indicates that the microbial communities of cohabiting individuals converge, forming a shared "social microbiome." Cohabiting partners have been shown to exchange and harbor more similar microbiomes across various body sites including gut, oral, skin, and genital regions compared to unrelated individuals [1]. This protocol specifically outlines the procedures for quantifying and comparing microbial similarity between partners against other familial relationships such as siblings, with an emphasis on strain-resolved transmission and its implications for health outcomes.

The establishment of a reproducible framework for couple-level analysis is crucial for advancing hypotheses on person-to-person microbial transmission, co-adaptation, and their relevance for preconception care, fertility optimization, and early-life microbiome seeding [1]. This document provides the experimental workflows, analytical pipelines, and visualization tools necessary to operationalize the couple as the fundamental unit of analysis in microbiome research.

Quantitative Comparison of Microbial Similarity

Analysis of microbiome similarity across different relationship types reveals distinct patterns of microbial sharing. The following table synthesizes key quantitative findings from comparative studies:

Table 1: Quantitative Comparison of Microbiome Similarity Across Relationship Types

Relationship Type Body Site Similarity Metric Key Findings Reference
Spousal/Partner Gut Strain Sharing Median ~12% strain sharing; scales with cohabitation duration [1]
Oral Strain Sharing Median ~32% strain sharing [1]
Overall Microbiota Compositional Similarity Significantly more similar microbiota than siblings [2]
Gut Diversity Married individuals show greater diversity & richness than those living alone [2]
Sibling Pairs Gut Compositional Similarity No significant difference in similarity compared to unrelated pairs [2]
Parent-Child Gut Strain Sharing At age 30, ~14% of gut strains still shared with mother [66]

These quantitative differences highlight that spouses have more similar microbiota and more bacterial taxa in common than siblings, with no observed differences between sibling and unrelated pairs [2]. These differences held even after accounting for dietary factors, suggesting that cohabitation itself, rather than just shared genetics or upbringing, drives microbial convergence [1] [2]. Furthermore, the quality of the relationship matters; differences between unrelated individuals and married couples were driven entirely by couples reporting close relationships [2].

Detailed Experimental Protocols

Sample Collection and Metadata Harmonization

Purpose: To ensure consistent, comparable sample and data collection across all participants, including couples, siblings, and unrelated controls.

  • Participant Recruitment and Grouping: Recruit heterosexual cohabiting partners (married or unmarried) with a minimum cohabitation duration of 6 months. Include sibling pairs (cohabiting and non-cohabiting) and unrelated, non-cohabiting individuals as control groups. Record detailed metadata for all participants using standardized questionnaires.
  • Metadata Collection: Collect comprehensive metadata, including:
    • Demographics: Age, sex, genetic ancestry.
    • Relationship Factors: Relationship duration, closeness metrics (e.g., self-reported intimacy scores), cohabitation duration.
    • Lifestyle and Clinical Data: Dietary habits (via food frequency questionnaires), medication use (especially antibiotics within the last 3 months), smoking status, alcohol consumption, health status (including BMI, chronic conditions).
  • Sample Collection:
    • Body Sites: Collect samples from gut (fecal), oral (saliva or buccal swabs), skin (forearm and foot swabs), and genital (vaginal or penile swabs) sites.
    • Standardization: Use identical, commercially available collection kits (e.g., Oragene kits for saliva, specific fecal collection kits) for all participants [67]. Follow a consistent sampling time (e.g., morning, before eating or brushing teeth) [67].
    • Storage: Immediately freeze samples at -20°C post-collection, with transfer to -80°C for long-term storage within 1-2 hours [68].

Metagenomic Sequencing and Bioinformatic Processing

Purpose: To generate high-quality, profile microbial communities from collected samples in a reproducible manner.

  • DNA Extraction and Sequencing:
    • Extraction: Perform DNA extraction using kits optimized for the specific sample type (e.g., MoBio PowerSoil kit for fecal samples) to ensure efficient lysis of diverse microbial taxa.
    • Sequencing: For comprehensive analysis, conduct shotgun metagenomic sequencing on all samples. As a cost-effective alternative for larger cohorts, 16S rRNA gene amplicon sequencing (targeting V4 region) can be used, with reprocessing of all data through a uniform pipeline [1].
  • Bioinformatic Processing Workflow:
    • Quality Control: Use FastQC for raw read quality assessment. Trim adapters and low-quality bases with Trimmomatic or Cutadapt.
    • Metagenomic Profiling:
      • Host Depletion: Align reads to the human reference genome (e.g., hg38) using Bowtie2 and remove matching sequences.
      • Species Profiling: Profile microbial communities using MetaPhlAn 4 to obtain taxonomic abundances [1].
      • Functional Profiling: Reconstruct metabolic pathways with HUMAnN 3 to determine the abundance of gene families and metabolic pathways [1].
    • Strain-Level Analysis:
      • Strain Sharing Quantification: Use StrainPhlAn or inStrain to identify and compare specific bacterial strains between individuals [1].
      • Stringent Filtering: Apply stringent thresholds for Average Nucleotide Identity (ANI >99.9%) and genome breadth (>90% of the genome covered) to minimize false positives in strain sharing calls [1].

The following diagram illustrates the core bioinformatic workflow:

G Start Raw Sequencing Reads (Shotgun/16S) QC Quality Control & Host Depletion Start->QC FastQC, Bowtie2 Profiling Taxonomic & Functional Profiling QC->Profiling Filtered Reads Strain Strain-Level Analysis Profiling->Strain MetaPhlAn4, HUMAnN3 Stats Dyadic Statistical Analysis Strain->Stats StrainPhlAn/inStrain

Dyadic Statistical Analysis for Similarity Assessment

Purpose: To quantitatively compare microbiome similarity within couples versus other relationship pairs, controlling for confounding factors.

  • Beta-Diversity Analysis:
    • Calculate between-sample dissimilarity using Bray-Curtis (for species abundance) and UniFrac (for phylogenetic distance) metrics.
    • Conduct permutation tests (PERMANOVA) to determine if partner pairs have significantly lower beta-diversity (i.e., are more similar) than sibling or unrelated pairs, while adjusting for covariates like diet and age [1] [2].
  • Strain Sharing Analysis:
    • Calculate the percentage of shared bacterial strains for each pair of individuals.
    • Use generalized linear mixed-effects models (GLMMs) to test if the rate of strain sharing is significantly higher in partners compared to other relationship types, including household as a random effect [1].
  • Actor-Partner Interdependence Modeling (APIM):
    • Apply APIM, a dyadic data analysis framework, to model how one partner's microbiome characteristics (e.g., diversity, abundance of a key taxon) may predict the other partner's health outcome (e.g., BMI, inflammatory markers), thereby accounting for the non-independence of data from couples [1].

Table 2: Key Research Reagent Solutions for Couples' Microbiome Studies

Item Function/Application Example Kits/Tools
DNA Collection Kits Standardized sample collection and stabilization for diverse body sites. Oragene DNA kits (saliva), Fecal Collection kits with stabilizers [67] [68].
DNA Extraction Kits High-yield microbial DNA extraction, optimized for different sample matrices. MoBio PowerSoil Pro Kit (fecal), specialized kits for low-biomass samples (skin, oral) [68].
16S rRNA Primers Amplification of target variable regions for taxonomic profiling. 515F/806R (V4 region) for 16S amplicon sequencing.
Shotgun Metagenomic Library Prep Kits Preparation of sequencing libraries from fragmented genomic DNA. Illumina DNA Prep kits.
Bioinformatic Pipelines Integrated software for end-to-end analysis of microbiome data. QIIME 2 (16S data), MOTHUR (16S data) [2] [67].
Taxonomic Profiling Tools Accurate quantification of microbial abundances from sequencing reads. MetaPhlAn 4 [1].
Functional Profiling Tools Inference of metabolic potential and pathway abundance. HUMAnN 3 [1].
Strain-Level Analysis Tools High-resolution tracking of strain sharing between individuals. StrainPhlAn, inStrain [1].

Signaling Pathways and Functional Implications

Microbial sharing between partners is not merely compositional but has functional consequences mediated through specific host-microbe interactions. The convergence of microbiomes in couples can influence shared health outcomes through several biological pathways. The following diagram summarizes the primary signaling mechanisms through which shared microbes can influence host physiology:

G SharedMicrobe Shared Microbial Strains (Between Partners) Metabolites Microbial Metabolite Production (SCFAs, Neurotransmitters) SharedMicrobe->Metabolites Immune Immune System Modulation (Cytokine signaling, Inflammation) Metabolites->Immune SCFA Signaling Neuro Neuroendocrine Pathways (HPA Axis, Cortisol, Vagus Nerve) Metabolites->Neuro Tryptophan/Serotonin GABA Pathways HealthOutcome Shared Health Outcomes (Metabolic, Mental, Inflammatory) Immune->HealthOutcome e.g., BV Recurrence [1] Neuro->HealthOutcome e.g., Depression/Anxiety [67] [68]

  • Immune System Modulation: Shared microbes, particularly in the gut, continuously shape the partners' immune responses. Microbial metabolites like short-chain fatty acids (SCFAs) regulate inflammatory pathways [69]. This shared immune environment can explain the couple-level dynamics in conditions like bacterial vaginosis (BV), where treating the male partner alongside the female partner reduces recurrence rates, breaking the cycle of reinfection [1].

  • Neuroendocrine Pathways: The gut-brain axis serves as a critical pathway. Shared microbes influence the host's hypothalamic-pituitary-adrenal (HPA) axis, modulating stress responses and salivary cortisol levels [50] [70]. Recent research in newlywed couples demonstrates that oral microbiota transmission partially mediates symptoms of depression and anxiety, with microbial changes correlating with alterations in salivary cortisol [67] [68]. Furthermore, the microbiota can produce or precursors to neurotransmitters (e.g., GABA, serotonin), directly influencing mood and behavior [50].

  • Metabolic Cross-Talk: Partners often develop correlated metabolic profiles and weights. The shared gut microbiome contributes to this via differential energy harvest from diet, bile acid metabolism, and regulation of adipose tissue storage [1] [70]. This suggests that a "dysbiotic" metabolic profile in one partner could potentially influence the other's metabolic health.

The developing understanding of the human microbiome has revealed its profound influence on human health, particularly in the context of reproduction. A growing body of evidence demonstrates that microbial communities within individuals do not exist in isolation but converge between intimate partners, forming a "social microbiome" with direct implications for reproductive success [1]. This application note details the mechanistic pathways and provides standardized protocols for investigating how microbial convergence between couples influences critical clinical endpoints, including fertility rates, pregnancy maintenance, and neonatal health outcomes. This framework supports the broader thesis that couples' shared microbiomes represent a modifiable factor for improving reproductive health.

The maternal microbiome undergoes significant restructuring during pregnancy, characterized by reduced diversity in the gut and vagina and enrichment of specific taxa like Bifidobacterium and Streptococcus, which are also early colonizers of the infant gut [71]. These transmitted microbes are crucial for immune maturation and metabolic programming in the neonate [71]. However, microbial dysbiosis in either partner can disrupt this careful succession, potentially contributing to conditions such as infertility, preterm birth, and gestational diabetes mellitus (GDM) [71] [72].

Quantitative Data on Microbial Convergence and Clinical Endpoints

The association between microbial sharing and health outcomes can be quantified through strain sharing rates, diversity indices, and specific taxon abundances. The following tables summarize key quantitative findings from recent research.

Table 1: Microbial Strain Sharing Rates Between Cohabiting Partners

Body Site Median Strain Sharing Rate Key Shared Taxa Influencing Factors
Gut ~12% [1] Bacteroides, Bifidobacterium [1] Cohabitation duration, diet [1]
Oral ~32% [1] Veillonella [67] Intimate contact (e.g., kissing) [1]
Skin Highly Similar [1] Staphylococcus, Corynebacterium [1] Shared environment, physical contact [1]

Table 2: Maternal Microbiome Changes Linked to Pregnancy Outcomes

Microbiome State Associated Clinical Endpoint Key Microbial Shifts Proposed Mechanism
Vaginal Dysbiosis Preterm Birth, Miscarriage [71] Lactobacillus dominance; ↑ diversity [71] Loss of protective acidic environment, inflammation [71]
Gut Dysbiosis in Pregnancy Gestational Diabetes Mellitus (GDM) [71] ↓ Butyrate-producers (e.g., Faecalibacterium); ↑ Proteobacteria [71] Insulin resistance, metabolic inflammation [71]
Partner-Associated Dysbiosis Bacterial Vaginosis (BV) Recurrence [1] Shared Gardnerella strains between partners [1] Reintroduction of pathobionts post-treatment [1]
Oral Dysbiosis in Couples Depression & Anxiety (DA phenotype) [67] Bacteroidetes, Proteobacteria; ↓ Firmicutes [67] Microbial transmission, altered salivary cortisol [67]

Experimental Protocols for Couples' Microbiome Analysis

This section provides a detailed, step-by-step protocol for a longitudinal study designed to analyze couples' microbiomes and link them to fertility and pregnancy outcomes. The protocol emphasizes multi-site sampling, robust sequencing, and dyadic statistical models.

Participant Recruitment and Phenotyping

  • Cohort Definition: Recruit couples planning pregnancy or in early pregnancy (<12 weeks). Include detailed metadata: age, BMI, medical history, lifestyle (diet, smoking), and relationship duration [1] [67].
  • Clinical Endpoints: Track time-to-conception, pregnancy loss, gestational diabetes, preeclampsia, preterm birth, and neonatal metrics (birth weight, microbiome composition) [71] [72].
  • Psychometric Assessment: Administer standardized questionnaires (e.g., Beck Depression Inventory-II, Beck Anxiety Inventory, Pittsburgh Sleep Quality Index) to account for psychological confounders [67].

Multi-Site Biospecimen Collection

Collection should occur at baseline and regular intervals throughout pregnancy and postpartum.

  • Oral Sample Collection: Swab the palatine tonsils and posterior pharynx using a sterile swab. Place the swab in a saline solution or stabilization buffer, store immediately at -20°C, and transfer to -80°C within 1-4 hours for long-term storage [67].
  • Gut Sample Collection: Provide participants with standardized kits for self-collection of fecal samples. Samples should be stored at -80°C until DNA extraction [1].
  • Vaginal Sample Collection: Instruct participants or clinicians to collect vaginal swabs from the mid-vagina. Store swabs in a DNA stabilization buffer at -80°C [71].
  • Salivary Cortisol: Collect saliva using kits like Oragene OG-500. Participants should fast (except water) for 30 minutes prior. Analyze cortisol levels using LC-MS/MS [67].

Metagenomic Sequencing and Bioinformatics

  • DNA Extraction & Sequencing: Perform DNA extraction using a kit optimized for microbial DNA (e.g., MoBio PowerSoil DNA Isolation Kit). Conduct shotgun metagenomic sequencing on an Illumina platform to achieve high taxonomic and functional resolution [1].
  • Bioinformatic Processing:
    • Quality Control: Use Trimmomatic or Fastp to remove low-quality reads and adapters.
    • Host Depletion: Align reads to the human genome (e.g., hg38) and remove matching sequences.
    • Profiling: Perform species profiling with MetaPhlAn 4 and pathway profiling with HUMAnN 3 [1].
    • Strain-Level Analysis: Quantify strain sharing between partners using StrainPhlAn or inStrain with stringent thresholds (Average Nucleotide Identity >99.9%, breadth >90%) to minimize false positives [1].

Statistical Analysis and Data Integration

  • Dyadic Analytics: Use specialized statistical models to account for non-independence within couples.
    • Permutation Tests: Test for significant similarity in beta-diversity (Bray-Curtis dissimilarity) between partners compared to random pairs [1].
    • Actor-Partner Interdependence Models (APIM): Model how one partner's microbiome influences the other's health outcomes [1].
    • Linear Discriminant Analysis (LDA): Identify taxa most likely to discriminate between clinical outcome groups (e.g., fertile vs. infertile couples) [67].
  • Mediation Analysis: Formal mediation analysis can test if the effect of one partner's health status (e.g., DA phenotype) on the other is mediated by microbial transmission [67].
  • Covariate Adjustment: Ensure all models control for key confounders such as age, BMI, diet, and medication use [67].

G Microbial Transmission & Hormonal Signaling Pathway cluster_couple Cohabiting Couple cluster_immune Systemic Effects cluster_outcomes Clinical Endpoints P1 Partner A Microbiome Trans Microbial Transmission P1->Trans P2 Partner B Microbiome SC Microbial Metabolites (SCFAs) P2->SC Trans->P2 IM Immune & Inflammatory Response SC->IM HPG HPG Axis Dysregulation IM->HPG GDM Gestational Diabetes (GDM) IM->GDM PTB Preterm Birth (PTB) IM->PTB NHP Neonatal Health & Programming IM->NHP INF Impaired Fertility (Altered Hormones) HPG->INF HPG->NHP

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents and Materials for Couples' Microbiome Studies

Item Function/Application Example Product/Kit
DNA Stabilization Buffer Preserves microbial DNA integrity at room temperature post-collection for reliable sequencing. Oragene OG-500 kits [67], MoBio buffer [67]
Shotgun Metagenomic Sequencing Kit Provides comprehensive taxonomic and functional profiling of microbial communities. Illumina DNA Prep kits [1]
LC-MS/MS Kit Precisely quantifies steroid hormone levels (e.g., salivary cortisol) as a stress and mental health biomarker. Commercial cortisol immunoassays [67]
Bioinformatic Pipelines Standardized tools for processing sequence data, from quality control to strain-level analysis. QIIME 2 [67], MetaPhlAn 4, HUMAnN 3, StrainPhlAn [1]
Validated Psychometric Inventories Quantifies psychological states (depression, anxiety, sleep quality) that interact with the microbiome. Beck Depression Inventory-II (BDI-II), Beck Anxiety Inventory (BAI), Pittsburgh Sleep Quality Index (PSQI) [67]

G Experimental Workflow for Couples Microbiome Analysis cluster_details Key Protocol Details S1 1. Cohort Definition & Phenotyping S2 2. Multi-Site Sample Collection S1->S2 S3 3. Metagenomic Sequencing S2->S3 D2 Oral, Gut, Vaginal, Saliva Samples Stored at -80°C S2->D2 S4 4. Bioinformatic Analysis S3->S4 S5 5. Dyadic Statistical Modeling S4->S5 D4 Strain-Level Analysis using StrainPhlAn/ inStrain S4->D4 S6 6. Linkage to Clinical Endpoints S5->S6 D5 Actor-Partner Interdependence Models (APIM) S5->D5

The protocols and data presented herein establish a rigorous framework for investigating the couples' microbiome as an integrated unit influencing reproductive health. The evidence confirms that microbial convergence is a measurable phenomenon with direct links to clinical endpoints like fertility, pregnancy complications, and neonatal outcomes. By adopting the detailed experimental and analytical workflows, researchers can systematically quantify strain sharing, identify dysbiotic states transmissible between partners, and elucidate underlying immunoendocrine mechanisms. This approach refines our understanding of reproductive pathophysiology and paves the way for novel couple-based interventions, such as coordinated probiotic regimens or partner-inclusive treatment strategies, to mitigate shared microbial risk and improve health outcomes across the family unit.

Cross-Study Comparisons of Functional Similarity and Resistome Profiles

Comparative analysis of functional potential and antibiotic resistance gene profiles across multiple studies provides a powerful framework for understanding microbial ecology and adaptation. This protocol details a standardized bioinformatic workflow for cross-study comparison of gut microbiome resistomes and metabolic pathways, with a specific application for dyadic analysis in couples' research. The methodology encompasses robust public data mining, unified processing, functional profiling, and statistical integration to identify shared and divergent microbial features. Application of this pipeline to couples' microbiome data enables the investigation of microbial co-adaptation, including strain sharing, convergent resistome expansion, and shared metabolic traits that may influence collective health outcomes.

The human microbiome is a complex ecosystem whose functional capacity significantly influences host health and disease states. Cross-study comparisons of metagenomic data are essential for discerning consistent patterns beyond single-cohort observations, enhancing statistical power, and validating findings across diverse populations. Within the context of couples' microbiome research, such analyses are particularly pertinent. Cohabiting partners demonstrate significant microbiome similarity across gut, oral, and skin sites, with measurable strain sharing (median ~12% gut; ~32% oral) that scales with cohabitation duration [1]. This convergence suggests that the couple, rather than the individual, may be a critical unit for understanding microbiome-mediated health effects.

A key functional component of the microbiome is its resistome—the collection of all antibiotic resistance genes (ARGs). Disease states, especially those commonly treated with antibiotics, are associated with an expanded gut resistome, indicating considerable selective pressure for ARG acquisition [73]. Furthermore, medical staff, including nurses and nursing workers, have been shown to exhibit distinct gut and hand resistome profiles, characterized by a higher abundance of multi-drug resistance genes, underscoring the role of environmental exposure [74]. Comparing resistomes and metabolic pathways across studies of couples can reveal the extent of functional co-adaptation and shared ARG reservoirs, which may have implications for shared disease risk and transmission dynamics.

This application note provides a detailed protocol for the cross-study comparison of functional and resistome profiles, framing the methodology within a comprehensive couples' health research thesis.

Materials and Methods

Data Acquisition and Harmonization

The first phase involves the systematic gathering and initial processing of publicly available metagenomic datasets to create a unified analysis-ready cohort.

  • Public Data Mining: Identify human gut metagenomic shotgun sequencing studies with publicly available raw data and metadata from repositories such as the Sequence Read Archive (SRA). For couples-specific research, prioritize datasets with identifiable partner/household links and rich phenotypic metadata [1].
  • Cohort Definition and Subsetting: For each included study, review metadata to define appropriate case-control comparisons. For longitudinal studies, select a single time point per participant (e.g., the first sample) to maintain independence. Exclude samples from participants with recent antibiotic treatment to study historical evolutionary adaptation rather than acute effects, unless antibiotic use is intrinsic to the disease being studied (e.g., cystic fibrosis) [73]. For multi-country/city studies, split the dataset for separate analysis to avoid geographic confounding.
  • Data Retrieval: Use tools like NCBI fastq-dump or fasterq-dump to download sequencing reads for all selected samples.
Unified Metagenomic Processing and Profiling

This phase transforms raw sequencing data from multiple sources into consistent, comparable profiles of taxonomic composition, resistance genes, and metabolic potential.

  • Taxonomic Profiling: Perform taxonomic assignment of reads using Kraken 2 [73] or a similar tool against a comprehensive database. Adjust relative abundances to account for variable levels of host DNA contamination by normalizing to the proportion of reads classified as bacteria [73].
  • Resistome Profiling:
    • ARG Database Alignment: Use MMseqs2 [73] or map reads via Bowtie 2 [74] to the Comprehensive Antibiotic Resistance Database (CARD) [74] or ResFinder [73].
    • Gene Clustering: To reduce noise, cluster all reference ARG sequences at 90% identity using MMseqs2 easy-cluster [73].
    • Read Mapping and Quantification: Map metagenomic reads to the representative cluster sequences using MMseqs2 easy-search (with parameters -s 4.5 and minimum 50 bp alignment at 80% identity) or a similar aligner [73]. Accept the best hit.
    • Normalization: Normalize ARG abundance to Reads Per Kilobase per Million reads (RPKM) to account for gene length and sequencing depth [73].
  • Functional Profiling: Use HUMAnN 3 [1] to characterize the abundance of microbial metabolic pathways from metagenomic reads. This tool provides a stratified output linking pathways to the contributing microbial taxa.
Cross-Study Comparative Analysis

The final phase involves statistical and ecological comparisons to identify robust patterns across the harmonized datasets.

  • Diversity and Composition Analysis:
    • Calculate α-diversity (within-sample diversity) for species, ARGs, and pathways.
    • Calculate β-diversity (between-sample dissimilarity) using Bray-Curtis dissimilarity on taxonomic, ARG, and pathway abundance matrices [74].
    • Perform ordination (e.g., PCoA, NMDS) and test for group differences with PERMANOVA using the vegan package in R [73] [74].
  • Differential Abundance Testing: Use non-parametric tests like the Wilcoxon rank-sum test to assess differences in total ARG abundance (resistome expansion) or specific pathway abundances between case and control groups across studies [73]. Apply false discovery rate (FDR) correction for multiple hypothesis testing.
  • Strain-Level Analysis: For couples' data, quantify strain sharing between partners using StrainPhlAn or inStrain with stringent ANI and breadth thresholds to reduce false positives [1].
  • Correlation and Network Analysis: Perform Spearman's correlation analysis between the relative abundances of ARGs and bacterial species in paired samples [74]. Reconstruct co-occurrence networks to visualize relationships within the microbial community.

Experimental Workflow and Visualization

The following diagram illustrates the integrated bioinformatic pipeline for cross-study functional and resistome analysis.

workflow Start Start: Study Design DataAcquisition Data Acquisition & Harmonization Start->DataAcquisition Profiling Unified Metagenomic Profiling DataAcquisition->Profiling Mine Mine Public Data (SRA, ENA) DataAcquisition->Mine 1.1 Define Define Cohort & Subset Samples DataAcquisition->Define 1.2 Retrieve Retrieve Raw Reads DataAcquisition->Retrieve 1.3 Analysis Cross-Study Comparative Analysis Profiling->Analysis Taxonomy Taxonomic Profiling (Kraken 2) Profiling->Taxonomy 2.1 Resistome Resistome Profiling (MMseqs2 + CARD) Profiling->Resistome 2.2 Functional Functional Profiling (HUMAnN 3) Profiling->Functional 2.3 Output Integrated Results & Visualization Analysis->Output Diversity Diversity Analysis (Bray-Curtis, PCoA) Analysis->Diversity 3.1 Differential Differential Abundance (Wilcoxon Test) Analysis->Differential 3.2 Strain Strain Sharing (StrainPhlAn/inStrain) Analysis->Strain 3.3

Figure 1: Cross-Study Functional & Resistome Analysis Pipeline.

The Scientist's Toolkit: Research Reagent Solutions

Table 1: Essential bioinformatic tools and databases for metagenomic resistome and functional profiling.

Item Name Type Primary Function Key Features
CARD (v3.0.0+) [74] Database ARG Reference Curated repository of ARGs and associated variants; used for read mapping.
ResFinder [73] Database ARG Reference Focused database of ARGs; sequences can be clustered to reduce noise.
MMseqs2 [73] Software Sequence Search & Clustering Fast, sensitive protein sequence search for mapping reads to ARG clusters.
Kraken 2 [73] Software Taxonomic Profiling Rapid taxonomic classification of metagenomic sequencing reads.
HUMAnN 3 [1] Software Functional Profiling Quantifies microbial metabolic pathways from metagenomic data.
StrainPhlAn [1] Software Strain-Level Analysis Infers strain-level genotypes and measures strain sharing between samples.
Bowtie 2 [74] Software Sequence Alignment Efficient short-read aligner for mapping sequences to reference databases.
R package: vegan [73] [74] Software Statistical Analysis Performs ecological analysis (e.g., PERMANOVA, PCoA, diversity indices).

Quantitative Data Comparison and Interpretation

Key Metrics from Foundational Resistome Studies

The following table summarizes quantitative findings from recent studies that can serve as benchmarks for cross-study comparison, particularly in assessing resistome expansion and the impact of occupational exposure.

Table 2: Comparative summary of resistome profiles from published studies.

Study Cohort Key Finding Statistical Result Primary ARGs/Methods Identified
Antibiotic-Treated Diseases (e.g., Cystic Fibrosis, Diarrhoea) [73] Significantly expanded resistome in cases vs. controls. 8/35 datasets showed significantly (p < 0.05, FDR corrected) higher total ARG abundance in cases [73]. Not specified in detail; overall ARG abundance was quantified via RPKM.
Nursing Workers (NWs) vs. Nurses (NSs) [74] Higher diversity and abundance of multi-drug resistance ARGs on hands of NWs. Worse hand hygiene in NWs characterized by higher abundance of multi-drug resistance genes [74]. mdtF, acrB, AcrF, evgS [74].
Non-Medical Controls (NC) [74] Baseline gut and hand resistome. Used as a reference group for comparison with medical staff [74]. ARG profiles were less abundant and diverse than in medical staff.
Application to Couples' Microbiome Analysis

When applying this protocol to couples, the analysis focuses on dyadic-level metrics. Key quantitative outputs include:

  • Strain Sharing Rate: The percentage of shared bacterial strains between partners (median ~12% in gut, ~32% in oral) [1].
  • Beta-Diversity Similarity: Bray-Curtis dissimilarity between partners' microbiomes should be significantly lower than between randomly paired individuals from different households (p < 0.01) [1].
  • Resistome Convergence: Correlation in the abundance and composition of ARGs between partners, which may indicate shared environmental exposure and horizontal gene transfer.
  • Functional Pathway Similarity: Correlation in the abundance of MetaCyc pathways (from HUMAnN 3) between partners, suggesting convergence in microbial community function.

Discussion and Outlook

The standardized protocol outlined here enables robust identification of consistent resistome and functional patterns across diverse studies. The re-analysis of 26 case-control studies confirmed that diseases commonly treated with antibiotics, like cystic fibrosis and diarrhoea, are strongly associated with expanded gut resistomes [73]. Applying this framework to couples' microbiome research opens new avenues for investigating health dynamics. The documented microbiome similarity in cohabiting partners [1], combined with the potential for resistome expansion under selective pressure [73], suggests that couples may develop a shared reservoir of antibiotic resistance. This has profound implications for understanding the spread of ARGs within households and for designing targeted interventions.

Future applications of this protocol should integrate multi-omics data to explore host-microbe interactions underlying the observed functional similarities. Furthermore, longitudinal sampling of couples will be crucial to establish causality and understand the temporal dynamics of microbial and resistome convergence. This approach solidifies the concept of the couple as a critical unit of analysis for advancing our understanding of microbiome-associated health outcomes.

The human microbiome, the complex ecosystem of microorganisms inhabiting our bodies, is increasingly recognized as a biomarker for various health states. Recent research has expanded this concept to the dyadic level, investigating whether cohabiting partners share similar microbial communities. This application note explores the compelling evidence that microbiome data can indeed identify couples with significant accuracy, framing this predictive power within protocols for analyzing couples' microbiomes and their health implications. The convergence of partners' microbial profiles arises from sustained close contact, shared environments, and intimate behaviors, creating a "social microbiome" with potential predictive value for relationship research, personalized medicine, and public health interventions.

Cohabitation has a profound influence on human biology, extending to microbial ecosystems. Studies demonstrate that couples living together exhibit significant similarities in their gut, oral, and skin microbiomes, with metagenomic analyses revealing measurable strain sharing between partners [1]. This convergence provides the biological foundation for using microbiome data to identify coupled pairs. Beyond mere academic interest, this predictive capacity offers insights into microbial transmission dynamics, co-adaptation processes, and their collective implications for reproductive health, metabolic disease risk, and child development [1].

The investigation of couples' microbiome similarity represents a paradigm shift from individual-focused analyses to dyadic approaches that recognize the interconnected nature of human health. By establishing protocols for assessing the predictive power of microbiome data in identifying couples, researchers can leverage this biological phenomenon to advance understanding of how intimate relationships shape our microbial selves, with broad implications for disease prevention and health promotion.

Background and Rationale

Scientific Foundations of Microbial Similarity in Couples

The conceptual framework for using microbiome data to identify couples rests on robust evidence of microbial sharing between cohabiting partners. Research integrating microbiome data has demonstrated that spouses possess significantly more similar gut microbiota compositions and share more bacterial taxa than either siblings or random unrelated pairs, despite siblings sharing genetics and upbringing [1]. Notably, these similarities persist after adjusting for dietary factors, indicating that marital cohabitation itself exerts influence on the gut microbiome independent of shared nutrition [1].

Physical interaction represents a primary mechanism for microbial exchange between partners. Studies indicate that an intimate 10-second kiss can transfer approximately 80 million bacteria between partners, with frequent kissing leading couples to develop a shared salivary microbiome over time [1]. The skin microbiome shows particularly strong partner influence, with one landmark study finding that partners' skin microbiomes were significantly more similar than expected by chance, especially on the feet where shared environments facilitate microbial exchange [1]. Remarkably, algorithms could identify couples with approximately 86% accuracy based solely on skin microbiome similarity, underscoring the predictive potential of microbial profiling [1].

Methodological Considerations for Predictive Analysis

The statistical analysis of microbiome data presents unique challenges that must be addressed in couple identification protocols. Microbiome data are typically characterized by zero inflation (excessive zero values), overdispersion (variance exceeding the mean), high dimensionality (many more microbial features than samples), and compositional nature (relative abundance data) [17]. These characteristics necessitate specialized analytical approaches that account for the complex structure of microbial data while maintaining statistical power for couple discrimination.

Furthermore, technical variability in sequencing depth, DNA extraction methods, and batch effects can introduce noise that obscures biological signals [17] [25]. Robust experimental protocols must incorporate normalization strategies and batch effect correction methods to ensure that observed similarities truly reflect partner relationships rather than technical artifacts. The Strengthening The Organization and Reporting of Microbiome Studies (STORMS) checklist provides comprehensive guidance for reporting microbiome studies to enhance reproducibility and comparative analysis [25].

Quantitative Evidence of Couple Similarity

Research across multiple body sites has generated quantitative benchmarks for microbial similarity between partners, providing a foundation for predictive models. The table below summarizes key findings from recent studies on couple microbiome similarity:

Table 1: Quantitative Evidence of Microbiome Similarity in Couples

Body Site Similarity Metric Quantitative Finding Reference
Gut Strain Sharing Median ~12% shared strains [1]
Oral Strain Sharing Median ~32% shared strains [1]
Skin Classification Accuracy ~86% couple identification accuracy [1]
Saliva Bacterial Transfer ~80 million bacteria transferred in 10-second kiss [1]
Multiple Sites Overall Similarity Significant similarity across gut, oral, skin, and genital sites [1]
Gut Diversity Married individuals show greater microbial diversity than singles [1]

The elevated partner similarity in oral compared to gut microbiomes likely reflects more frequent and direct microbial exchange through behaviors like kissing, while gut microbial convergence may depend more on shared environmental factors and diet over longer timeframes [1]. The striking accuracy of couple identification based on skin microbiomes underscores the powerful effect of shared physical environments and direct contact on microbial communities [1].

Beyond simple similarity measures, couples exhibit convergence in functional potential of their microbial communities. Metagenomic studies have revealed that partners share not only microbial strains but also genetic functional pathways, suggesting that their microbiomes may influence health outcomes through coordinated metabolic capabilities [1]. This functional convergence provides additional dimensions for predictive models seeking to identify couples based on microbiome data.

Experimental Protocols

Study Design and Sample Collection

Robust experimental design is essential for assessing the predictive power of microbiome data for couple identification. The following workflow outlines key stages in the experimental protocol:

G A Study Population Recruitment B Sample Collection Multi-site Protocol A->B C DNA Extraction & Library Preparation B->C D Sequencing & Quality Control C->D E Bioinformatic Processing D->E F Statistical Analysis & Model Building E->F G Validation & Performance Metrics F->G

Figure 1: Experimental workflow for assessing microbiome-based couple identification

Population Recruitment and Ethical Considerations: Studies should recruit couples with varying cohabitation durations to assess time-dependent effects on microbiome similarity. Inclusion criteria should specify minimum cohabitation periods (e.g., ≥6 months) to ensure adequate opportunity for microbial exchange. Control groups of age- and sex-matched unrelated individuals from similar geographical areas are essential for establishing baseline similarity measures. Ethical review must address the particular privacy concerns of couple-based research, especially regarding relationship status and intimate behaviors [25].

Multi-site Sample Collection: Comprehensive assessment requires sampling from multiple body sites to capture the full spectrum of microbial sharing. Protocols should include:

  • Gut microbiome: Collection of fecal samples using pre-moistened wipes or stool collection kits with preservation solutions (e.g., modified Cary-Blair medium) to maintain microbial viability [75].
  • Oral microbiome: Collection of saliva samples (5 ml in sterile tubes) or buccal swabs from inner cheeks [75].
  • Skin microbiome: Swabbing of standardized skin sites (e.g., forearms, feet) using flocked nylon swabs [75].
  • Vaginal/penile microbiome: For studies including genital sites, collection by healthcare professionals using appropriate swabs [75].

All samples should be immediately frozen at -20°C or -80°C until processing to prevent microbial growth that could bias results [75]. Standardized collection kits with detailed instructions improve consistency across participants collecting samples at home [75].

Laboratory and Bioinformatics Processing

DNA Extraction and Sequencing: DNA should be extracted using kits validated for microbiome studies to ensure efficient lysis of diverse microbial taxa. For 16S rRNA sequencing, amplification should target the V4 or other appropriate hypervariable regions using barcoded primers to enable multiplexing. Shotgun metagenomic sequencing provides higher resolution for strain-level analysis but at greater cost [17]. Quality control measures should include negative extraction controls and positive mock community controls to monitor contamination and technical variability [25].

Bioinformatic Processing: Raw sequencing data requires rigorous processing:

  • For 16S rRNA data: Use DADA2 or Deblur to generate amplicon sequence variants (ASVs) rather than operational taxonomic units (OTUs) for higher resolution [17].
  • For shotgun metagenomic data: Perform quality filtering, host DNA depletion, and taxonomic profiling using tools like MetaPhlAn 4 for species-level identification [1].
  • Strain-level analysis: Apply tools like StrainPhlAn or inStrain to identify shared bacterial strains between partners using single-nucleotide polymorphism patterns [1].

Table 2: Essential Research Reagents and Computational Tools

Category Item Function/Application Examples/Alternatives
Sample Collection Flocked nylon swabs Microbial collection from skin/mucosal surfaces Copan Diagnostics swabs [75]
Stool collection kit Fecal sample preservation & transport Modified Cary-Blair medium [75]
Saliva collection tubes Standardized saliva sample acquisition 50ml conical tubes [75]
Laboratory DNA extraction kits Microbial DNA isolation MoBio PowerSoil Kit, DNeasy Blood & Tissue Kit
Sequencing kits Library preparation for NGS Illumina MiSeq, NovaSeq
Bioinformatics Taxonomic profilers Species-level identification MetaPhlAn 4 [1]
Strain analysis tools Strain-level sharing analysis StrainPhlAn, inStrain [1]
Statistical frameworks Differential abundance testing DESeq2, edgeR, metagenomeSeq [17]
Diversity analysis Alpha/beta diversity calculations QIIME 2, phyloseq [17]

Statistical Analysis and Predictive Modeling

Similarity Quantification: Calculate within-couple similarity using distance metrics such as Bray-Curtis dissimilarity, Jaccard index, or UniFrac distances. Compare these values to between-couple distances using permutation tests to establish statistical significance. For strain-sharing analysis, apply stringent thresholds (e.g., average nucleotide identity >99% and breadth of coverage >80%) to minimize false positives [1].

Predictive Model Building: Develop classification models to distinguish couples from non-couples:

  • Apply machine learning algorithms (random forests, support vector machines) trained on microbial abundance profiles.
  • Use nested cross-validation to avoid overfitting, especially with high-dimensional microbiome data.
  • Evaluate model performance using receiver operating characteristic curves, precision-recall curves, and balanced accuracy metrics.
  • For comparison, establish baseline performance using demographic data alone.

Dyadic Analytics: Implement specialized statistical approaches for paired data:

  • Use mixed-effects models to account for the non-independence of partners' data.
  • Apply actor-partner interdependence models to examine bidirectional influences on microbiome composition.
  • Conduct permutation tests for multivariate analyses like PERMANOVA to assess overall microbiome similarity between partners [76].

Expected Results and Interpretation

Anticipated Findings

Well-executed studies following this protocol should yield several key outcomes:

  • Elevated similarity metrics: Partners should show significantly reduced beta-diversity distances compared to unrelated pairs across multiple body sites, with strongest effects expected for skin and oral microbiomes [1].
  • Measurable strain sharing: Analysis should detect shared microbial strains between partners, with median rates around 12% for gut microbes and 32% for oral microbes [1].
  • Successful classification: Predictive models should achieve high accuracy (potentially >85% for skin microbiomes) in distinguishing couples from non-couples based solely on microbiome profiles [1].
  • Cohabitation duration effects: Microbial similarity should correlate positively with relationship duration, reflecting gradual convergence over time [1].

The following diagram illustrates the key analytical pathways and expected outcomes when assessing couple identification using microbiome data:

Figure 2: Analytical pathway for microbiome-based couple identification and health implications

Interpretation and Contextualization

When interpreting results, researchers should consider several contextual factors:

  • Relationship behaviors: Similarity may vary with intimacy levels, co-sleeping, pet ownership, and other relationship characteristics that influence microbial exchange [77] [1].
  • Demographic factors: Age, socioeconomic status, and geographic location may affect microbiome composition independently of partnership status [25].
  • Health status: Shared disease states or medication use (especially antibiotics) may concurrently affect both partners' microbiomes, potentially confounding similarity measures [77] [25].
  • Temporal dynamics: Microbial similarity may fluctuate over time in response to life events, travel, or health changes, suggesting the value of longitudinal sampling [1].

The predictive power of microbiome data for couple identification should be interpreted as evidence of shared environments and behaviors rather than necessarily indicating health outcomes. While some studies suggest that relationship quality correlates with microbiome diversity [1], causal relationships remain speculative and require further investigation.

Troubleshooting and Technical Considerations

Common Methodological Challenges

Several technical challenges may arise when implementing this protocol:

  • Batch effects: Systematic technical variation between sequencing batches can create spurious similarity patterns. Implement batch correction methods such as ComBat or remove unwanted variation (RUV) approaches [17].
  • Low biomass samples: Skin and oral samples may yield limited DNA, increasing susceptibility to contamination. Include extraction controls and use low-biomass optimized protocols [75].
  • Missing data: Participant compliance with self-collection protocols varies. Plan for adequate sample sizes to account for potential dropouts [75] [25].
  • Privacy concerns: Couple-based research raises unique confidentiality issues. Implement robust data anonymization and secure storage solutions [25].

Validation and Reproducibility

To ensure robust and reproducible findings:

  • Follow reporting guidelines: Adhere to the STORMS checklist for comprehensive reporting of microbiome studies [25].
  • Public data deposition: Share raw sequencing data in public repositories such as the Sequence Read Archive to enable independent verification.
  • Code availability: Provide analysis scripts to facilitate method reproduction and extension.
  • Multi-cohort validation: Validate predictive models in independent populations to assess generalizability across diverse demographics and environments.

This application note outlines a comprehensive protocol for assessing the predictive power of microbiome data to identify couples, bringing together evidence from microbial ecology, statistical methodology, and relationship science. The substantial similarity between partners' microbiomes across multiple body sites, particularly the demonstrated ~86% classification accuracy based on skin microbiomes, provides a compelling basis for using microbial profiles as biomarkers of couple relationships [1].

The protocols detailed here emphasize rigorous experimental design, appropriate statistical handling of microbiome-specific data challenges, and thoughtful interpretation within relationship and health contexts. As research in this area advances, microbiome-based couple identification may find applications in understanding relationship quality, tracking microbial transmission dynamics, and designing targeted interventions for shared health risks.

Future directions should focus on longitudinal studies to track microbial convergence throughout relationship development, investigation of the mechanisms underlying partner similarity, and exploration of how couple-level microbial profiles influence shared health outcomes. By standardizing approaches to assessing microbiome-based couple identification, researchers can accelerate progress in understanding the dyadic nature of the human microbiome and its implications for health and disease.

Conclusion

The analysis of couples' microbiomes provides a powerful, dyadic framework for understanding how intimate social relationships get under the skin, influencing health and disease. This protocol synthesizes a reproducible path from foundational concepts and methodological rigor to analytical validation, establishing the couple as a critical unit of analysis in biomedical research. The key takeaways underscore that microbial sharing is a measurable phenomenon with direct implications for managing conditions like bacterial vaginosis recurrence, optimizing fertility, and understanding the shared risk of metabolic diseases. Future directions must focus on longitudinal studies to establish causality, the integration of multi-omics data to elucidate mechanisms, and the translation of these findings into couple-based clinical interventions and therapeutic strategies, ultimately paving the way for a new era in personalized and partner-informed medicine.

References